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Abstract 
Streptococcus pneumoniae (pneumococcus) is a gram-positive bacterium that can cause 
significant morbidity and mortality in humans especially in children and elderly. T 
regulatory cells (Treg) have an important role in modulation of immune responses to 
microbial infection. Although Th17 cells are involved in autoimmune diseases, these cells 
may play a protective role against pathogens. In this PhD project, Th17 and Treg cells in 
nasal-associated lymphoid tissue were characterised and their relationship with 
nasopharyngeal carriage of pneumococcus studied in children and adults.  
Frequencies of Th17 and Treg in tonsillar tissue and peripheral blood samples obtained 
from children and adults were analysed for intracellular expression of IL17A and Foxp3 by 
flow cytometry. Also, tonsillar MNC and PBMC were stimulated by pneumococcal culture 
supernatant (CCS) derived from wild type stain D39. The ratio of Th17/Treg cells in NALT 
was studied in both children and adults together with their association with pneumococcal 
carriage. 
Numbers of Th17 and Treg cells in in tonsillar tissues were shown to be significantly 
higher than in peripheral blood in both children and adults. The ratio of tonsillar Th17/Treg 
was shown to increase with age and tended to be higher in pneumococcal culture-
negative children than in culture-positive. It is suggested that the balance of Th17/Treg is 
a crucial determinant of pneumococcal clearance or persistence/carriage in human 
nasopharynx. A significant increase in numbers of Th17 and Treg cells were shown 
following pneumococcal CCS stimulation. CCS derived from isogenic mutant strains (i.e., 
Ply- and CbpA-) elicited lower numbers of Th17 and Treg cells. It is suggested that 
pneumococcal proteins including Ply and CbpA may activate Th17 and Treg cells in 
human NALT, and therefore may contribute to the regulation of pneumococcal carriage or 
clearance in human nasopharynx.  Induction of Th17 and Treg from tonsillar MNC were 
studied using tonsillar MNC depleted of activated and memory T cells. Stimulation with 
pneumococcal CCS induced Th17 from naïve T cells in tonsillar MNC in the presence of 
exogenous cytokines (i.e., TGF-β/IL21/IL1-β). TGFβ was shown to be crucial in Treg 
induction. Thus, the induction of both Th17 and Treg in human tonsillar tissue may be 
common in humans especially in children during natural infection/carriage, and the 
balance of the two may determine the clearance or carriage of pneumococcus in 
nasopharynx. Pneumococcal proteins including pneumolysin (Ply), its toxoid (PdB) and 
choline binding proteins (CBP) were shown to activate and promote Treg and Th17 cells in 
tonsillar MNC, thus they may play an important part in modulation of pneumococcal 
carriage in human nasopharynx. 
Understanding the development of natural immunity to pneumococcus and to 
pneumococcal proteins in particular may provide important information in the development 
of protein-based vaccines against pneumococcal infection in humans.  
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1.1  Streptococcus pneumoniae 
Streptococcus pneumoniae (pneumococcus) is a gram positive and encapsulated 
bacterium. This bacterium was first identified in 1880 and was described 
independently by Sternberg and Pasteur through incubation of injected rabbits with 
human saliva; Pasteur used saliva from a child who had died from rabies, whereas 
Sternberg used his own saliva. After that instant development of septicaemic 
disease was observed (Watson et al. 1993). Globally, this pathogen is a major 
cause of morbidity and mortality among risk groups, including young children, 
elderly people and immunodeficient patients. It can cause a range of diseases 
such as acquired meningitis, septicaemia, and pneumonia. Also, it can cause 
acute otitis media in children (O'Brien et al. 2009).   
Pneumococcus is a common cause of respiratory tract infections in both 
developing and developed countries, especially the former. Annually, 
pneumococcal diseases are responsible for around 1 million deaths of young 
children under 5 years (Obaro & Adegbola 2002). Healthy individuals are colonized 
the upper respiratory tract (URT) by asymptomatic pneumococcus. Approximately 
40-50% of infants (0-2 years) in the United Kingdom are colonized by 
pneumococcus (Hussain et al. 2005), whereas the prevalence of nasopharyngeal 
carriage in African infants with the same age group, ranging from 48-90% 
(Abdullahi et al. 2008; Hill et al. 2008; Obaro et al. 1996). In humans, the main 
reservoir for S. pneumoniea is nasopharynx. Colonisation with pneumococcus in 
the nasopharnyx is very common in infants, reaching 90% of carriage rates 
(Bogaert, De Groot & Hermans 2004). However, the rates of carriage decrease 
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thereafter to 10% in late childhood and adults (Granat et al. 2009). Because of the 
high rates of pneumococcal colonisation in children, they may play a vital role in 
the transmission of the community between different individuals. Pneumococcal 
colonisation in some individuals can lead to infections. It might be due to 
acquirement of a recent serotype rather than the existing serotype in 
nasopharyngeal compartment (Obaro & Adegbola 2002). There was a gradual 
decrease of the duration of the pneumococcal carriage for specific serotypes (6, 9, 
14, 15, 19, and 23) with age. Between 1995 and 2003 in Sweden the mean 
duration of carriage in younger children under age of 5 was 43 days which is 
longer than older children (25 days). Also it was shown that in children aged 
<1years (74 days), 1-2 years (47 days), 3-4 years (34 days) (Hogberg et al. 2007).  
	  
1.2  Virulence factors of pneumococcus 
S. pneumoniae has several ways to invade and modulate the host defence by 
using their virulence factors. These factors range form the polysaccharide capsule 
to cell surface proteins and all have different roles in protecting pneumococcus 
from the immune system (Figure1.1.).  
The definite etiological agent of pneumococcus is polysaccharide capsule. 
Although there are at least 93 distinct capsule serotypes which have been 
identified, just several of these account for the majority of pneumococcal infection. 
The most common serotypes in younger children are 6B, 9V, 14, 19F and 23F 
(Henriques-Normark & Tuomanen 2013).  
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Polysaccharide capsules have many functions. They enable the bacteria easily to 
evade the host immune system. Pneumococcus can remain protected from 
polymorphonuclear (PMN) leukocyte attack thanks to their polysaccharide capsule 
which protect them against phagocytosis and enable them to induce inflammation 
and disease (Kadioglu et al. 2008). This capsule delay complements attachment 
and immunoglobulins (Ig) with bacterial cell wall (Mitchell & Mitchell 2010). Also, 
pneumococcus can be protected from mucus and easily reach the epithelial 
surface due to the negative charges of capsules (Henriques-Normark & Tuomanen 
2013). Capsulated and unencapsulated pneumococus can bind to mucus of 
human upper airway. A study has demonstrated that unencapsulated pneumococci 
were trapped into the cell surface mucus and incapable to be free. However, 
encapsulated pneumococci were capable to escape from mucus binding and 
therefore attach to the epithelial cells to initiate nasopharyngeal colonisation 
(Nelson et al. 2007). 
 
There are several virulence factors beside capsule types including cell wall, 
pneumolysin, surface proteins, autolysin, neuraminidase, peptide permeases, 
hydrogen peroxide (H2O2) and IgA protease ('Should We Develop an Inhaled Anti-
pneumococcal Vaccine for Adults?'  2005). Several proteins of pneumococci 
including pneumolysin, pneumococcal surface protein A (PspA), pneumococcal 
surface adhesin A (PsaA), and choline-binding protein A (CbpA) have been 
studied as vaccine candidates (Kadioglu et al. 2008) (see Table 1.1).  
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Figure 1.1 Streptococcus pneumoniae virulence factors.  
The capsule; the cell wall; choline-binding proteins; pneumococcal surface proteins A and C (PspA 
and PspC); the LPXTG-anchored neuraminidase proteins; hyaluronate lyase (Hyl); pneumococcal 
adhesion and virulence A (PavA); enolase (Eno); pneumolysin; autolysin A (LytA); and the metal-
binding proteins pneumococcal surface antigen A (PsaA), pneumococcal iron acquisition A (PiaA) 
and pneumococcal iron uptake A (PiuA;).  Adapted from (Kadioglu et al. 2008).  
 
Pneumolysin is the most widely studied pneumococcal protein virulence factor. It is 
a member of the cholesterol-dependent cytolytic (CDC) pore-forming toxins family 
(~53-kDa). It has many activities, such as classical complement activation 
(Kadioglu et al. 2008), stimulation of host cell apoptosis, binds to cholesterol 
molecules in the host cells plasma membrane and then enters into membrane to 
form a pore 350 to 450 Å in diameter (Price & Camilli 2009). In term of the 
activation of complement, the deposition of C3b on cells surface was more 
observed on the Ply and PspA-mutant strains and on the unencapsulated 
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pneumococci. In strains deficient for Ply, PspA and PspC, the clearance of 
pneumococci from the blood stream has been shown (Quin, Moore & McDaniel 
2007). It has been shown that pneumococcal strains can release the Ply into the 
culture supernatant despite the absence of cells autolysis. This phenomenon is 
occurred especially at the beginning of the stationary phase. Thus, the release of 
Ply can be autolysis-independent (Price & Camilli 2009).  
Additionally, it was shown that Ply could activate the nucleotide-binding 
oligomerization domain (Onoda et al.) receptors, Leucine rich repeat and Pyrin 
domain containing proteins (NLRP) inflammasome which are members of NLR 
(Nod-like receptors) (McNeela et al. 2010; Tian, Pascal & Monget 2009) and in 
turn activates caspase-1. The activation of caspase-1 is very important to generate 
the active form of cytokines such as IL-1 and IL-18. Both cytokines have role in an 
inflammatory response and recruitment the immune cells to the site of infection 
(Dinarello 2009).   
Choline Binding Proteins (CBP) bind to the cell wall of pneumococci non-
covalently. Generally, they comprise three different segments; leader peptide, N-
terminal domains and conserved choline binding domain (CBD). Thirteen to 
sixteen CBPs can be generated from pneumococci (Bergmann & Hammerschmidt 
2006). One of CBPs is the pneumopcoccal surface protein C (PspC) also known 
as choline binding protein A (CbpA) (Quin, Moore & McDaniel 2007). The 
molecular weight of PspC protein is ~75Kda and this virulence factor has many 
functions (Jedrzejas 2001). The main role of this protein is to promote the 
pneumococcal adherence either to nasopharynx causing colonisation or lung 
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epithelia cells. This interaction facilitates translocation of the pathogen across the 
layer of epithelial cells. Thus it might facilitate the host cell invasion by 
pneumococci (Ogunniyi et al. 2007).  
PspC is capable of binding to the secretory component of human secretory 
immunoglobulin A, human factor H and complement component C3 (Ogunniyi et 
al. 2007). The adherence of PspC to that niche is through the interaction with the 
secretory component (SC) which known as the ectodomain of polymeric 
Immunoglobulin receptors (PIgR). A study demonstrated that PIgR knockout mice 
had a reduced colonisation if PspC lost its function (Bergmann & Hammerschmidt 
2006). This protein seems to be expressed by most isolates and contributes to 
pneumococcal colonisation. Some studies of mice revealed that using this protein 
and other pneumococcal proteins such as pneumolysin, PspA, and PsaA in 
intranasal immunisation can protect against multiple serotypes of pneumococci 
and/or prevent pneumococcal carriage (Briles et al. 2000a; Briles et al. 2000b; 
Ogunniyi et al. 2001) therefore, CbpA is likely a candidate vaccine against 
nasopharyngeal carriage of pneumococcus. The ability of PspC to adhere to 
nasopharynx epithelial cells may contribute to the prolonged colonisation of the 
nasopharynx (Zhang, Choo & Finn 2002).  
 PspA has been demonstrated in mice to be important in invasive pneumococcal 
infections. PspA immunization has been shown in mice to induce protection 
against pneumococcal infection and nasal carriage (Shaper et al. 2004). 
Pneumococcus has the ability to bind lactoferrin which is source of iron and is 
considered bactericidal (Bergmann & Hammerschmidt 2006). There are many 
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sources of lactoferrin such as tears and saliva and it might protect against nasal 
ccolonisation. According to Shaper et al., pneumococci can be protected from the 
killing effect by PspA expression (Shaper et al. 2004). It has been showed by Baril 
and collogues (Baril et al. 2006) that PspA has an efficient ability to trigger CD4+ T 
cells and antibody responses. Thus it suggested that this pneumococcal protein 
antigen is effective vaccine against pneumococcal carriage (Baril et al. 2006).     
A number of pneumococcal proteins have been studied in individual immunizations 
to induce protection against infection of pneumococci and nasopharyngeal 
carriage (Briles et al. 2000a; Briles et al. 2000b). PsaA, pnuemolysin, and PspA 
are expressed by nearly all of pneumococcal isolates (Morrison et al. 2000; Paton 
1998; Zhang, Choo & Finn 2002). Because Ply and CbpA are important virulence 
factors and have been shown to induce protective immunity (Mureithi et al. 2009; 
Zhang et al. 2007), both proteins as well as the PdB derivative of pneumolysin are 
used as antigens in this study. 
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Table 1.1 The main role of pneumococcal virulence factors in ccolonisation and 
disease.   
Adapted from (Kadioglu et al. 2008). 
 
 
 
Pneumococcal virulence 
factors  
 
Main function 
 
Upper-airway colonisation:  
Capsule 
1- Prevents entrapment in the nasal mucus, thereby allowing 
access to epithelial surfaces. 
2- Suppresses effective opsonophagocytosis 
ChoP Binding of rPAF on the epithelial surface of the nasopharynx.  
CbpA (also known as PspC) 
Binds to human SC on a PIgR during the first step of translocation 
across the epithelium. 
 
Hyaluronidase Cleavage of extracellular matrix components that has hyaluronan 
 
Respiratory-tract infection 
and pneumonia 
 
 
Ply 
1- Complement activation.  
2- Wide range of effects on host immune components at 
sub-lytic concentrations. 
 
PspA 1- Lactoferrin binding. 2- Avoid binding of C3 onto pneumococcal surface.  
LytA Facilitate the release of pneumolysin.  
PsaA Component of the ABC transport system, which is involved in resistance to oxidative stress 
PiaA and PiuA Component of the ABC transport system. 
IgA Breakdown IgA1.  
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1.3  Pneumococcal colonisation  
Pneumococcus is opportunistic microorganism capable of colonising the upper 
respiratory tract and it can cause invasive disease, especially in the high-risk 
groups. Since pneumococci can colonize in the nasopharynx, mucosal vaccination 
may be an effective way to protect against mucosal infection. Some studies in 
mice models have revealed that the immunization with pneumococcal antigens, 
including PspA, pneumolysin, PsaA, and CbpA by intranasal route, are more 
efficient against invasive disease as well as nasopharyngeal carriage (Alexander 
et al. 1994; Briles et al. 2000a; Briles et al. 2000b; Paton 1998), especially if there 
is a combination of virulence proteins factors. It has been recommended that non-
capsular-based vaccine can probably protect both human and mice from 
pneumococcal proteins (Richards et al. 2010).   
 
1.3.1 Mechanisms of pneumococcal colonisation 
Pneumococcal outer surface is a highly heterogeneous and immunogenic 
polysaccharide capsule, which is considered as a significant virulence factor of 
pneumococci as a shield protecting them from phagocytosis, and crucial for 
colonisation. The next layer which comprises polysaccarides and teichoic acid is 
named the cell wall. This surface is crucial for stimulating immune response 
especially the inflammatory cells and triggering the complement cascade and 
cytokine production. The dynamic inflammatory reaction, which is caused by the 
pneumococcal cell wall, is the primary trigger to ccolonisation (Bogaert, De Groot 
& Hermans 2004).  
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The establishment of ccolonisation is by adhering S. pneumoniae with epithelial 
cells of the respiratory tract. Cell wall associated surface proteins such as PsaA 
binds to cell surface receptor of epithelial cell termed N-acetylglucosamine that is 
exposed after the cleavage of mucus layer by neuraminidase. Pneumococcal 
colonisation is generally not followed by symptomatic disease (Bogaert, De Groot 
& Hermans 2004) unless the local production of inflammatory factors such as IL-1 
and TNF are triggered (Tuomanen 1997).  
Subsequently, the receptors on the epithelial and endothelial cells are subjected to 
change by the cascade of inflammatory response. One of those receptors named 
platelet activating factor receptor (PAFr) which is up-regulated by the inflammatory 
factors shows a high affinity to the pneumococcal cell wall choline. When the 
binding occurs, pneumococci migrate through the epithelial cells of the respiratory 
tract leading to the invasion (Baril et al. 2006). Moreover, there is an increased 
affinity of choline binding protein A (CbpA) toward sialic acid and lacto-N-
neotetreose on human cells that are activated by cytokines, and binds directly to 
the polymeric Ig receptor (pIgR), and thus the migration through the mucosal 
barrier (Balachandran et al. 2002). It has been recently revealed that IgA 
proteases of pneumococcus strongly adhere to epithelial cells of the lung in the 
presence of human IgA (Weiser et al. 2003). Therefore, the cleavage of opsonising 
IgA by pneumococcal IgA1 protease lead to in a modification (neutralisation) of 
surface charge (Weiser et al. 2003). In addition, CbpA is capable of bind secretory 
component of Immunoglobulin A (S-IgA) and thus associate with the complement 
pathway which compose the immune response (Balachandran et al. 2002; 
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Hammerschmidt et al. 1997). The activity of virus (influenza) protein such as 
neuraminidase may contribute to the improvement of pneumococcal adherence, 
especially in the presence of viral infection (Bogaert, De Groot & Hermans 2004). 
Both IgA and IgG antibodies specific to pneumococcal strains have been shown to 
contribute to killing pneumococcus and in the reduction of pneumococcal carriage 
in the presence of complement and phagocytes (Weiser et al. 2003). But IgA1 
protease enables the pneumococcus to interact and persist on the mucosal 
surface of the host tissue (Weiser et al. 2003).      
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Figure 1.2 Interaction between pneumococcal surface proteins and epithelial cell 
components in the mucosal cavity.  
The thickness of the layer of mucus is reduced by neuraminidase (NanA) which in turn exposes the 
N-acetylglycosamine (GlcNAc) receptors on the epithelial cells. Then after, that receptor interacts 
with pneumococcal PsaA. The platelet-activating-factor receptors (PAFr) is upregulated by 
epithelial cells in response to cytokine trigger. There was a strong affinity between cell-wall 
phosphocholine (ChoP) and PAFr. CbpA binds to the polymeric Ig receptor (pIgR) directly which 
results in microbial passage via the mucosal barrier (transcytosis). The cleavage of opsonising IgA 
is occurred by IgA1 protease. Consequently, this action changes the charge of pneumococcal 
surface and in turn enhances the attachment ChoP to the PAFr. Adapted from (Bogaert, De Groot 
& Hermans 2004).	  
 
1.4  Mucosal immune system 
The mucosal immune system is the first line of physical and immunological 
defence against invaders. Mucosal-associated lymphoid tissue (MALT) is a 
general term for mucosal immune system in humans which includes 1) 
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gastrointestinal-associated lymphoid tissue (GALT), 2) bronchial/nasopharynx-
associated lymphoid tissue (B/NALT). Mucosal tissue covers large area of human 
body and is unique in its structure and function. It provides protection to humans 
through induction of mucosal immunity, which depends on lymphocytes activation 
within MALT (Lee, Lee & Gu 2005). 
Mucosal immune system consists of induction and effector sites. Induction site 
includes the Peyers patches (PP) in the gut and NALT in the oropharyngeal cavity, 
which are two major compartments of the MALT.  Effecter site includes mucosal 
lamina propria (LP) and glandular tissue. Both inductive and effector sites are 
under the term of mucosal immune system working together to generate antigen-
specific immune responses at mucosal surfaces (Kiyono & Fukuyama 2004).      
Waldeyer’s ring in humans consists of the main inductive sites in NALT. The nasal 
route has been considered an effective way of vaccine administration for both 
mucosal and systemic antibody production (Brandtzaeg 2011). Nasopharyngeal 
tonsil (adenoids), and paired plataine tonsils are major components in Waldeyer’s 
ring in addition to lingual tonsils, tubal tonsils and lateral pharyngeal bands (Dolen, 
Spofford & Selner 1990). Human tonsils are composed of several different specific 
tissue sections all compartments of which take part functionally in the immune 
response (Brandtzaeg 2011). 
 
1.5  Mucosal immunity against pneumococcal ccolonisation 
There are various immune cells in nasopharynx involved in preventing bacterial 
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colonisation. The host immune responses against pneumococcus include 
phagocytes (neutrophils and macrophages), T cells and B cells that produce 
antibodies to different targets such as proteins and polysaccharides of S. 
pneumoniae. Both arms of host defence mechanisms (innate and adaptive 
immunity) are required against S. pneumoniae (Jambo et al. 2010). 
 
1.5.1 Innate immune response to S. pneumoniae 
During colonisation, innate immune response is considered the first and early non-
specific defence, which has the ability to act fast against diverse array of 
pathogens. Also, it is very important to initiate adaptive immune response including 
T cell and B cell responses. Many immune cells participate to protect the host from 
any intruder, including macrophages neturophils, natural killer (NK) cells and 
innate-like T (iLT) cells.  
 
1.5.1.1 Role of complement against S. pneumoniae  
Complement is considered a bridge between innate and adaptive immune 
response. The classical pathway of complement activation is predominant major 
pathway for innate immunity against pneumococcal infections in mediating a 
clearance of pneumococcus (Brown et al. 2002).  
The complement system incorporates three different pathways: classical pathway, 
alternative pathway and lectin pathway. All three pathways require the main 
component of complement (C3) which when activated leads to the clearance of 
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microorganism (Kadioglu & Andrew 2004). Opsonophagocytosis by macrophages 
and neutrophils and inflammation induction both result from deposition of 
complement components on the surface of foreign antigens and followed by 
microbial degradation by forming membrane attack complex (MAC). A contribution 
of acute phase proteins, e.g. serum amuloid protein and C-reactive protein (CRP) 
are found to be crucial for the activation of classical pathway during pneumococcal 
infections. Moreover, direct binding of C1q to the surface of pneumococcus is 
involved (Brown et al. 2002; Kadioglu & Andrew 2004; Mold & Du Clos 2006). In 
contrast to other complement pathway (alternative and lectin), the classical 
pathway is much contributed to protective innate response. The elimination of a 
microorganism begins when the components of complement deposit on its 
surfaces. Pneumococcus use strategies such as capsules, cell wall proteins and 
other antigens to inhibit the complement pathway (Paterson & Orihuela 2010). 
Pneumococcus has polysaccharide capsule that plays a key role in pathogenesis. 
It prevents pathogens from being trapped by mucus and to be 
opsonophagocytosized through mechanism that involves a decrease activation of 
the classical pathway. Complement is key elements in protection against 
pneumococcal infection via opsonophagocytosis ((Brown et al. 2002; Roy et al. 
2002). Co-colonisation of mice with S. pneumoniae and H. influenzae induces 
complement and neutrophil-like cells which help to clear pneumococci from 
nasopharynx through phagocytosis by neutrophils (Lysenko et al. 2005).  
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1.5.1.2 Toll-like receptor (TLR) 
TLRs are part of a family called pathogen recognition receptor (PRRs). These 
receptors can recognize conserved microbial components, known as pathogen-
associated molecular patterns (PAMPs) and trigger inflammatory responses. There 
are more than 10 TLRs discovered in humans, some have been found to 
contribute to pneumococcal infection (Paterson & Orihuela 2010). Once TLRs are 
stimulated by PAMP, the activation of signaling pathways will lead the production 
of inflammatory cytokines. Maturation of dendritic cells is often triggered after TLRs 
are activated, and as a consequence, co-stimulatory molecules and capacity of 
antigen presentation will be induced and enhanced (Janeway & Medzhitov 2002).   
 
1.5.1.2.1 TLR2 
TLR2 receptor is capable of recognising a large selection of microbial ligands, 
including peptidoglycan, lipoproteins, zymosan (Janeway & Medzhitov 2002), and 
pneumococcal lipoteichoic acid (LTA) and cell wall peptidoglycan (Paterson & 
Mitchell 2006). TLR2 normally works by formation of heterodimers with either 
TLR1 or TLR6 (Janeway & Medzhitov 2002; Ozinsky et al. 2000; Takeuchi et al. 
2001). In case of pneumococcal carriage, the role of TLR2 is very essential to 
pneumococcal clearance (van Rossum, Lysenko & Weiser 2005).     
 
It has been investigated that TLR2 knockout mice (TLR2-/-) following intranasal 
infection with pneumococcus revealed a moderate contribution in host response, 
compared with wild type mice. That is due to compensatory and effective role of 
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TLR4 recognition of pneumolysin (Knapp et al. 2004). Moreover, CD14 is a 
membrane-bound and soluble receptor which act as co-receptor along with TLR2 
in order to augment the LPS response (Abeyta, Hardy & Yother 2003), also it can 
contribute to pneumococcal recognition (Schroder et al. 2003).  
 
1.5.1.2.2 TLR4   
TLR4 has been shown to activate the innate immune response to gram-negative 
infections mainly. This receptor has been studied widely inclduing its role to LPS 
response and pneumolysin. TLR4 is involved in the recognition of LPS (Paterson & 
Orihuela 2010; Srivastava et al. 2005), in combination with CD14 (Hoshino et al. 
1999) and LPS-binding protein (LBP) (Hoshino et al. 1999).  
 
Ply was shown to activate TLR4 on macrophages and enhances the pro-
inflammatory response (figure 1.3) which may contribute to invasive disease 
(Malley et al. 2003). To determine the interaction between pneumolysin and TLR4 
during the pneumococcal colonisation, Malley et al has compared between wild 
type and TLR4-deficient mice in a nasopharyngeal carriage model. The findings 
revealed that mice lacking TLR4 were more subjected to colonisation and to 
develop invasive disease (Malley et al. 2003).  
 
However, another study by Rossum and colleagues (van Rossum, Lysenko & 
Weiser 2005) revealed that no difference between wild-type and TLR4-/- mice. The 
use of different bacterial strains might be one of the explanations to the apparent 
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difference. In case of pneumococcal pneumonia, TLR4 has been suggested to 
play a defensive role (Branger et al. 2004) and it has also been suggested that the 
important of TLR4 pneumococcal infections may be restricted to the airway surface 
(Paterson & Orihuela 2010). 
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Figure 1.3 The recognition and initiation of the immune response against 
pneumococcal components by different PPRs. 
TLR2 and TLR4 can recognise cell wall components and Ply respectively. Phagocytic cells 
internalize S. pneumoniae and then a degration in phagosomes. Therefore, bacterial peptidoglycan 
and nucleic acids are released. Unmethylated CpG-containing DNA activates TLR9 within the 
endosomes. The secrestion of NF-kB-dependent cytokines is elicited by TLRs as well as NOD2. 
Adapted from (Koppe, Suttorp & Opitz 2012).  
 
 
1.5.2 Adaptive response to S. pneumoniae 
1.5.2.1 Antibody-mediated response 
It has been long assumed that immunity to extracellular encapsulated bacteria was 
humoral-dependent response. The immune response to pneumococcal 
colonisation and disease has been attributed to antibodies against capsular 
polysaccharide of pneumococcus (Malley et al. 2005). Antibodies to pneumococcal 
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capsular polysaccharide produced by vaccination can provide protection to 
humans (Dagan et al. 2002) and animals (Malley et al. 1998) against colonisation. 
Mice were protected from colonisation when specific antigens administrated 
systemically (Ogunniyi et al. 2000) or intranasally (Briles et al. 2000a).  
However, recent studies have suggested that antibodies to capsular antigens are 
not required for naturally-developed immune protection against carriage following 
exposure to live pneumococci (Trzcinski et al. 2008), and this protection requires 
the presence of CD4+ cells (Malley et al. 2005). A study by McCool et al. also 
showed that pneumococcal carriage clearance was antibody-independent despite 
the presence of antibodies. (McCool et al. 2002).  
Nevertheless, antibodies to capsular polysaccharide of pneumococcus induced by 
vaacination are known to prevent invasive disease and pneumococcal 
colonisation. Both secretory IgA antibodies in mucosal site and IgG in serum may 
mediate protection (Jambo et al. 2010). It is likely that antibodies may contribute to 
protection against pneumococcal ccolonisation/carriage, but recent evidences 
suggest CD4 T cell response, T helper 17 (Th17) in particular, may also be 
important, and perhaps more crucial in promoting clearance of pneumococcal 
carriage (Malley et al. 2005).  
 
1.5.2.2 Cellular-mediated response 
In addition to antibodies, the generation of specific memory T cells against 
pneumococcal antigens can be elicited by pneumococcal colonisation (Zhang, 
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Clarke & Weiser 2009). T cell response is triggered by antigen presenting cells 
(APCs) via PRR signals and induction of cytokine production (Gerosa et al. 2008). 
Protection against colonisation has been suggested to be mediated by CD4+ T 
cells, particularly IL17–producing CD4+ T cells which have the potential to recruit 
neutrophils through the production of chemokines (Malley et al. 2005). On the 
other hand, T regulatory cells have been suggested to be important in mediating 
pneumococcal carriage (Zhang et al. 2011). 
 
1.6  Regulatory T cells 
1.6.1 Classification and function  
Regulatory T cells (Treg) have a crucial role in modulation of different immune 
responses, in microbial infection, allergy, tumours, autoimmunity, and 
transplantation (Lim, Hillsamer & Kim 2004). Natural regulatory T cells (nTregs) 
and inducible or adaptive regulatory T cells (iTregs) are two main subsets of Tregs 
that differ in term of action and generation (Fig.1.4.). The subset of CD4 T cells 
that expresses constitutively the interleukin (IL)-2 receptor alpha-chain (CD25) 
possesses potent immunosuppressive functions toward auto-reactive peripheral T 
cells (Huibregtse, van Lent & van Deventer 2007; Mills 2004). Thymus-derived 
Treg cells (CD4+CD25+Foxp3+) which are known as natural Treg (nTreg) were first 
defined in 1995 by Sakaguchi and colleagues. The mean proportion of these cells 
is approximately 5-10 % of the total CD4+ T cells in thymus, peripheral blood 
(Campbell et al.) and lymphoid tissues (Mills 2004). Once these cells are produced 
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and developed in the thymus, they migrate to the peripheral blood, remain and 
survive in there for normal surveillance of self antigens and avoid autoimmune 
responses (Piccirillo 2008).  
 
In addition to nTreg cells, adaptive or inducible Tregs are derived from 
conventional CD4+ T cells or naïve T cells (non-Treg cells) after exposure to 
antigens and they include IL-10-secreting T regulatory 1 (Tr1) cells and 
transforming growth factor (TGF)-beta-secreting T helper (Th) 3 cells (Miyara & 
Sakaguchi 2007). Table 1.2. showing the difference between these subsets in 
terms of markers expression. Their regulatory activity is mediated by the 
expression of IL10 and/or TGF-β although the specificity of antigens is still elusive 
in terms of inducible Treg cells (Vernal & Garcia-Sanz 2008).  
 
The interactions between T cell receptors (TCR) of CD4+CD25+ Treg cells and self 
peptide-Major Histocompatibility Complexes (MHC), which are expressed by 
thymic stromal cells, is a requirement for CD4+CD25+Treg cell development. In 
contrast to T cell selection in the thymus, avidity interactions between TCR of 
CD4+CD25+Treg cells and self-peptide/MHC, which is presented on the cortical 
epithelial cells, is another necessity to Treg cell development. However, if there is 
a high avidity, the deletion of Treg cells will occur (Fehervari & Sakaguchi 2004). It 
has been stated that in mouse models, the adaptive Treg cells can be induced ex 
vivo in the presence of TGF-β (dependent manner) (Chatila 2005).  
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Figure 1.4 Generation of T regulatory cells.  
Thymus derived regulatory T cells which are termed naturally occurring regulatory T cells (nTreg) 
differentiate in the thymus and migrate to peripheral tissues. Adaptive peripheral inducible 
regulatory T cells (iTreg) differentiate in secondary lymphoid organs and tissues and incorporate 
three different types of cells Tr1, Th3 and CD8 (CD4+CD25+Foxp3-). (Curotto de Lafaille & Lafaille 
2009).  
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Table 1.2 Comparison between natural and inducible Treg cells.  
Adapted from (Abdulahad, Boots & Kallenberg 2010). 
	  
 
(? = not known yet) 
	  
1.6.2 Expression of Foxp3 in T regulatory cells 
The transcription regulator factor forkhead box P3 or winged helix (Foxp3) is a 
chief controller in nTregs development and function (Gavin et al. 2006). The Foxp3 
is a member of the fork-head family of transcription factor. It is characterized by the 
existence of a winged helix DNA-binding domain. Adjacent to forkhead homology 
domain of C-terminal in Foxp3 gene, there are zinc finger motif and a leucine 
Phenotype/feature nTreg Tr1 Tr3 
Place of origin Thymus Periphery Periphery 
L-2Ra (CD25) ++ +/- + 
Foxp3 (activated/resting) +High/+Low _ _ 
CD45RA (activated/resting) -/+ ? ? 
LAG-3 + ? ? 
GITR + - ? 
CTLA-4 + + + 
IL-10 - ++ +/- 
TGF-β +/- +/- ++ 
FR4 ++ ? ? 
CD39 + ? ? 
LAP + ? ? 
IL-1R I/II + ? ? 
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zipper domain. Another N-terminal domain in this gene which has the capability to 
inhibit the transcription from nuclear factor of activated T cells and nuclear factor-
kB (NF-κB) response elements is identified by its high proline content (Chatila 
2005). Transformation of Foxp3 gene can be generated in human subjects from 
any deletion of a single amino acid of these domains. Thus, the function and the 
development of nTregs will be affected. Therefore, the spontaneous development 
of various autoimmune or inflammatory diseases will occur including the human 
genetic disease termed immune dysregulation, polyendocrinopathy, enteropathy-
X-linked syndrome (IPEX) (Miyara & Sakaguchi 2007) and X-linked autoimmunity–
allergic dysregulation syndrome (XLAAD) (Chatila 2005). The loss of nTregs could 
be compensated by infusion of CD4+CD25+Treg cells to prevent those disorders 
(Piccirillo 2008). The expression of Foxp3 in natural CD4+CD25+ Tregs either in 
humans or animal facilitates the control of their development and function. The 
expression of Foxp3 arises at the late stage of double positive T cell development 
in the thymus. The proportion of Treg cells represents approximately 6% of human 
CD4+ subsets. Natural Treg cells (CD4+CD25high) can permanently express Foxp3 
(Gavin et al. 2006).  
 
It has been investigated that nTreg cells can be identified by a low expression of 
CD127 (IL-7-Ra) with a high expression of CD25 (Liu et al. 2006; Seddiki et al. 
2006). By using these surface markers, the percentage of circulating nTreg cells in 
human was around 6-10% of the total of CD4+ cells. Irrespective of CD25 surface 
expression, Foxp3 is considered currently the most specific and reliable molecular 
Chapter 1: General introduction 
Page	  |	  27	  	  
	  
marker either for thymic or peripheral nTreg cells in rodents and humans. It is 
known that the over-expression of Foxp3 in mice has an increased development of 
nTreg cells, and also can suppress the T cell proliferation and cytokine production 
of effector T cells (Piccirillo 2008).  
 
1.6.3 The characteristic markers of Treg cells 
There are a number of constitutive expressions reported on Treg cells in addition 
to CD25 and Foxp3 (Table 1.2.) They include cytotoxic T lymphocyte-associated 
antigen-4 (CTLA-4), glucocorticoid-induced tumor necrosis factor receptor (GITR), 
lymphocyte activation gene-3 (LAG-3) L-selectin (CD62L) integrin αEβ7 (CD103), 
C-C chemokine receptor 7 (CCR7), CCR4, CCR8, and CD39 (Abdulahad, Boots & 
Kallenberg 2010) and neuropilin-1 (Bruder et al. 2004; Fehervari & Sakaguchi 
2004).  
 
It has been shown that CD25 is crucial for nTreg cells (CD4+ CD25high) function. 
Mice that lack CD25 (IL-2Rα) or IL-2 can develop a fatal disease termed IL-2 
deficiency syndrome. According to Fehérvari et al., number of CD4+CD25high Treg 
cells was reduced in healthy mice after the neutralization of IL-2. As a result, 
organ-specific autoimmune diseases may occur. It is suggested that IL-2 is 
indispensable in the development, preservation and the function of 
CD25highCD4+Treg cells (Fehervari & Sakaguchi 2004).  
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GITR molecule is a constitutively expressed marker for nTreg cells and its role in 
CD4+CD25+Treg cells is considered important. The natural ligand for GITR which 
is expressed on APCs (DCs, macrophages, and B cells) is GITRL. Treg cells 
express a low level of IL-7R receptor alpha chain (CD127). This marker has been 
used as a marker to distinguish Tregs from other activated effector T cells. The 
expression of CD127 is correlated with the expression and suppressive function of 
Foxp3, and thus highly purified populations of Treg cells can be sorted by those 
surface markers described previously (Abdulahad, Boots & Kallenberg 2010). 
Nevertheless, activated T cells, activated T follicular helper cells (Tfh) might lose 
the expression of CD127 (Eddahri et al. 2006; Seddiki et al. 2006; Zhou et al. 
2010). So this marker is not specific and needs to be used in combination of 
others.  
 
There are also a variety of adhesion molecules and ckemokine receptors 
expressed by Foxp3 Treg cells that allow homing to the site of inflammation 
(Allakhverdi et al. 2006; Kleinewietfeld et al. 2005; Schneider et al. 2007). 
Foxp3+Treg cells express chemokine receptor 4 (CCR4), CCR5, CCR6, CCR7 
and CCR8 relatively higher than effector T cells. For example, CCR7, which is 
expressed by the vast majority of Foxp3+Treg cells, enables these cells to migrate 
towards chemokines CCL19 and CCL21. It has been demonstrated that IL-10-
producing nTreg cells can be recruited into the site of infection when they express 
CCR5; and inhibit the development of effector T cells and the production of IFN-γ. 
Therefore, the survival of pathogens for long period will be promoted in the site of 
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inflammation (Piccirillo 2008). Generally, when Treg cells express a range of 
homing receptors, these cells can migrate to the inflammation site and inhibit the 
immune response (Bruder et al. 2004; Fehervari & Sakaguchi 2004).  
 
1.6.4 The immune suppression mechanisms by Treg cells 
The suppression of CD4+ and CD8+ T effector cell proliferation occurs upon the 
activation of nTregs through TCR (Bacchetta, Gambineri & Roncarolo 2007). Also, 
antibody production by B cells, Natural killer (NK) cells, and the maturation of 
dendritic cells are suppressed by nTregs (Miyara & Sakaguchi 2007). Recently, it 
was revealed that CD39 is an ectoenzyme and is considered as activated surface 
marker of human Tregs. It has the ability to degrade adenosine tri-phosphate 
(ATP) to adenosine mono-phosphate (AMP) (Bacchetta, Gambineri & Roncarolo 
2007). The generation of adenosine can inhibit the effector T cells function via the 
adenosine receptor 2A activation (A2AR) (Fig.1.5.c) (Deaglio et al. 2007). 
Amazingly, although binding of adenosine to its receptor A2AR suppresses the 
function of effector T cells, it can augment induced Treg generation by inhibiting 
the expression of IL-6, whereas it encourages the secretion of TGF-β (Vignali, 
Collison & Workman 2008). The expression of Foxp3 and differentiation of Treg is 
promoted by TGF-β. However, the generation of Treg cells can be suppressed by 
IL-6. As a consequence, suppressing IL-6 has a great implication in Treg cells 
preservation (Vignali, Collison & Workman 2008).  
 
Chapter 1: General introduction 
Page	  |	  30	  	  
	  
In addition to direct effect of Tregs on T cells function, there is another suppression 
mechanism of Treg cells which is by targeting dendritic cells (DCs). There are 
direct interactions between Tregs and DCs in vivo through CTLA-4 which is 
constitutively expressed by Tregs, and CD80 and/or CD86 (Read, Malmstrom & 
Powrie 2000). It is known that the activation and maturation of DCs is crucial for 
the activation of T cells, but it has been suggested that the function might be 
orchestrated by Tregs. Indoleamine 2, 3-dioxygenase (IDO) expression by APC 
(i.e. DC) could be modulated by Tregs (Fig.1.5.d) and has the ability to catalyse 
the conversion of tryptophan to kynurenine and other metabolites and thus inhibits 
the effector T cells (Sakaguchi 2005). Treg cells may reduce the capability of DCs 
to activate T cells (Fallarino et al. 2003; Mellor & Munn 2004). It has been shown 
that CTLA-4 triggering can stimulate the production of IDO by human DCs (Boasso 
et al. 2005). CD4+ CD25- cells can be converted to CD4+ CD25+ cells by IDO (Curti 
et al. 2007).   
 
Another mechanism of Treg-mediated suppression may be through killing the 
effector cells (cytotoxicity). Treg cells may have the ability to release perforin and 
granzyme A (Fig.1.5.b), therefore promoting death of T cells, monocytes and DCs. 
However, through perforin-independent and perforin-dependent pathways, the T 
cells and B cells could be damaged by the release of granzyme B (Miyara & 
Sakaguchi 2007).  
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CD4+CD25+ Treg cells may act through cytokine production such as interleukin-10 
(IL-10) and transforming growth factor beta (TGF-β) (Fig.1.5.a). These cells may 
suppress the proliferation of T cells and interferon gamma (IFN-γ) production via 
cell-cell contact, which could be mediated by CTLA-4 (Ozeki et al. 2010).  It is 
important to control the level of Treg cells suppression so that host protection 
against pathogens won’t be compromised. For instance, cytokines co-stimulation 
molecules have a key role in host protection, and suppression of these will make 
the host susceptible to infection.  On the other hand, autoimmunity and allergy may 
occur in the deficiency of suppression. When the host encounters microbes, the 
requirement of Treg immune regulation is crucial for preventing excessive tissue 
damage and possible autoimmune response during the inflammatory response 
(Miyara & Sakaguchi 2007).      
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Figure 1.5 Mechanisms of suppression by Treg cells. 
(a) Regulatory T cells secrete interleukin-10 (IL-10), IL-35, and transforming growth factor (TGF-β), 
and directly inhibit T-cell activation. (b) Activated human TReg cells directly destroy target cells such 
as T cells and APCs through perforin - or granzyme B-dependent pathways. (c) CD39 as activated 
surface marker of human Tregs degrade adenosine triphosphate (ATP) to adenosine 
monophosphate (AMP) and the generation of adenosine can inhibit the effector T cells function 
through the adenosine receptor 2A activation (A2AR). (d) The expression of indoleamine 2, 3-
dioxygenase (IDO) by APCs is provoked by cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) 
TReg cells, and IDO-expressing APCs in turn suppress T-cell activation by reducing tryptophan. 
Also, regulatory T cells can suppress APC function, by inhibiting expression of MHC molecules, 
CD80, CD86 and IL-12 through CTLA-4. Adapted from (Vignali, Collison & Workman 2008). 
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1.7  The protective role of Treg cells in infectious diseases 
CD4+CD25+ Regulatory T cells have been shown to be crucial in protection 
against several conditions such as autoimmune disease, allograft rejection and 
allergy. The effector immune cells have a protective role against microbial 
infection, but pathogenic effects can occur during the immune-inflammatory 
response to the pathogens (Mills 2004). In this case, the induction of Treg cells is 
crucial to tackle immunopathology via TGF-β and IL-10 dependent pathway. It has 
been shown that memory Treg cells, which were obtained from mice infected with 
bacterial infection such as Helicobacter hepaticus, were capable of preventing 
intestinal inflammation progress. Also, the production of IFN-γ can be inhibited 
after exposing to antigens of H. hepaticus in vitro by the CD4+CD45RBlow Treg 
cells which were obtained from the same infected mice lack of IL-10 generation 
(Maloy et al. 2003).  
Those generated Treg cells may be memory Treg due to the previous exposure to 
similar antigens (Mills 2004). It has been demonstrated that lack of IL-10 in mice 
has a negative impact on host tissue and can lead to increased disease severity, 
and pro-inflammatory cytokine production (Deckert et al. 2001). Additionally, IL-10 
deficient mice has a reduced ccolonisation of Helicobacter pylori in gastric 
mucosa, although the severity of gastric inflammation was considerably greater 
than in wild-type mice (Chen, Shu & Chadwick 2001) and this severe inflammation 
was associated with IL-12 release and Th1 cells response (Mills 2004).               
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1.8  The role of Regulatory T cells in pathogen persistence  
There are several studies demonstrating the role of Treg cells in bacterial and viral 
persistence, through their inhibition of T cell proliferation and cytokine production. 
For example, the cytotoxicity of effector CD8+ T cells is suppressed by Treg cell 
during viral infection such as cytomegalovirus, HIV (Aandahl et al. 2004) , and 
hepatitis C virus (HCV) (Cabrera et al. 2004). Once Treg cells are activated, they 
are expanded and suppress CD4+ and CD8+ T cell responses (Keynan et al. 
2008). Additionally, a suppression of immune response to non-self antigens can be 
seen also from the non-specific activation, suggesting that Treg cells are not only 
specific for self antigens but also can be triggered by cross-reactive antigens 
(Keynan et al. 2008). As stated by Macleod and Wetzler, regulatory T cells can be 
activated by TLR activation and that leads to a reversal effect on their suppressive 
activity, and if the agonist of TLRs is removed, Treg cells can regain suppression 
(MacLeod & Wetzler 2007). 
 
Specific Treg cells to particular viruses showed a potent inhibitory function in the 
presence of relevant viral antigens (i.e. human papillomavirus 16 and 18 proteins).  
Studies in rabbits, mice and humans on controlling T cell immune response 
against herpes simplex virus type 1 (HSV-1) indicated that Treg cells concentrate 
at the site of inflammation, but they are effective at manipulating the response of T 
cells. It was suggested that Treg cells act during the development of memory cells 
as well as during the infection especially during the acute phase. In terms of HCV, 
after depleting CD4+CD25+ cells from infected individual, the proliferation and the 
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production of cytokines by memory T cells to specific HCV antigens have been 
recovered (Keynan et al. 2008).   
In comparison to uninfected people, infected individuals with chronic HCV were 
shown to have substantial number of Treg cells in their circulation. The higher ratio 
of Foxp3+ Treg cells to other lymphocytes in chronic HCV infection helps to 
explain how T cell responses against HCV infection were attenuated by the 
elevated numbers of Treg cells (Keynan et al. 2008; Ward et al. 2007).  TGF-β and 
IL-10 may be involved in the suppressive action (Cabrera et al. 2004), although IL-
10 and TGF-β independent pathway may also be involved (Keynan et al. 2008; 
Rushbrook et al. 2005).       
    
1.9 T helper-17 cells 
Mosmann and Coffman have discovered two different subsets of T helper (Th) 
cells, including Th1 and Th2 cells based on specific cytokines and effector 
functions (Mosmann & Coffman 1989). A new subset of T helper cells named Th17 
cells which produce Interleukine-17 (IL-17) were identified more recently (Park et 
al. 2005). The expression of transcriptional factor retinoic-acid-related orphan 
receptor γ t (ROR-γ t) is the main characterization of human Th17 cells. During 
microbial infection, Th17 have been shown to accelerate the clearance of 
extracellular pathogens (van de Veerdonk et al. 2009). However, Th17 cells can be 
involved in chronic inflammation and in the pathogenesis of autoimmune disease 
such as rheumatoid arthritis, multiple sclerosis (Oukka 2008; Ouyang, Kolls & 
Zheng 2008). IL-17 is a family of cytokines (including IL-17A, B, C, D, F) which are 
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structurally homologous to each other (Afzali et al. 2007). IL-17A and IL-17F are 
considered the major types part of this family. These cytokines participate in the 
recruitment, activation and migration of neutrophils, which are important in 
microbial removal (Matsuzaki & Umemura 2007). 
 
Moreover, IL17 promotes cells such as macrophages, fibroblasts, endothelial cells 
and epithelial cells to produce IL-1 β, IL-6, tumour necrosis factor alpha (TNF-α) 
and chemokines (CXCL9, CXCL10 and CXCL11) which attract interferon-
producing CD4+Th1 cells (Oukka 2008). They act as multiple pro-inflammatory 
mediators (Bacellar et al. 2009). It have been demonstrated that these mediators 
have an effect on pathogenicity especially in autoimmune diseases (Lu et al. 2009; 
Sutton et al. 2006). It has been reported that human memory Th17 cells are 
categorized as CCR2+CCR5- and produce high level of IL17, whereas the cells 
expressing both CCR2 and CCR5 produce only a low level of IL17 (Sato, Aranami 
& Yamamura 2007). It was suggested that the discrimination between Th17 and 
Th1 could be helped by the expression of CCR5 (Sato, Aranami & Yamamura 
2007).  It has been reported that ROR-γ t is important for generation of Th17 cells 
in vitro and in vivo (Aujla, Dubin & Kolls 2007a; Lim et al. 2008; Ortega et al. 
2009). Not only IL-17, but also TNF-α, IL-6, IL-21 and IL-22 can be produced from 
Th17 (Ortega et al. 2009; Wilson et al. 2007). Despite large quantities of IL-17 
produced by Th17, this particular cytokine is also generated by other cells of the 
innate immune system (Oukka 2008). There are several other cells which have the 
capability to express IL-17 including Natural Killer T (NKT) cells, γδ T cells, 
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neutrophils, monocytes and NK cells (Bhan, Cornicelli & Standiford 2008).  It is 
suggested that the immune cells of innate response are also very important for 
IL17 production and these IL17-producing T cells provide  efficient first line 
defence during microbial invasion .  
 
1.9.1 The role of IL-17 against infections 
Despite IL17 is involved in autoimmune diseases, It has may play a protective role 
against pathogens. It has been shown that IL17 provides protection against 
intracellular pathogens such as mycobacterium (Gaffen 2009; Matsuzaki & 
Umemura 2007). 
 
Experiments have shown that mice without IL17R had a lower survival rateafter 
Klebsiella pneumonia infection (Matsuzaki & Umemura 2007). This bacterium is 
associated with an increase of bacterial numbers and the decrease of neutrophil 
emigration into the lung (Aujla, Dubin & Kolls 2007a; Matsuzaki & Umemura 2007). 
This is due to reduced levels of chemokines such as CXCL1 and CXCL2 in the 
lung (Aujla, Dubin & Kolls 2007a). These findings support the importance of IL17 in 
protective response against infections. Notably, the lack of IL17R led to reduced 
defence in the first phase of infection (Matsuzaki & Umemura 2007). It has been 
reported that lack of IL-17A in mice resulted in reduction of granulocyte colony-
stimulating factor (G-CSF) and CXCL1 in the lung; therefore it may lead to 
infection (Ouyang, Kolls & Zheng 2008). Huter et al. suggested that the 
differentiation of Th17 cells cannot be controlled by CD4+CD25+ natural Treg cells 
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in autoimmune disease (Huter et al. 2008). However, another study by Zhou et al 
reported that purified Foxp3 Treg cells inhibited Th17 cells and may suppressed 
Th17 activity in vivo or ex vivo (Zhou et al. 2010).  
 
There are multiple steps in the pathway of IL-17-mediated protection against 
infections as illustrated in figure1.6. First of all, transforming growth factor-beta 
(TGF-β) from Treg cells and IL-6 from activated APCs helps to induce Th17 
differentiation. In next stage, after the recognition of antigens, Th17 cells will 
produce IL-17 in the presence of IL-23 from activated APCs. Finally, IL17R+ cells 
are activated by IL-17 and these cells; i.e. endothelial cells and bronchio-epithelial 
cells induce the production of G-CSF (Aujla, Dubin & Kolls 2007a), granulocyte 
macrophage colony-stimulating factor (GM-CSF) (Vernal & Garcia-Sanz 2008) , 
which activate the neutrophils. Additionally, IL17R+ cells produce β-defensin to 
enhance bactericidal activity, so the pathogens can be killed (Matsuzaki & 
Umemura 2007).  
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Figure 1.6 Th17 engagement in mucosal infection.  
Mucosal DCs activated by pathogens secrete IL23 (A), leading the memory Th17 cells to produce 
IL17 and IL22 (B). These proinflammatory cytokines promote the secretion of antimicrobial peptides 
from epithelial cells (C). The expression of granulopoietic and chemotactic factors is driven by IL17. 
DCs are accumulated at the mucosal surface and phagocytosed the infected and apoptotic 
neurophils (D). Adapted from (Peck & Mellins 2010) .  
 
1.9.2  The role of IL-17 against streptococcus pneumoniae 
IL17 response can be induced by pneumococcal antigens such as cell wall 
polysaccharide (CWP) or whole cell antigens (WCA) (Bogaert et al. 2009; Lin, 
Slight & Khader 2010; Malley et al. 2006), especially with adjuvant cholera toxin 
and when given via natural route; i.e. mucosal administration (Malley et al. 2006). 
Neutralization of IL17 or IL17 receptor leads to increase in pneumococcal 
ccolonisation. Mice deficient of Th1 and Th2 cytokines, IFN-gamma and IL4 
respectively were still capable of protection (Lu et al. 2008). Following secondary 
challenge with pneumococcus, recruitment of protective immune cells such as 
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monocytes, macrophages and neutrophils was shown to be mediated by IL-17-
producing cells leading to clearance of pneumococcus. Upon antigen exposure, 
IL17 can be produced from CD4+Th17 memory cells in tonsillar tissues in both 
adults and children (Lin, Slight & Khader 2010; Lu et al. 2008).  It has been 
reported that pneumococcal clearance in animal models is correlated with the 
cytokine IL-17A expression (Richards et al. 2010). Both IL-17A and neutrophils are 
likely to accelerate the clearance of ccolonisation of pneumococci. With the 
cooperation of antibody response, it may lead to effective immunity against this 
bacterial infection (Richards et al. 2010). 
 
In HIV/AIDs patients, it was shown that with defects in the expansion of Th17cells, 
they were more susceptible to infections by Staphylococcus aureus, Haemophilus 
influenzae, and Streptococcus pneumoniae (Crum-Cianflone, Weekes & Bavaro 
2009; Hirschtick et al. 1995). 
 
1.10 Development of pneumococcal protein vaccines   
Currently, there are two types of vaccines, including 23-valent capsular 
polysaccharide vaccine (CPCV23) and pneumococcal conjugate vaccine (PCV). 
CPCV23 is immunogenic in adults and children older than 5 years. It induces a T-
cell independent immune response. However, it is ineffective for children under 2 
years (Bogaert, De Groot & Hermans 2004; Lu et al. 2009), because it does not 
induce activation of T cells (Bogaert, De Groot & Hermans 2004).  
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PCV, on the other hand, is more effective and immunogenic in children younger 
than 2 years due to the induction of a T-cell dependent immune response. 
Incidence of pneumococcal disease has been dramatically reduced by the 
introduction of PCV vaccines. However, pneumococcal infections due to non-
vaccine serotypes (eg. 3, 7F, 19A) have been shown to increase following 
conjugate vaccination (CDC 2010; Lu et al. 2009).  
 
Recent efforts have been made in the development of pneumococcal protein 
vaccines with well-preserved protein antigens among all pneumococcal strains. 
Protein antigens induce T cell dependent antibody response in all age groups and 
likely to induce immunological memory. Also, recombinant proteins are also cheap 
to produce. The best combination of proteins to be selected for vaccination 
purposes remains to be examined (Bogaert, De Groot & Hermans 2004). Ply and 
CbpA have been shown to be well conserved among pneumococcal strains, and 
are considered as promising vaccine candidates against carriage (Zhang et al. 
2007; Zhang et al. 2006b). 
 
1.11 Aims of study 
As S. pneumoniae is a mucosal pathogen colonising human nasopharynx, local 
mucosal immunity in NALT is likely to be crucial in mediating protection against 
pneumococcal ccolonisation or carriage. It is hypothesised that mucosal Treg and 
Th17 in NALT are critical determinants in pneumococcal persistence/carriage or 
clearance. Therefore, this PhD project was designed to investigate: 
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1. The frequency of Treg and Th17 cells, and the ratio of Th17/Treg cells in 
NALT and PBMC in both children and adults, and their association with 
pneumococcal carriage.  
2. What components of pneumococcal culture supernanant (CCS) 
activate/induce Foxp3+ Treg and Th17 cells? 
3. Whether pneumococcal protein antigens activate/induce Th17 and Treg cells 
from tonsillar MNC or CD45RO-depleted MNC respectively.  
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Chapter 2: Materials and Methods 
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2.1  Human subjects and samples  
Tonsillar tissues, peripheral blood and nasal swabs were obtained from subjects 
aged between 2 and 36 years undergoing adenoidectomy and/or tonsillectomy, 
Alder Hey Hospital for Children and Royal Liverpool and Broadgreen University 
hospitals Trusts due to upper airway abstruction or tonsillitis. Tonsillar tissues were 
collected into 25ml universal tube, containing 10ml Hank’s balanced salt solution 
(HBSS) (Sigma Aldrich, UK) supplemented with 10µg/ml gentamycin and 1% L-
glutamine (Sigma). Peripheral blood sample (2-5ml) was collected into a 25ml 
universal tube containing anticoagulant (heparin 100µl, LEO Pharma, UK). The 
patients’ samples were then transported to the laboratory for processing. 
Individuals in this study who were received antibiotics and had serious infection or 
immunodeficiency were excluded.  
 
2.2  Study ethics 
This study was approved by the local research ethics committee, and informed 
consent was obtained from the volunteers and children’s parents or custodian in 
each case. The project was performed in the laboratories of Clinical infection, 
Microbiology and Immunology department at the University of Liverpool.    
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2.3  Nasopharyngeal swab culture for detection of Streptococcus 
pneumoniae 
2.3.1 Nasopharyngeal swab medium 
On the day of that operation was performed, a nasopharyngeal (NP) swab was 
collected using a sterile Dryswab™ (Medical Wire & Equipment, UK), and reserved 
in screw-capped 1.5ml sterile vials containing 1ml of a special medium, contains 
skim milk (oxoid, UK), tryptone soya broth (TSB, from oxoid, UK), glucose (Sigma 
Aldrich, UK) and glycerol (Sigma Aldrich, UK). This medium is known as Skim-milk 
Tryptone Glucose Glycerol (STGG) transport medium (O'Brien et al. 2001) 
(appendix 1). Then the vial was transported into the laboratory to be stored at -
80˚C and then cultured later for pneumococcus.  
 
2.3.2 Detection and identification of pneumococcal isolates  
The NP swab was thawed out at room temperature (25°C) and vortexed for 
approximately 10-20 second. Following a standard procedure as described 
previously (O'Brien & Nohynek 2003), 50µl of the NP swab was subcultured on a 
blood agar (BA) medium plate (Oxoid, UK), containing 5% sheep blood. Then it 
was streaked in 4-quadrant fashion for colony isolation by a sterile 5µl plastic loop 
(Technical Service Consultants Ltd, UK) using standard inoculating procedure. 
Then it was incubated for 18-24 hours (hr) at 37°C in CO2 incubator. The growth 
on blood agar was carefully examined for the typical pneumococcal morphology, 
i.e. small, grayish, moist, watery surrounded by a greenish zone of alpha-
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hemolysis (Fig.2.1.). Each suspected α-haemolytic growth was subcultured and 
confirmed by standard optochin disc inhibition test.  
 
To perform the optochin susceptibility test, streaking the suspect alpha-hemolytic 
colony onto blood agar plate using 5µl plastic loops.  An optochin disc (5ug) with 
6mm diameters (Oxoid, UK) was placed onto the streaked area and then 
incubated in 5% CO2 incubator at 37°C for 18-24 hr. If isolates sensitive to 
optochin (halo diameter >14mm), it is identified as S. pneumonia (pneumococcus) 
(O'Brien & Nohynek 2003).   
 
(a)   (b) 
 
 
Figure 2.1 Identification of Streptococcus pneumoniae on blood agar plates.  
Typical colonies of pneumococci with a small greenish α-haemolytic (a) compared with 
non-α-haemolytic non-pneumococcal colonies (b) of nasopharyngeal swabs.   
 
  
Chapter	  2:	  	  Materials	  and	  methods	  
Page	  |	  47	  	  
	  
2.4  Pneumococcal culture supernatant  
A standard laboratory strain known as Streptococcus pneumoniae encapsulated 
type 2 strain D39 (NCTC7466) (Ogunniyi et al. 2000) was used in this project for 
cells stimulation beside other strains such as an isogenic choline binding protein 
A–deficient mutant (CbpA-), and an isogenic pneumolysin-deficient mutant (Ply-) 
(Berry et al. 1999). Pneumococcal concentrated culture supernatants 
(Pneumococcal CCS) were prepared from these three strains mentioned above. 
The CCS was prepared and concentrated using a specific method as described in 
a previous paper (Zhang, Choo & Finn 2002) and it will be described later in this 
chapter. During this stage of the project, different types of pneumococcal CCS 
were used at a protein concentration of 2µg/ml after determining the optimal 
concentration and dose response for cell stimulation.  
 
2.4.1 Preparation of pneumococcal CCS 
Todd-Hewitt Broth (THB) (Oxoid, UK) with yeast extract (0.5%) was used following 
manufacturer’s instructions. Different pneumococcus strains such as wild type 
(D39 type 2) and mutant stains (CbpA- and Ply-) were taken out from -80°C 
freezer and defrosted.  After that 5-10µl of each different strain was subcultured on 
BA medium for overnight in 5% CO2 at 37°C. Following 18 hr approximately, 
typical observation of α-hemolytic colonies of streptococcus was grown on the BA. 
Subsequently, several colonies were picked up by sterile loop and cultured them 
overnight in the earlier prepared 3ml of THB in 5% CO2 at 37°C. The turbidity of 
media indicates the bacterial growth. All 3ml of bacteria culture were added into 
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large cell culture bottles containing 100ml of THB media. The turbidity and optical 
density (O.D) of bacterial growth was read at 620nm using spectrophotometer. The 
growth was observed about 2–4 hr and depends on the how the quickness of 
bacterial growth was, then half hourly observation until O.D. value reach about 0.4-
0.5 (approximately 108 cfu/ml). Culture tubes were centrifuged at 3000×g for 30 
minutes (min) in order to remove the bacteria and the supernatant was filtered first 
through 0.4µm pore size and then 0.2µm sterile filter to remove the remaining 
bacteria. Finally, the filtered supernatants were concentrated to reach 10-fold at 
3000×g for 30 min using Vivaspin15 concentrators (Sartorius Stedim Biotech, 
Germany). Numerous aliquots of CCS (1.5ml) were prepared and stored in freezer 
-80°C.  
 
2.4.2 Biorad protein assay for measuring CCS protein concentration 
The protein concentrations in the CCS were determined by the Bio-Rad protein 
assay through using Bradford protein dye reagent (Sigma) according to the 
manufacturer’s instructions. Briefly, first, 2-fold of 8 serial dilutions of standard 
control bovine serum albumin (BSA) (starting with 1mg/ml) must be prepared in 
eppendorf tubes in order to perform the standard curve (Fig. 2.1. and table 2.1.). 
Furthermore, a preparation of CCS was assayed in duplicate and three different 
concentrations; started from the net and other two serial dilutions (1:10 and 1:100) 
in eppendorf tubes. A volume of 5µl of the prepared serial dilutions from standard 
and samples were dispensed into each well of a 96-well Costar plate in a 
duplicate. Then, 250µl of Bradford solution was added to the control and samples 
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then mixed thoroughly. The plate was incubated at room temperature in dark for 5 
min. This solution is working as substrate. Samples and control were developed to 
navy colour. Finally, the plate was read at 595nm wavelength using a microtiter 
plate reader (Opsys MR, Thermo labsystems, UK). After determining the O.D of 
the control (BSA standard) and each sample, a calculation of protein concentration 
(mg/ml) was done against the standard curve produced from BSA standard.  
Deltasoft software (Biometallics Inc., USA) was used for analysis. Then the mean 
of 3 serial dilutions of CCS was compared with the control and interpolated to give 
appropriate concentration of BSA.  The concentration of CCS that been measured 
by this assay was shown in table 2.2. 
 
Table 2. 1 Mean OD of the BSA standard control measured by Biorad protein assay. 
 
 
 
 
 
 
 
 
 
 
 
 
BSA (Standard) Con. (mg/ml) Mean OD 
1 0.008 0.399 
2 0.016 0.406 
3 0.031 0.409 
4 0.063 0.427 
5 0.125 0.449 
6 0.25 0.491 
7 0.5 0.578 
8 1 0.708 
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Table 2.2 Concentration of the pneumococcal CCS measured by Biorad protein 
assay. 
 
 
 
 
 
2.4.3 Western blotting for detection of Ply and CbpA in CCS 
Western blotting was used to confirm the presence or absence of CbpA and Ply 
proteins in pneumococcal CCS derived from D39 strain and that there was no 
expression of CbpA or Ply in the CCS derived from the CbpA- and Ply- mutant 
strains (data shown in figure 2.2 below). The protein bands were separated on 
sodium dodecyl sulphate-polyacrylamide (SDS-PAGE) gels dependent on the 
molecular weights of proteins.     
 
2.4.3.1 Preparation of SDS-PAGE Gel: 
Glass plate sandwich, casting stand and resolving (separating) gel (12%) should 
be prepared first. After preparing the resolving gel (appendix-1), the gel was 
poured quickly into the casting stand with leaving 5 mm gap from the top (up to the 
margin). Immediately, isopropanol was added on the top for leaving and smoothing 
the upper margin. The gel was left 15-20 min for setting. Isopropanol was washed 
from the top with d H2O to allow drying by using filter paper for water absorbance. 
Then the stacking gel (appendix-1) was poured quickly into the casting stand. The 
Pneumococcal CCS Conc. (mg/ml) 
Concentration used for 
stimulation 
D39wt 0.19 2µg/ml 
Ply- 0.340 2µg/ml 
CbpA- 0.24 2µg/ml 
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comb was applied carefully from an angle to avoid trapping of air bubbles. Finally, 
the gel was left 15-20 min for setting. 
 
2.4.3.2 Sample Preparation 
Samples (pneumococcal CCS) were diluted 1:3 with the prepared Laemmli buffer 
act as reducing buffer (appendix-1). The mixture was heated on a heat block at 
100°C for 5 minutes to denature proteins. For recombinant CbpA and Ply proteins 
1:60 dilutions were used. Then, 30µl of CCSwt, CbpA- and Ply- strains as well as 
5µl of the ladder (Bio-Rad, UK) were loaded into the prepared gel or a 12% mini 
protean precast TGXTM gels (BioRad).  
 
2.4.3.3 Gel Electrophoresis 
The gel was loaded on the tank and the running buffer (appendix-1) was poured in 
the middle and side of gel chamber. The comb was removed gently then samples 
were loaded to the wells with long sample loading tips. The lid was placed on the 
top. Electrodes were connected with power-pack and run for 1 hr at constant volts 
(50m.Amp with a maximum 250V). Bromophenol blue was allowed to run through 
the gel until reached the bottom of the gel. At this point, the gel was taken out and 
put into transfer buffer. The small gel was removed carefully and the stacking gel 
was cut from the resolving gel using a scalpel. 
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2.4.3.4 Protein Transfer  
A Transblot TurboTM transfer system (Biorad) was used to perform Western blotting 
protein transfer into a 0.2µm nitrocellulose membrane (Transblot turbo transfer 
pack). The gel was placed onto a nitrocellulose membrane and then placed on to 
the bottom ion reservoir (anode) stack. The top ion reservoir (cathode) stack was 
then laid over the gel, and run for 10 min at a constant 25V and 1000Amp. 
 
2.4.3.5 Western blotting detection of CbpA and Ply in pneumococcal CCS 
Following Western blot transfer, the Nitrocellulose membrane was blocked with 5% 
skimmed milk in 0.05% PBS Tween-20 (appendix-1) for 90 min on the shaker with 
gentle shaking at room temperature (RT). The blocking solution was aspirated and 
0.05% PBS Tween-20 was added for 5 min wash (repeated twice). The primary 
antibodies; rabbit anti-Ply and mouse anti-CbpA antiserum, were diluted 1:5000 in 
blocking solution then added and the membrane were incubated for 120 min at RT. 
The solution was poured and 0.05% PBS Tween-20 was added for 5 min wash 
(wash was repeated 4 times). The secondary antibody was prepared as follows: 
donkey anti-rabbit or anti-mouse IgG-HRP (1:10000 in blocking solution) and 3µl of 
StrepTactin-HRP (Bio-rad). Then it was added and incubated for 60 min. The 
solution was poured and 0.05% PBS Tween-20 was added for one minute wash 
(repeated 4 times). Finally, the substrate was prepared by adding equal volume 
(1:1) of Immun-star Western C chemiluminescence reagent A and B (BioRad). 
Before adding substrate, the membrane was washed with PBS then all PBS was 
removed. The prepared substrate was decanted onto the membrane and 
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incubated for 5 min. Excess substrate was removed with PBS and visualised and 
imaged using the Bio-Rad Chemi-Doc XRS system (Bio-Rad). 
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(A)                                   (C) 
 
           (B) 
 
Figure 2.2 Western blot analysis of pneumococcal CCS (D39wt, CbpA- and Ply-) and 
recombinant Ply (rPly).  
(a) Nitrocellulose membrane blotted with pneumococcal CCS were immunostained with 
rabbit anti-Ply antiserum showing that, Ply band is present in D39wt, CbpA- CCS but 
absent in Ply- mutant CCS. (B) Blotted with mouse anti-CbpA antiserum showing that, 
CbpA band is present in D39wt and Ply- CCS but absent in CbpA- mutant CCS. (C) 
Probing with rabbit anti-Ply antiserum showing the Ply band. (L: Ladder). 
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2.5  Pneumococcal antigens and mitogens 
Some recombinant and native proteins were used as antigen stimulants such as 
rPly (WT) and PdB (W433F, provided by Profs Tim Mitchell (University of 
Birmingham) which were purified from recombinant Escherichia coli that expresses 
the respective cloned genes.  Also, a affinity purified choline binding protein 
preparation (CBP) from pneumococcal CCS was used; type 2 strain D39wt. 
Recombinant pneumolysin (Ply) protein has a strong hemolytic activity, whereas 
PdB antigen is a toxoid derivative form of pneumolysin with a mutation of amino 
acid Trp433-Phe which reduces the hemolytic activity to approximately 1% without 
affecting antigenicity (Palaniappan et al. 2005; Paton et al. 1991). The endotoxin 
levels of the recombinant proteins were <0.01ng/µg of protein, as determined by 
the Limulus assay (Zhang et al. 2006a). To determine the best concentration of 
those proteins for cell stimulation, a range of concentrations of rPly at 10, 50 and 
100ng/ml and of PdB at 100, 250 and 500ng/ml was used for cell stimulation. The 
optimal-dose response of both rPly and PdB for the induction of Treg and Th17 
cells was at 50ng/ml and 250ng/ml, respectively.   
 
Phorbol 12-myristate 13-acetate (PMA) and ionomycin (Ion) were used for 
stimulation of existing Th17 by co-culture with adenotonsillar cells for 5 hours. 
Also, these mitogens were used in induction of IL17 from naïve T cells (CD45RO-). 
The optimal concentration of PMA used in these experiments was at 40pg/ml and 
for Ion was at 1µg/ml.  
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2.6  Affinity purification of Choline-binding proteins (CBP) 
First, Vinylsulphone-activated agarose beads (1g, Sigma, Aldrich), which were 
immobilized with choline matrix were prepared by washing the beads with 10ml 
dH2O. Addition of 10mM choline was added in sodium carbonate buffer (pH 11.5) 
into column (20ml) containing the prepared agarose and then rotated overnight at 
RT. Agraose beads were washed with 10ml PBS to get rid of unbound choline. 5-
10ml of pneumococcal CCS was added into the econo-column chromatography 
(Bio-Rad) containing the choline-agarose beads and incubated for 30 min. The 
column was washed with 0.5M NaCL. Therefore, non-specifically binding 
components was washed out from the column and collected in new tubes (control). 
After that, choline-bound materials were passed though and eluted using 10% 
choline in PBS (w/v) (dissolving 2g of choline in 20ml PBS). This eluate was 
collected into a new tube containing mixture of proteins which were designated the 
CBPs. Finally, this mixture was concentrated by using Vivaspin15 concentrator at 
3000×g for 30 min.  As this technique is similar to the method used in Rosenow et 
al for isolation of CBPs (Rosenow et al. 1997), but instead of using live culture of 
pneumococci, a prepared pneumococcal CCS was used for the purification.   
 
2.7  Protein quantification by Nanodrop spectrophotometer 
Purified CBP preparation was quantified by Nanodrop 1000 spectrophotometer 
(Thermo Scientific). First the Nanodrop software was opened and selected at 
A280. After that, 2µl of deionized water was dropped on to the detector and the 
machine was calibrated. Then the detector was cleaned. Two µl of the buffer which 
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the proteins were being reserved in, was added to the detector as a blank control. 
Different protein elutions were then added to the detector, separately. Between 
each elution measurement, the machine was blanked by the buffer. The 
concentration of protein was determined and displayed on the software in mg/ml. 
The CBP concentration of the first elution was 0.05mg/ml. 
 
2.8  Sample processing and cell separation 
Patient’s samples consist of tonsils, blood and nasopharyngeal swabs were 
transported to the laboratory and processed within few hours.  
2.8.1 Isolation of mononuclear cells from tonsils 
The sample tube that contained tonsils was rinsed with 10ml of HBSS. Then, the 
tonsils were transferred into a sterile petri dish containing HBSS. With the help of 
sterile forceps and the scalpel, tonsilar tissues were cut into small pieces and then 
teased to release cells into the HBSS medium. The HBSS containing the cells was 
passed through a cell strainer with pore size 70µm (BD bioscience, USA) into a 
fresh centrifuge tube (Falcon 50ml tube). Fifteen ml of Ficoll-Paque (Jencons) was 
added to an orange falcon tube and then the cell suspension were carefully 
pipetted on top of the Ficoll without disturbing it by letting it slowly runs down the 
side of the tube. Carefully, the tube was transferred to the centrifuge and spun for 
30 min at 400x gravity (g) at 10°C. The interface layer of mononuclear cells was 
removed into a new orange tube and top up to around 45ml with sterile PBS. The 
tube was centrifuged for 10 min at 400xg at 10°C. The supernatant was poured off 
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and 3ml of PBS or RPMI medium (Sigma) was added to the cell pellet. Any remain 
tissue left over from tonsils was transferred into the sample tube with virkon and 
disposed into appropriate bins for autoclaving. 
 
2.8.2 Serum preparation and isolation of peripheral blood mononuclear cells 
(PBMCs) 
Blood sample was placed in the centrifuge and centrifuged for 10 min at 400g at 
10°C. After that, the top yellow layer (serum) was pipetted off carefully using a 
sterile pasteur and transferred to 1.5ml eppendorf tube. Tube of serum was placed 
in -80°C freezers in the box marked serum. The rest of the blood was diluted with 
an approximately equal volume of PBS. Subsequently, the blood was treated as 
the same manner as described for tonsils except the cell pellet was re-suspended 
in 1ml of PBS or RPMI medium.  
 
2.9  Cell counting 
Cells isolated were diluted [tonsillar MNC (1:100) and PBMC (1:10) into eppendorf 
tube (1.5ml) through adding 10µl to an eppendorf containing 990µl of PBS. 
Subsequently, 10µl of the cell’ suspension were transferred to the haemocytometer 
for counting in a 4 large squares. After that, the mean of the cells was obtained 
and multiplied by 104 and dilution factor if so, to give the number of the cells per 
ml. Alternatively, a disposal haemocytometer was used by transferring 10ul into it 
and the cells were counted by automated cell counter (Bio-Rad, UK).   
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2.10  Cell culture and stimulation: 
Mononuclear cells (MNC) from peripheral blood and tonsillar tissues were isolated 
by Ficoll-Paque density centrifugation. MNC were re-suspended and cultured at 
4X106/ml in RPMI-1640 medium (sigma) supplemented with 1% L-glutamine, 
10µg/ml gentamycin and 10% FBS (Sigma). In a sterile condition, aliquot of 0.5 ml 
of the cells was prepared per stimulation. Cells were cultured in 96-well flat bottom 
plate (Corning Incorporated, Corning, USA) with medium containing cells only or 
the addition of different stimulants after optimal concentration was determined 
such as D39wt CCS (2ug/ml), Ply- (2ug/ml), CbpA- (2ug/ml), recombinant ply 
(0.05ug/ml, PdB (0.25ug/ml) and CBP (2ug/ml). The plate was incubated in 5% 
CO2 for up to 24 hr at 37˚C. Additionally, the cells were stimulated and reactivated 
by PMA (40pg/ml) and Ion (1ug/ml) in the presence of 3ug/ml brefeldin A (BFA) as 
a protein transport inhibitor (BD GolgiStop, eBiosciences) and incubated at 37°C in 
5% CO2 for 5hr. Plate was washed with 0.02% PBS/BSA and the cells were 
harvested into a new eppendorf tube for both extracellular and intracellular 
staining. 
 
2.11 Depletion of CD45RO+ cells or CD45RO+ CD25+ cells from tonsillar 
MNC 
In experiments designed for the induction of Th17 cells from naïve T cells, cellular 
depletion of CD45RO+ (memory and effector T cell phenotype) cells was 
performed by using magnetic cell sorting (MACS) according to the instructions of 
the manufacturer (Miltenyi Biotec). For experiments on the induction of Treg cells, 
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both CD45RO+ cells and CD25+ cells were depleted from tonsillar MNC using 
MACS sorting. 
 
The cells were firstly prepared using magnetic labelling. The cell numbers were 
determined and the suspension of the cells centrifuged at 300xg for 10 min. After 
discarding the supernatant, the cell pellets were re-suspended in 80µl of buffer 
(0.5% BSA in PBS) per 107 total cells. Twenty micro-liters of anti-human 
CD45RO+ micro-beads per 107 total cells were added, mixed well, and incubated 
for 15 minutes in the refrigerator (2-8˚C). The cells were washed by adding 2ml of 
buffer per 107 cells and then centrifuged at 300xg for 10 min. The cells were re-
suspended up to 108 in 500µl of the buffer. The magnetic separation with LS 
column (Miltenyi Biotech) was used after labeling the cells with proper micro-
beads. The LS column was placed in the magnetic field of suitable MACS 
separator. After rinsing the column with 2ml of the buffer, the cells suspension was 
applied onto the column. Eventually, the unlabelled cells (CD45RO- cells fraction) 
that passed through were collected into a new tube and the magnetic-labeled cells 
with CD45RO+ were retained on the column. This cell fraction can be eluted as a 
positive selected cell fraction.  
 
Likewise, similar methods were performed for depletion of CD25+ cells. However, 
to deplete both CD25+ and CD45RO+, the appropriate amount of beads was 
added together at the same time to obtain CD25- CD45RO- MNC population 
(containing naïve T cells). The purity of depleted cells that yielded either CD45RO- 
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cells or CD25- CD45RO- was > 96%.     
 
2.12 Induction of Th17 cells  
In this experiment, CD45RO+ cell depleted MNC were used and cultured for 7 
days in the medium alone or with the addition of different combination of cytokines 
that were in the presence or without pneumococcal stimulants. A number of 
cytokines were tested separately for optimal induction, including IL21, IL1-β and 
TGF-β. The optimal concentration of IL21 and IL1-β was 50ng/ml and of TGF-β 
was 2.5ng/ml. This combination of cytokines (IL21/IL1-beta/TGF-β) was added in 
the cells with or without antigens (all recombinant cytokines were bought from R & 
D Systems and also optimized for the best dose). Different controls including 
medium alone, cytokines alone and antigen alone were included. On day 7, the 
supernatants were collected and stored in the freezer at -80°C for further analysis 
by ELISA techniques to measure the level of IL17A, IL17F and IL22. Following 
antigenic stimulation (with/without cytokines), PMA/Ion and brefeldin A (BFA) were 
added to the cells on day 7 and incubated for another 5 hours in the incubator. The 
cells were harvested and washed with a cold buffer (BSA/PBS 0.02%) and 
transferred into the new eppendorf tubes for intracellular staining.  
 
2.13 Induction of Treg cells  
CD45RO+ and CD25+ cell--depleted tonsillar MNC were co-cultured for 7 days 
with pneumococcal antigens in the presence or absence of 2.5ng/ml of TGF-β 
(R&D system). Different controls were used including medium alone, antigen 
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alone, or cytokine alone were used to determine the individual effect in the 
induction of Treg. On day 7, the cells were harvested and the plate was washed 
with a cold buffer (BSA/PBS 0.02 %) and transferred into the new eppendorf tubes 
for intracellular staining, which is described in 2.15.  
 
2.14 Flow cytometric analysis 
Adenotonsillar MNC or PBMC were incubated for 20 min at RT in the dark place 
with mouse monoclonal anti-human antibodies. These antibodies were labeled 
with different fluorochromes (i.e. phycoerythrin (PE), fluorescein isothiocyanate 
(FITC), allophycocyanin (APC), phycoerythrin (PE)-Cy5), such as anti-CD4, anti-
CD25 and anti-CD127 as the surface staining for Treg phenotyping (BD 
Biosciences). After that, cells were washed with cold PBS/BSA 0.02% to remove 
the non-binding antibodies. Before analysis by flow-cytometry, 300-400uL of the 
washing buffer (depends on the cells numbers) was added to the cells and then 
the suspension was transferred into the FACS tube. Flow-cytometric data were 
analyzed using WinMDI software (version 2.9). Lymphocytes were gated and 
based on FSC/SSC and Treg cell markers (CD25 and CD127) and were 
determined within the CD4 and CD3 gate.  
 
2.15 Intracellular staining for IL-17A and Foxp3 
The fixation/permeabilisation solution (eBioscence) was prepared by adding one 
part of concentrated solution to 3 parts of diluents.  A volume of 300µl of the 
prepared fixation/permeabilisation solution has been used to fix the surface marker 
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for 30-60 min at 4˚C in the dark place, followed by washing with 1-2ml of 
permeabilisation buffer diluted 1x. Subsequently, monoclonal antibodies labelled 
with fluorescence such as anti-foxp3-alexa@488, anti-IL17A-PE (BD bioscience) 
were added and incubated for at least further 30 min in the dark place at RT. 
However, a 100ul of fixative solution (eBiosciences) was used instead of using 
fixation/permeabilisation solution for IL17 staining.  The cells were washed with 
permeabilisation buffer 1x. Finally, the cells were re-suspended in the buffer for 
analysis by flow-cytometry (FACSCalibur; BD Biosciences). The frequency of Treg 
cells was determined as the percentage of Foxp3+ or CD4+CD25high/CD127low cells 
in CD4+ T cells.  
 
2.16 Enzyme-Linked Immunosorbent Assay (ELISA) 
2.16.1 Measurement of cytokine production in cell culture supernatants 
There are several ELISA techniques but the one used in this study for cytokine 
detection was sandwich technique for obtaining a high sensitivity. ELISA (Ready-
SET-Go was used and bought from e biosciences. It was for determining the level 
of cytokines in the supernatant after stimulating the cells with pneumococcal 
antigens and other related proteins. The supernatant which was stored in the 
freezer at -80°C was performed by ELISA kit according to the instructions of the 
manufacturer.  
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2.16.1.1 Measurement of IL-17A  
ELISA 96-well plate (Corning Costar) was coated with 100µl/well of capture 
antibody in Coating Buffer. The plate was sealed and incubated overnight at 4°C. 
Next day, the wells were aspirated and washed 3 times with buffer (1x PBS, 0.05% 
Tween-20) using plate washer. To increase the effectiveness of the washes, the 
wells were soaked (~1 min) during each wash step. Plate was blotted on absorbent 
paper to remove any residual buffer. One part of 5X concentrated assay diluent 
was diluted first with 4 parts of dH2O. Then the wells were blocked with 200µl/well 
of 1X assay diluent and incubated at RT for 1hr. The plate was washed once with 
wash buffer. To prepare the top concentration of the standard (500pg), 1X assay 
diluent was used. Then 100µl/well of top standard concentration was added to the 
appropriate wells. Two-fold serial dilutions of the top standards were performed to 
make the standard curve for a total of 8 points. After optimizing the samples’ 
dilution in the block buffer, 1:10 and 1:5 were the greatest dilutions for 
supernatants derived from both MNCs and CD45R0- depleted MNCs (after 3 and 7 
days of incubation, respectively). A hundred µl/well of the diluted samples were 
added to the appropriate wells. The plate was sealed and incubated at RT for 2 hr 
(or overnight at 4°C for maximal sensitivity). The plate was aspirated and washed 
as mentioned above and repeated for a total of 3-5 washes. A hundred µl/well of 
detection antibody diluted in 1X assay diluent was added into the wells. The plate 
was sealed and incubated at room temperature for 1 hr. The plate was aspirated 
and washed as mentioned above and repeated for a total of 3-5 washes. Addition 
of 100µl/well of avidin-horse radish peroxidase (HRP) diluted in 1X assay diluent 
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(dilution was prepared as noted in appendix 1) was added and the plate was 
sealed and incubated at RT for 30 min. The plate was aspirated and washed and 
repeated for a total of 5 washes. In this wash step, the wells were soaked in wash 
buffer for 1-2 min prior aspiration. To each well, 100µl of tetramethyl benzidine 
(TMB) substrate solution was added and the plate was incubated at RT for 15 
minutes. Finally, to stop the reaction, 50µl of stop solution (2N H2SO4) was added 
to each well. The plate was read at 450nm 15 min later using a plate reader 
(Opsys MR, Thermo labsystems, UK). The cytokine concentration (pg/ml) was 
calculated against the standard curve, with the help of microplate analysis 
DeltasoftPC (Biometallics, Inc., USA). 
 
2.16.1.2 Measurement of IL-17F 
IL17F was measured following a stimulation of CD45RO+cell-depleted MNC. 
Human IL-17F ELISA Ready-Set-Go® set (eBioscience) was used following 
manufacturer’s instructions. The top standard concentration was used at 500pg/ml. 
The protocol was the same as described for IL17A; except that the samples were 
diluted (1:10) in blocking buffer and been optimised for supernatants derived from 
CD45RO+ cell- depleted MNC.  
 
2.16.1.3 Measurement of IL-22 
IL22 was measured following stimulation of CD45RO+ cell-depleted MNC. Human 
IL-22 ELISA Ready-Set-Go® set (eBioscience), was used following manufacturer’s 
instructions. The top standard concentration was used at 500pg/ml. The protocol 
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was the same as described for IL17A; except, the samples were diluted (1:40) in 
blocking buffer and been optimised for supernatants derived from CD45R0- 
depleted MNC.  
 
2.16.1.4 Measurement of TGF-beta 
Human TGF-β ELISA Ready-Set-Go® set (eBioscience) was used for this assay to 
detect human TGF-β in tonsillar MNC culture supernatants following 72 hr 
stimulation by pneumococcal CCS.This assay was conducted to recognise the 
mature/active form of TGF-β without the association of latency association peptide 
(LAP). A standard ELISA procedure was performed following manufacturer’s 
instructions as in IL17A. Unlike IL17A, IL17F andIL22, the samples (but not the 
standard) were acid-activated (HCl treatment) in order to activate latent TGF-β to 
immunoreactive form and then neutralized. Briefly, the samples were diluted first to 
1:10 (the optimised dilution). After that, 20µl of 1N HCl were added to per 100µl of 
samples then incubated for 10min at RT. Twentey µl of 1N NaOH was added for 
neutralisation. The final concentration of the samples were calculated and 
corrected to dilution factor (1.4.) and the final dilution become 1:14. The top 
standard concentration was used at 1000pg/ml, and then the procedure was the 
same as described for IL-17A measurement. 
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2.16.1.5 Measurement of CbpA-specific IgG antibody in cell culture 
supernatants 
CbpA specific antibodies (anti-CbpA) were detected in cell culture supernatant by 
ELISA using the following protocol. Antigen coating solution (1µg/ml) was prepared 
from recombinant CbpA (1mg/ml) into 10ml of sterile PBS. A 96-well plate 
(Corning) was coated with 100µl of coating solution per well. The plate was then 
incubated overnight in 4°C. Next day, the plate was washed 5 times with PBS 
containing 0.05% Tween 20. The plate was then blocked (200µl/well) with blocking 
buffer (10% FBS in PBS) at 37°C for 1 hr. During that time, samples and standards 
were prepared by diluting them (1:30) in blocking buffer. Human immunoglobulin 
(sandoglobulin, Sandoz, UK), containing high IgG antibody titers to CbpA antigens, 
was used as a reference standard for measurement of IgG antibodies. Two-fold 
serial dilutions of the top standards were performed to make the standard curve for 
a total of 8 points. The plate was incubated at RT for 2 hr. The plate was washed 5 
times with washing buffer. 100µl of alkaline phosphatase-conjugated mouse anti-
human IgG (1:2000 dilutions) (Sigma) was added into each well. Then the plate 
was incubated at RT for 2 hr. Thereafter, the plate had been washed 5 times with 
the buffer. Addition of 50µl of freshly prepared P-Nitrophenyl phosphate (PNPP) 
substrate into every well (appendix-I), then the plate was incubated in the dark 
room at RT until the colour devolved. Finally, the absorbance (OD) was measured 
using a microtiter plate reader (Opsys MR, Thermo labsystems, UK) at 405nm. 
The concentration (units/ml) of each sample was calculated against the standard 
curve with serial dilution of Sandoglobulin (Sandoz, UK). DeltasoftPC microplate 
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analysis software (BioMetallics, Inc., USA) was used for data analysis. The optical 
density (OD) at 405nm was measured after 60 min of adding the substrate 
solutions. The anti-CbpA titre of sandoglobulin was assigned as the reciprocal 
dilutions at which their corresponding OD reached to 1.00 at that time point. Based 
on this, the stock solution of Sandoglobulin was assigned to an antibody titre of 
1000units/ml for anti-CbpA. 
 
2.17 Statistical analysis 
Statistical analysis in this study was performed using GraphPad Prism software 
(version 5.5). Differences between two groups were analysed by student t test. 
The difference between un-stimulated and stimulated cells by all different 
pneumococcal CCS and proteins’ antigens was assessed by paired t (parametric) 
test. Difference among groups (>2) were analysed by one-way variance (ANOVA). 
Two-factor correlation analysis was performed by Pearson’s correlation test 
(parametric). A p value of < 0.05 was considered statistically significant  
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3.1. Introduction 
Regulatory T cells (Treg) have been shown to be essential in immune regulation 
during microbial infection, allergy, autoimmunity and transplantation. There are two 
main types of Treg, known as natural Treg (nTreg) and inducible Treg (iTreg). Treg 
express a number of markers, including CD25, CTLA-4, GITR, LAG-3, CD62L, 
CD103 and CD39 (Abdulahad, Boots & Kallenberg 2010). CD25high Treg possess 
potent immunosuppressive function towards auto-reactive peripheral T cells 
observed either in vivo or ex vivo (Huibregtse, van Lent & van Deventer 2007; Mills 
2004). In addition to the surface markers, Treg express an intracellular 
transcription factor Foxp3 which is considered to be a specific molecular marker for 
both thymic and peripheral Treg (Piccirillo 2008).   
It has been shown that Treg play an important role in suppressing immune 
responses to pathogens, including T helper 1 (Th1), T helper 2 (Th2) or cytotoxic T 
lymphocytes (CTL) type response (Mills 2004). Treg have been suggested to 
contribute to the persistence of bacterial and viral infection via their ability to inhibit 
activation of effector immunity including the production of proinflammatory 
cytokines (Chen & Konkel 2010). Th1 and Th2 were first discovered by Mosmann 
and Coffman based on specific cytokines and effector functions (Mosmann & 
Coffman 1989). A new subset of T helper (Th) cells named Th17 has been 
identified more recently. Th17 cells have been shown to produce Interleukine (IL)-
17A, IL-17F and IL-22. Th17 cells express transcriptional factor retinoic-acid-
related orphan receptor γ t (ROR-γ t). During infection, Th17 have been shown to 
accelerate the clearance of extracellular pathogens (Miossec 2009). Th17 are 
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generally characterised as CD4+ IL17A-producing cells, although co-expression of 
chemokine receptors including CCR4 and CCR6 have also been used for the 
identification of memory Th17 cells (Korn et al. 2009) .    
Unlike Treg, Th17 may have a detrimental role in the pathogenesis of autoimmune 
diseases. Th17 may play an important role in protection against microbial 
infections. It has been shown that Th17 provide protection against intracellular 
pathogens such as mycobacterium (Matsuzaki & Umemura 2007). However, Th17 
may contribute to tissue damage, particularly during intracellular infection (Bacellar 
et al. 2009). It has been reported that clearance of pneumococcal colonisation in 
animal models was correlated with cytokine IL-17A expression (Lu et al. 2008; 
Richards et al. 2010). It has been suggested that IL-17A may promote the 
clearance of pneumococci through chemokine-mediated neutrophils. In 
combination with antigen-specific antibody responses, Th17 will likely elicit an 
effective immunity against this bacterial infection (Richards et al. 2010). In this 
study, we aimed to study the association between Th17 and Foxp3+Treg in 
nasopharynx-associated lymphoid tissue (NALT) and their relationship with 
nasopharyngeal carriage of pneumococcus in children and adults.  
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3.2. Aim of the study 
To investigate:  
1- The frequency of Treg and Th17 cells, and the ratio of Th17/Treg cells in 
NALT and PBMC in both children and adults, and their association with 
pneumococcal carriage.  
2- Whether pneumococcal CCS induces/activates Th17 and Treg.  
3- The effect of Treg cells in NALT on antibody production. 
 
3.3. Experimental design 
To determine the frequency of Treg and Th17, freshly isolated MNC from tonsillar 
tissue and peripheral blood were stained with fluorescence-labelled mouse anti-
human antibodies to CD4, CD25, CD127 and Foxp3 (for Treg) or intracellular IL-
17A (for Th17) and analyzed by flowcytometry on a FACSCalibur (BD Bioscience). 
The frequencies of Treg and Th17 were then analysed in association with 
pneumococcal carriage in children and adults.  
 
To determine whether pneumococcal stimulation induces Treg or Th17, tonsillar 
MNC were stimulated with pneumococcal culture supernatant (CCS, prepared 
from wild type pneumococcus D39) for 24 hours then the intracellular expression 
of Foxp3 and IL17A were analysed by flow-cytometry following cell 
permeabilisation and fixation (eBioscience).  
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3.3.1. Human subjects and samples  
In this study, tonsillar tissues and peripheral blood samples were taken from adults 
and children aged between 2-36 years who had tonsillectomy. On the day of the 
operation, a nasopharyngeal (NP) swab was taken and stored at -80˚C for later 
pneumococcus culture. Individuals who had serious infection or immunodeficiency 
and had received antibiotics 3 weeks prior to operation were excluded from this 
study. Informed consent was obtained from the children’s parents or custodian in 
each case.  
 
3.3.2. Detection of Th17 cells 
To determine the frequencies of Th17 in NALT and peripheral blood, tonsillar MNC 
or PBMC were isolated and stimulated by Phorbol 12-myristate 13-acetate (PMA) 
and ionomycin (Ion) for 5 hr in order to activate Th17. The optimal concentration of 
PMA used in this experiment was at 40pg/ml and for Ion was at 0.5µg/ml. The 
concentrations were determined from testing a range of different concentrations 
and optimal concentrations were chosen.   
 
3.3.3. Staining of the surface and intracellular markers of Treg and Th17 
cells 
Mononuclear cells (MNCs) were isolated either from the tonsillar tissues or 
peripheral blood by Ficoll gradient centrifugation, the cells were stained with anti-
CD3, -CD4, -CD25 and -CD127 (BD Biosciences) as surface markers for Treg and 
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incubated for 20 minutes (min) at the room temperature (RT) and in the dark. 
Fixation/Permeabilisation buffer (eBiosciences) were used after staining the 
surface markers and incubated for 30 min at 4˚C.  Subsequently, cells were 
incubated with mouse anti-Foxp3-Alexa-488 and anti-IL17-PE (BD Bioscience) for 
30 min in the dark at room temperature. Cells were then washed with 
permeabilisation buffer. Finally, the cells were re-suspended in the buffer for 
analysis by flow cytometry (FACSCalibur; BD Biosciences).  
 
Th17 cell and Treg were determined within CD3+ and CD4+ T lymphocyte gate 
and the frequencies of Th17 cells were expressed as the percentage of CD4+ T 
cells staining positive for IL17A. Frequencies of Treg were expressed as the 
percentage of CD4+ T cells staining positive for Foxp3 or as CD25high, CD127low. 
Flow cytometric data were analysed using WinMDI software (version 2.9).   
 
3.3.4. Cell culture and stimulation by pneumococcal CCS 
Tonsillar MNC or PBMC were incubated with wild-type pneumococcal CCS for 24 
hours and followed by addition of brefeldin A (BFA) for 6 hr (details see in chapter 
2, materials and methods). Briefly, tonsillar MNC or PBMC were isolated and 
cultured at 4 X 106/ml in RPMI medium (sigma) supplemented with glutamine, 
penicillin, streptomycin and 10% FBS. The cells were cultured in 96-well flat bottom 
plate (Corning Incorporated, Corning, USA) with or without the addition of 
pneumococcal CCS at 2µg/ml (protein concentration). The culture plate was 
incubated for up to 24 hr at 37˚C, in the presence of CO2 (5%). The cells were 
Chapter 3: Results 
	  
Page	  |	  75	  	  
	  
harvested into a new eppendorf tubes for both extracellular and intracellular 
staining as described in chapter 2, materials and methods.   
 
3.3.5. ELISA assay for IL17A measurement 
To assess the level of IL17A in culture supernatant of tonsillar MNC, ELISA plate 
(Corning Costar 9018) was coated with 100µl/well of capture antibody in Coating 
Buffer. The plate was incubated overnight at 4°C. Next day, the wells were 
aspirated and washed 3 times with washing buffer (1x PBS, 0.05% Tween-20) 
using plate washer. Then the wells were blocked with 200µl/well of blocking buffer 
for one hour. The plate was washed once with wash buffer. Then 100µl/well of top 
standard concentration was added to the appropriate wells. Two-fold serial 
dilutions of the top standards were performed to make the standard curve for a 
total of 8 points. 100µl/well of the diluted samples were added to the appropriate 
wells and incubated at RT for 2 hr. The plate was washed before 100µl/well of 
diluted detection antibody was added into the wells and incubated at room 
temperature for 1 hr.  Following wash, 100µl/well of avidin-horse radish peroxidase 
(HRP) was added and incubated at RT for 30 min. The plate was washed for a 
total of 7 washes. To each well, 100µl of substrate solution was added and 
incubated at room temperature for 15 min. Finally, 50µl of stop solution (2N H2SO4) 
was added to each well. The plate was read at 450nm using a plate reader.   
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3.3.6. ELISA assay for TGF-β measurement 
This assay was conducted to recognise the mature/active form of TGF-β without 
the association of latency association peptide (LAP). To detect human TGF-β in 
tonsillar MNC culture supernatants following 72 hr stimulation by pneumococcal 
CCS, a standard ELISA procedure was performed following manufacturer’s 
instructions, which was similar to the above protocol except that samples were 
acid-treated with HCl and neutralised prior to evaluation in this assay. Also, the top 
standard concentration was used at 1000pg/ml (details see materials and 
methods).   
 
3.3.7. Detection of CbpA-specific IgG antibodies in cell culture supernatants 
by ELISA 
ELISA technique was performed as described in chapter 2. Briefly, recombinant 
CbpA antigen was used for coating ELISA plate and then incubated overnight at 
4°C in the fridge. After that the plate was washed and then blocked with 10% FBS-
PBS. Following incubation of cell culture supernatants, alkaline phosphatase 
conjugated anti-human IgG was added and incubated and followed by the addition 
of PNPP substrate. Finally, the plate was read at 405nm to measure the optical 
density. DeltasoftPC microplate analysis software (BioMetallics) was used for data 
analysis.   
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3.3.8. Statistical analysis 
Differences between groups were analysed by ANOVA and student-t test. 
Correlation between two factors was analyzed by Pearson’s correlation test. 
Student’s paired-t test was used to compare un-stimulated and stimulated cells. A 
p value of <0.05 was considered statistically significant. Statistical analysis was 
performed using GraphPad Prism software (version 5). 
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3.4. Results 
3.4.1. Frequencies of Treg in human NALT and peripheral blood 
To determine the frequency of Treg in tonsillar tissue and peripheral blood, 
tonsillar MNC and PBMC were stained with a combination of CD4, CD25 and 
CD127 surface markers or Foxp3. The frequency measured by 
CD4+CD25highCD127low and that by CD4+Foxp3+ showed that same pattern.  
Representative figures were shown in Fig.3.1. As can be seen in figure 3.2.a, the 
mean frequency of Treg cells in tonsillar MNCs (8.5%) was higher than in PBMCs 
(5.5%). There was a difference between children and adults in the frequency of 
Treg cells in both tonsillar tissues and peripheral blood. In children, the mean 
frequency of Treg cells in tonsillar MNC was 9.7% compared to 6.2% in PBMCs. In 
adults, the respective frequencies for tonsillar MNC and PBMC were 5.6% and 
4.1% respectively (Fig.3.2.b). Overall, Treg frequency in tonsillar tissue of children 
(mean: 9.7%) was higher than in adults (5.6%). 
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Figure 3.1 One representative sample analysis showing gating strategy for 
identification of Treg (CD4+CD25highCD127lowFoxp3+) in tonsillar MNC and PBMC.  
Freshly isolated tonsillar MNC and PBMC were stained for CD3, CD4, CD25 and CD127. 
Lymphocytes were defined by typical FSC and SSC (R1) (A).  CD4+ T cells were identified 
by positive staining of CD3+ and CD4+ cells (R2) Treg were identified by gating on CD4+ 
T cells (R2), and positive staining of CD25high CD127low (Treg). The percentage of Treg 
cells in CD4+ T cell population was defined as Treg frequency (R4).  
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Figure 3.2 Frequencies of Treg cells in tonsillar MNC and PBMC.  
(a) The frequency of Treg cells in tonsillar MNC is shown to be higher than in PBMC (**p< 
0.01, n=23). (b) Frequencies of Treg cells in tonsillar MNC and PBMC in both children 
(n=17) and adults (n=6) are shown. Mean+SEM are shown. *p<0.05, **p< 0.01, ***p< 
0.001. 
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3.4.2. Relationships between Treg frequencies, age and pneumococcal 
carriage 
Frequencies of Treg in tonsillar tissue were analysed in association with ages of 
patients. There appeared to be an inverse relationship between the Treg frequency 
in tonsillar tissues and age (Fig.3.3, ***p<0.001). Overall, younger children <10 
years were shown to have higher Treg numbers than those those subjects >10 
years.  
As we know from previous results that pneumococcal carriage rate also decreases 
with age, we analysed the relationship between Treg frequencies in tonsillar tissue 
and pneumococcal carriage in children. As can be seen from figure 3.4, children 
who were pneumococcal culture positive in nasopharynx had a high frequency of 
tonsillar Treg cells than those children who were pneumococcal culture negative 
(**p< 0.01). The mean frequency of tonsillar Treg cells in culture positive children 
was 9.2% compared to 6.8% in culture negative children. 
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Figure 3.3 Relationship between frequencies of tonsillar Treg cells and age.  
There is an inverse correlation between frequencies of tonsillar Treg cells and patients 
age (r=-0.63, n=57, ***p< 0.001). An age-related decrease in Treg numbers was shown 
between different age groups.  
 
 
 
 
 
 
 
 
. 
 
Figure 3.4 Comparison of tonsillar Treg frequencies between culture+ and culture- 
children:  
Frequencies of tonsillar Treg cells were compared between children who were culture 
positive (n=18) for pneumococcus and those who were culture negative (n=21). Mean + 
SEM are shown **p< 0.01 culture+ vs culture -. 
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3.4.3. Frequencies of Th17 cells in NALT and PBMC in children and adults 
To determine the frequencies of Th17 in NALT and peripheral blood, tonsillar MNC 
and PBMC were analysed by intracellular cytokine staining for IL-17A and the 
frequency was expressed as the % of IL17A-producing cells in CD4+ T cell 
population. A marked difference in Th17 frequencies between tonsillar MNC and 
PBMC was shown (figure 3.5.a). The mean frequency of Th17 in tonsillar MNC 
was 1.4% compared to 0.4 % in PBMC following stimulation by PMA/Ion (figure 
3.5. b). There was a significant difference between children and adults in the 
frequency of Th17 cells in tonsillar MNC (figure 3.6.a). The mean frequency of 
Th17 cells in tonsillar MNC in adults was higher than in children (figure 3.6.b, ***p˂ 
0.001).   
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Figure 3.5 Frequencies of Th17 cells in tonsil and PBMC.  
Tonsillar MNC and PBMC were stimulated with PMA/Ion for 5 hours followed by 
intracellular cytokine staining of IL17A. (a) A representative FACS dot plots showing 
intracellular staining of IL17A in tonsillar MNC and PBMC gated for lymphocytes. 
Frequency of Th17 is expressed as % of IL17+ cells in CD4+ T cells. Compared with 
unstimulated control, Th17 cells numbers between tonsillar MNC and PBMC after 
stimulation with PMA/Ion (**p< 0.01, PBMC vs tMNC, n=10). Mean+SEM are shown.  
PBMC tMNC
0.0
0.5
1.0
1.5
2.0
(b)
**
%
 T
h1
7 
ce
lls
Chapter 3: Results 
	  
Page	  |	  85	  	  
	  
(a) 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Figure 3.6 Comparison of frequencies of tonsillar Th17 between adults and children.  
Frequencies of Th17 in tonsillar MNCs in adults and children following stimulation by 
PMA/Ion for 5 hours. (a) A representative density plot of intracellular staining of IL17A in 
tonsillar MNC CD4+ T cells. (b) The mean frequencies of tonsillar Th17 in adults (n= 22) 
and children (n= 35). Mean + SEM are shown. ***p< 0.001, children vs adults. 
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3.4.4. Association of Th17 frequency and age and pneumococcal carriage 
The relationship between frequencies of tonsillar Th17 and ages of patients were 
analysed. There was a significant difference between older children younger 
children. The frequencies of tonsillar Th17 in younger children <10 were 
significantly lower than those subjects >10 years (figure 3.7.).  
Relationship between frequencies of tonsillar Th17 and pneumococcal carriage in 
children was also analysed. Children who were culture-negative for pneumococcus 
tended to have a relatively higher frequency of tonsillar Th17 cells compared to in 
those children who were culture-positive (figure 3.8, p>0.05), although the 
difference was not statistically significant. The mean frequency of tonsillar Th17 
cells in culture-positive children was 1% compared to 1.3% in culture-negative 
children. 
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Figure 3.7 The relationship between Th17 numbers and age. 
Tonsillar MNC were stimulated by PMA/Ion for 5 hours in the presence of brefeldin A. 
Flow cytometry of intracellular staining of IL17A in CD4+ T lymphocytes was used in this 
experiment.	  An age-related increase in Th17 numbers was shown between different age 
groups 2-4 years (n=22), 5-10 years (n=8), 11-16 years (n=5) 17-22 years (n=13) and 
=>25 years (n=9). Mean+ SEM are shown.   *p< 0.05, **p<0.01, **p<0.001 compared to 
groups 2-4 years. ANOVA and student-t test were used. 
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Figure 3.8 Comparison of tonsillar Th17 frequencies between culture+ and culture- 
children. 
Comparison between children who were culture+ (black column, n=14) for pneumococcus 
and those who were culture- (white column, n=21) in Th17 frequency in tonsillar MNC. 
Mean+SEM are used. p>0.05, culture+ vs culture -. 
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3.4.5. Relationship between the ratio of tonsillar Th17/Treg, age and 
pneumococcal carriage 
It has been postulated that mucosal Th17 and Treg play opposite roles in 
mediating immunity to an infection. We sought to find out whether the ratio of 
adenotonsillar Th17/Treg is important in mediating pneumococcal carriage in 
children and adults. There appeared to be a positive correlation between the ratio 
of Th17/Treg in tonsillar tisuues and age ((figure 3.9, ***p ˂ 0.001). In adults, the 
ratio of tonsillar Th17/Treg MNC was shown to be significantly higher than in 
children with a mean ratio of 0.67 in adults and 0.23 in children respectively  (figure 
3.10, ***p ˂ 0.001).   
When the ratio of tonsillar Th17/Treg was analysed in association with 
pneumococcal carriage, children who were culture positive for pneumococcus 
showed a higher ratio of Th17/Treg than those children who were negative culture 
with a mean ratio of 0.27 and 0.14 respectively (figure 3.11, *p< 0.05).   
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Figure 3.9 Relationship between the ratio of Th17/Treg and age. 
There is a positive correlation between Th17/Treg ratio and patients age (r=0.59, n=56, 
***p< 0.001). An age-related decrease in the ration is shown between different age 
groups. 
	  
	  
	  
	  
	  
	  
	  
	  
Figure 3.10 The ratio of Th17/Treg cells in adults is higher than children. 
The ratio of tonsillar Th17/Treg in adults (n=21) and children (n=35). Mean+SEM are 
shown. ***p<0.001, adults vs children. 
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Figure 3.11 Relationship between the ratio of Th17/Treg cells and pneumococcal 
carriage in NALT in children.  
The ratio of tonsillar Th17/Treg in children who were culture positive (n=13) with 
pneumococcus compared with those who were culture negative (n=22). Mean+SEM are 
shown. *p< 0.05 culture+ vs culture -. 
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3.4.6. Response of Th17 and Treg in pneumococcal carriage 
3.4.6.1. Pneumococcal culture supernatant activates Treg and Th17 
response  
To determine whether Streptococcus pneumoniae activates Treg and/or Th17 cell 
response, Pneumococcal (concentrated) culture supernantant (CCS) was 
prepared and used for stimulation of tonsillar MNC. As can be seen from figure 
3.12.a+b, there is a significant increase in both Th17 and Treg following 
pneumococcal CCS as compared to medium control (Todd-Hewitt Broth).  That 
suggests pneumococcal CCS (which contains secreted components of 
pneumococcus) can activate both Th17 and Treg.    
 
 
 
 
	  
	  
	  
Figure 3.12 Activation of tonsillar Th17 and Treg by pneumococcal CCS.  
Tonsillar MNC was co-incubated with pneumococcal CCS or with medium alone (Todd-
Hewitt Broth, THB) for 24 hours (n=6). (a) The response of Treg cells and (b) Th17 
response (*p< 0.05, ***p< 0.001 as compared to medium alone (control).  Mean+ SEM are 
shown. 
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3.4.6.2. Association of pneumococcal carriage and frequencies of tonsillar 
Th17 and Treg following pneumococcal CCS stimulation  
After stimulation of tonsillar MNCs with pneumococcal CCS (D39) for 24 hours, 
Frequencies of Foxp3+ Treg was determined (see materials and methods) as the 
percentage (%) of CD4+ cells. Pneumococcal CCS stimulation appeared to induce 
a stronger increase in Treg frequency in culture-positive children compared to 
culture-negative children (Fig.3.13.a, *p< 0.05). By contrast, following in vitro 
stimulation by pneumococcal CCS, the frequency of tonsillar Th17 was shown to 
be higher in culture-negative children (mean: 0.8%) compared to culture-positive 
children (mean: 0.4%) (Fig.3.13.b, **p< 0.01). Similarly, when the ratio of tonsillar 
Th17/Treg was analysed in association with pneumococcal carriage after 
pneumococcal stimulation, a higher ratio of Th17/Treg was shown in children who 
were culture-negative for pneumococcus than those children who were culture-
positive (Fig.3.13.c, *p< 0.05).  
Furthermore, data in Fig.3.14 showed that there was an inverse correlation 
between tonsillar Th17 and Treg frequencies in children after pneumococcal 
stimulation. It is possible that the pathway for the induction of one cell subset 
inhibits the pathway of the other.  
 
 
 
Chapter 3: Results 
	  
Page	  |	  94	  	  
	  
 
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
 
 
 
	  
Figure 3.13 Association of pneumococcal carriage status and Th17 and Treg 
response following stimulation by pneumococcal CCS in children  
Comparison of the frequencies of tonsillar Foxp3+ Treg (a), Th17 (b) and of the ratio of 
Th17/Treg (c) between culture+ and culture- children.  (culture +, n=13  and culture -, 
n=27). Significance (*p<0.05, **p< 0.01, student-t test) between culture – and culture + 
children.  
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Figure 3.14 Relationship between Th17 andTreg requencies in children. 
There is an inverse correlation between frequencies of tonsillar Treg cells Th17 cells in 
children following pneumococcal stimulation (r=-0.36, n=42, *p< 0.05).  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
0 1 2 3
0
5
10
15
r=-0.36
p= 0.03
n=42
% Treg
%
 T
h1
7
Chapter 3: Results 
	  
Page	  |	  96	  	  
	  
3.4.6.3. Production of IL17A and TGF-beta following pneumococcal CCS 
stimulation 
In vitro production of IL17A in human tonsillar MNC after stimulation with 
pneumococcal D39wt CCS was analysed by ELISA in cell culture supernatants. 
Kinetics of IL17A production in culture supernatants at different time points (0, 24, 
48, and 72 hours) following pneumococcal CCS stimulation was performed. The 
peak concentration of IL17A cytokine was shown at 72 hours following stimulation 
(figure 3.15 ***p<0.001).  
After stimulation by pneumococcal CCS, the level of IL17A in cell culture 
supernatant of adults was shown to be significantly higher than in children 
(Fig.3.16.a). The concentration of TGF-beta in cell culture supernatants of children 
was higher than adults although there was no significant difference between adults 
and children (Fig.3.16.b)  
Following pneumococcal CCS stimulation, the mean IL17A concentration in MNC 
culture supernatant of children who were culture-negative for pneumococcus was 
also shown to be higher than in children who were culture-positive (figure 3.17.b, 
**p<0.01). By comparison, the mean concentration of TGF-beta in MNC culture 
supernatants was higher in children who were culture positive (+) than in those 
who were culture negative (-) (Fig.3.17.a, *p< 0.05). 
 
 
 
Chapter 3: Results 
	  
Page	  |	  97	  	  
	  
 
 
 
 
 
 
 
 
Figure 3.15 Time curve of IL17A production in tonsillar MNC following 
pneumococcal CCS stimulation.  
The level of Il17A cytokine was measured by ELISA assay after cells stimulation with 
pneumococcal CCS at different time points (0hr-72hr; n=10). Mean+SEM are shown. ***p< 
0.001 one-way ANOVA to compare between different time points. 
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Figure 3.16 Comparison of the concentrations of IL17A and TGF-β in tonsillar MNC 
culture supernatants between adults and children.  
Cytokine measurement of IL17A (a) TGF-beta (b) in MNC culture supernatant of adults 
(n=5 a) and children (n=20), after 72 hours of CCS stimulation. Data represent the median 
with interquartile range of cytokine levels (pg/ml) measured by ELISA. Mean+ SEM are 
shown and student-t test was used (a). Data represent the median with interquartile range 
of TGF-beta levels (pg/ml) measured by ELISA (b). **p<0.01, compared adults vs children. 
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Figure 3.17 The concentrations of IL17A and TGF-β between between culture (-) and 
culture (+) Children. 
Concentrations of TGF-beta (a) and IL17 (b) in tonsillar MNC culture supernatant following 
pneumococcal CCS stimulation were analysed by ELISA in culture+ (n=11) and culture- 
children (n=16). Data represent the median with interquartile range of TGF-beta levels 
(pg/ml) measured by ELISA (a). Mean+ SEM are shown and student-t test was used (b). 
*p<0.05, **p<0.01 comparison between culture (–) and culture (+). 
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3.4.7. Effect of tonsillar Treg cells on pneumococcal CbpA- specific antibody 
production 
To assess the effect of Treg cells in NALT on antibody production, depletion of 
Treg cells from tonsillar MNC was performed using anti-CD25 antibody labelled 
magnetic beads and MACS cell separation. There was a significant increase in the 
level of IgG antibody to choline-binding protein (CbpA) following pneumococcal 
CCS stimulation in Treg-depleted MNC as compared to that in unfractionated MNC 
(Fig.3.18, **p< 0.01).  
 
 
 
 
 
 
 
 
 
Figure 3.18 Depletion of Treg cells from MNCs increases the level of CbpA- specific 
IgG antibody production following pneumococcal CCS stimulation. 
Culture supernatant was collected after 14 days of pneumococcal CCS stimulation of 
either unfractionated MNC or Treg-depleted MNC. The level of CbpA-specific IgG antibody 
production was measured by ELISA. n=8. Mean+ SEM are shown. **p< 0.01, compared to 
Treg-depleted MNC.  
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3.5. Discussion 
Data on the relationship between mucosal Th17 or Treg and age in humans are 
limited. This is the first study to show that there is a differential correlation between 
mucosal Th17 and Treg with age. 
It has been hypothesised that mucosal Treg and Th17 cells in NALT may play a 
crucial role in mediating the persistence or clearance of pneumococcal carriage in 
human nasopharynx. To determine whether this is true, we have performed a 
number of experiments to analyse the frequencies of Th17 and Treg in tonsillar 
tissues of children and adults and their relationship to pneumococcal carriage 
status.  
It has been shown that the frequency of Treg cells in tonsillar tissue in each 
subject was generally higher than in peripheral blood. This may suggest the 
mucosal compartment within human nasopharynx develops a higher number of 
Treg due to the exposure of microorganisms than in peripheral blood (representing 
systemic compartment which is normally sterile), and also suggest the presence of 
antigen-specific (inducible) Treg in human NALT. Furthermore, we showed that 
there was a difference between adults and children in the frequency of Treg in 
tonsillar tissues. The frequencies of tonsillar Treg of children were generally higher 
than in adults, and there appeared an age-associated decrease in tonsillar Treg 
numbers (Fig.3.1). That appeared to be an inverse relationship between the Treg 
frequency in tonsillar tissues and age (Fig.3.3). Overall, younger children <10 
years were shown to have higher Treg numbers than those those subjects >10 
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years. This would support the hypothesis that extensive exposures to 
microorganisms in childhood are associated with the induction of Treg. It may be 
that the local colonisation with microorganisms could induce antigen-specific Treg 
cells thus leading to high numbers of Treg in NALT tissues, and this may 
contribute to the persistence/carriage of specific microbes (Zhang et al. 2011). 
Induction of pathogen-specific Treg has been shown during infections with HIV, TB 
and leishmania in the local inflammation site (i.e.; lymphoid tissue) (Andersson et 
al. 2005; Belkaid et al. 2002; Nilsson et al. 2006; Shafiani et al. 2010). It has been 
suggested that the accumulation of stimulated natural and adaptive Treg cells 
might be induced by microbial pathogens in peripheral tissues and that may help to 
maintain the host homeostasis (Andersson et al. 2005; Belkaid 2008). By the age 
of 2 years in this study, the frequency of tonsillar Treg already reached a high 
level. Considering that earlier childhood (<2 years) is a period of intense exposure 
to multiple microorganisms, during which bacterial colonisations are common, the 
priming of antigen-specific Treg cells during this period is also likely to be intense 
and lead to the enrichment of Treg in the nasopharynx.     
Pneumococcal carriage is common in children especially in younger children. With 
increasing age, pneumococcal carriage rate gradually decreases (Bogaert, De 
Groot & Hermans 2004; Granat et al. 2009). During carriage, antigen-specific 
immunity develops to protect against the subsequent colonisation (Cohen et al. 
2011; Richards et al. 2010; Zhang, Clarke & Weiser 2009). There appeared to be a 
difference in the frequency of Treg cells which was higher in culture-positive than 
in culture-negative children. This suggests that the induction/promotion of Treg in 
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tonsillar tissues may contribute to pneumococcal colonisation in the nasopharynx. 
Also, the delayed clearance or pneumococcal colonisation persistence in children 
may occur in the existence of Treg cells (Zhang et al. 2011).  
In a mouse study, it has been suggested that the successful prevention of 
nasopharyngeal carriage with the same serotype of pneumococcus was not 
necessary (Richards et al. 2010). Also, young children who had previous 
pneumococcal carriage may develop serotype-independent immunity and thus 
reduce the rate of subsequent colonisation, regardless of the serotypes. (Granat et 
al. 2009). This was consistent with a study conducted on African children. It has 
showed that the pneumococcal response at mucosal surface was highly regulated 
by the presence of Treg cells. Thus, it prolonged the nasopharyngeal colonisation 
(Glennie et al. 2012). Regulation of the mucosal immune system is common in 
other bacterial colonisation including Neisseria meningitidis	   (Davenport et al. 
2007). MenB antigens enhanced the acquisition of mucosal immunity which is 
accompanied by the induction of regulatory activity. So, the activity of Treg cells is 
capable of limiting cellular response to the bacteria (Davenport et al. 2007). 
Then, the frequency of Th17 cells was analysed in tonsillar MNC following 
stimulation by PMA and ionomycin. It has been shown that Th17 frequency in 
tonsillar MNC was significantly higher than peripheral blood (Fig.3.5). It has been 
previously shown that the Th17 detected in NALT tissues were primarily memory 
Th17 cells, as depletion of CD45RO+ T cells abrogate the Th17 cells in tonsillar 
MNC (Gray et al. 2014).  It is likely that the mucosal Th17 in human NALT were 
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primed largely by previous microbial infection/colonisations in the nasopharynx. 
The relationship between frequencies of tonsillar Th17 and ages of patients was 
analysed. It has been demonstrated that the frequency of tonsillar Th17 in adults 
was higher than in children and further analysis showed there was an age-
associated increase in the Th17 frequency. Numbers of tonsillar Th17 in younger 
children <10 were significantly lower than those in subjects >10 years (Fig 3.7.).  
 
It is known pneumococcal carriage rate decreases with age. It has been 
hypothesised that mucosal Th17 in the nasopharynx may play a role in the age 
associated decrease in pneumococcal carriage because the human nasopharynx 
is a site of colonisation of many microorganisms that may prime for Th17 in NALT.  
 
The relationship between frequencies of tonsillar Th17 and pneumococcal carriage 
in children was analysed. There was a trend to show culture-negative children had 
higher frequency of tonsillar Th17 cells compared to in culture-positive children, 
although this difference was not statistically significant (Fig 3.8). This is consistent 
with the hypothesis that Th17 may play a role in mucosal defence against 
microbial infection (Wu et al. 2007). There is growing evidence of Th17 cells 
playing an important role in mediating host mucosal immunity to a number of 
pathogens including Klebsiella pneumoniae, Pseudomonas aeruginosa, and 
Candida albicans (Acosta-Rodriguez et al. 2007; Curtis & Way 2009; Huang et al. 
2004). 
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It has been sought to determine the relationship between the ratio of Th17/Treg in 
NALT and different ages. There appeared to be a positive correlation between the 
ratio of Th17/Treg in tonsillar tissues and different ages. The mean ratio of tonsillar 
Th17/Treg MNC was shown to be significantly higher in adults than children (Fig 
3.9). As we showed earlier that mucosal Treg frequency also appeared to be 
associated with pneumococcal carriage rate, we sought to determine the 
relationship between the ratio of Th17/Treg in NALT and carriage status of 
pneumococcus. Indeed, the mean ratio of Th17/Treg was shown to be higher in 
culture-negative children than culture-positive children. This suggests the ratio of 
Th17/Treg may be a crucial determinant of pnemococcal clearance. It may be 
argued that as the ratio of tonsillar Th17/Treg increases with age and both are 
inversely correlated with carriage rate, some other age-associated yet unknown 
immunological factor(s) may be important in this aspect.  
To ascertain the importance of the ratio of tonsillar Th17/Treg in pneumococcal 
carriage, children less than 10 years were further analysed, as within the age 
group, the mean ratio of Th17/Treg changes little. It was shown that in this age 
group, culture-negative children had higher ratio of tonsillar Th17/Treg than 
culture-positive children. This finding would support that a higher Th17/Treg ratio in 
NALT contributes to clearance of mucosal carriage of pneumococcus.  
In this study, pneumococcal culture supernatant (CCS, containing secreted 
pneumococcal components including proteins) derived from a wild type strain was 
used to stimulate tonsillar MNC. It was shown to elicit a significant increase in 
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Th17 number which was higher in culture-negative children than culture positive 
(Fig.3.13.b).  This would support the presence of memory Th17 in tonsillar tissue, 
presumably primed by previous pneumococcal colonisation in children, as 
pneumococcus is one of the most common colonisers in early childhood. Similarly, 
stimulation by pneumococcal CCS also elicited an increase in Foxp3+ Treg 
number (Fig.3.12.a). Our previous work suggested that within the adenotonsillar 
tissue, there were memory/effector Th17 and Treg (Gray et al. 2014; Zhang et al. 
2011), as specific stimulation by pneumococcal antigens could activate these cells. 
Moreover, the increase of Treg was shown to be higher in culture-positive children 
than culture negative children (Fig.3.13.a) whilst the ratio of Th17/Treg cells was 
much higher in culture negative than culture positive (Fig.3.13.c).  Again, this 
suggests the presence of pre-existing specific-Treg in NALT presumably primed by 
previous pneumococcal colonisation. Additionally, it may support the hypothesis 
that induction of antigen-specific Treg in vivo can be promoted by local 
colonisation with pneumococcus at mucosal site, which leads to the proliferation of 
Treg cells following stimulation with pneumococcal WCA (Zhang et al. 2011).  
 
It has been shown in this study that there was an inverse correlation between 
tonsillar Th17 and Treg frequencies (Fig.3.14). So it is possible that the pathway 
for the induction of one cell subset inhibits the pathway of the other. The induction 
of tonsillar Th17 cells in NALT may be inhibited by the early induction of inducible/ 
Treg cells in NALT in early childhood due to the enhanced exposure to 
microorganisms in the nasopharynx (Gray et al. 2014). Therefore, the increased 
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priming for IL17A secretion may consider as an important mechanism to clear 
pneumococcus from nasopharynx (Malley & Anderson 2012). Repeated exposure 
to pneumococcus in childhood may contribute to increase the inducible Treg cells 
in early childhood, and that may delay the induction of Th17 and contribute to the 
persistence of pneumococcal carriage. Priming for Th17 cells in early life, that may 
inhibit induction of Treg in NALT may be an attractive vaccination strategy against 
pneumococcal colonisation (Gray et al. 2014).  
 
Production of IL17A in human tonsillar MNC following stimulation with 
pneumococcal CCS was also observed, which was significantly higher in adults 
than children (Fig.3.16.a), which was consistent with tonsillar Th17 frequencies. 
IL17A produced from Th17 cells, is involved in the recruitment and activation of 
neutrophils that is associated with phagocytic killing (Lu et al. 2009), and likely act 
through the induction of pro-inflammatory mediators such as granulocyte colony-
stimulating factor (G-CSF) and CXC chemokines from epithelial cells (Aujla, Dubin 
& Kolls 2007b; Kolls & Linden 2004). A study carried out on adult volunteers 
revealed that rhIL-17A exposure to alveolar macrophages significantly increased 
the killing of opsonised pneumococcus (Wright et al. 2013).  Also, a similar study 
by Lu et al. (Lu et al. 2008) has shown the same pattern but they used human 
neutrophils instead for rhIL-17A exposure in order to increase the pneumococcal 
killing that is mediated by neutrophils.  In addition, it has been shown that the 
clearance of pneumococcal colonisation by activated monocyte/macrophages 
could be mediated via IL17A cytokine (Zhang, Clarke & Weiser 2009). It is possible 
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that IL17A promotes pneumococcal clearance through recruitment of neutrophils 
and monocyte/macrophages to mucosal site. It is suggested that macrophages are 
involved in the clearance of primary and secondary bacterial colonisation, but 
neutrophils are very crucial for the secondary colonisation (Zhang, Clarke & 
Weiser 2009). Studies in mice showed that the response of IL-17A following 
immunisation is associated with decreased pneumococcal carriage which supports 
a critical role of IL17A in pneumococcal clearance (Lu et al. 2009).  
TGF-β is known to be important in the induction of Foxp3+Treg and Th17.  At low 
concentrations, TGF-β1, together with IL -6 and IL-21 induces the expression of IL-
23 receptor, and promotes the differentiation of Th17 cells. At high concentrations, 
TGF-β1 promotes the development of Foxp3+Treg cells and suppresses the 
expression of IL-23 thus inhibiting the differentiation of Th17 (Zhou et al. 2008). 
This study has shown that the level of TGF- β in tonsillar cell culture supernatants 
was high, even without any stimulation, in both children and adults. There was a 
significant increase in TGF-beta concentration following pneumococcal CCS 
stimulation (Fig.3.16.b). It has been shown that many cells produce TGF-β 
including macrophages, antigen-presenting cells (APCs), epithelial cells as well as 
Treg of the mucosal tissues (Chen & Konkel 2010; Pyzik & Piccirillo 2007). It is 
possible that within adenotonsillar tissue, a number of cells produce TGF-β 
constitutively thus there is a relatively high level of TGF-β in NALT, which is 
considered as a favourable environment for the development of Treg cells when 
there are pathogen/antigens (eg. pneumococcus) in the nasopharynx. There was 
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no marked difference between children and adults although the median level of 
TGF-β in children was silightly higher than adults.  
It has been shown in murine studies that nasopharyngeal carriage of 
pneumococcus induces Treg cells that were associated with high levels of TGF-β 
in the nasopharynx. The initial colonisation at a low density may activate TGF-β- 
signalling leading to a high TGF-β environment and persistence of pneumococcal 
carriage (Neill et al. 2014). It has been shown that the level of TGF-β in tonsillar 
MNC culture supernatants was higher in children who were culture positive (+) 
than in those who were culture negative (-). On the contrary, IL17 production was 
higher in culture (-) than culture (+) (Fig.3.17.). Together with the finding that a 
higher Treg frequency was observed in culture-positive than negative children, this 
result supports the hypothesis that TGF-β signalling plays an important role in Treg 
cell induction in human NALT and nasopharyngeal carriage of pneumococcus.  
To determine whether the Treg in NALT are functional, we analysed their effect on 
antibody production by tonsillar cells. Depletion of Treg from tonsillar MNC leads to 
a significant increase in antibody production to pneumococcal choline binding 
protein following pneumococcal CCS stimulation (Fig.3.18). Treg cells may have 
direct or indirect effects on the antibody response through inhibition of effector T 
cell responses.   
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3.6. Summary 
Our results have suggested that there are prominent numbers of Th17 and Treg 
cells in tonsillar tissues that were significantly higher than in peripheral blood in 
children and adults, which may play an important role in mediating nasopharyngeal 
carriage of pneumococcus.  In general, the frequency of Treg in NALT decreases 
with age, whereas Th17 increase with age. Also the ratio of tonsillar Th17/Treg 
was shown to increase with age and shown to be higher in pneumococcal culture-
negative children than in culture-positive children.  Pneumococcal simulation of 
tonsillar cells elicited a significant increase in both Th17 and Foxp3+ Treg 
suggesting the presence of antigen-specific Th17 and Treg in human NALT, 
presumably primed by previous colonisation of pneumococcus. Our results 
suggest the ratio (or balance) of Th17/Treg in nasopharynx-associated lymphoid 
tissue is a critical determinant of pneumococcal clearance or persistence/carriage 
in human nasopharynx. 
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4.1. Introduction 
In the previous chapter, it has been shown that adenotonsillar tissue has a 
significant number of Th17 and Treg cells, and pneumococcal stimulation induces 
increases in numbers of Th17 and Treg. In this study, we aimed to study whether 
pneumococcal proteins are involved in activation of Th17 and Treg. 
Pneumococcus is a major cause of morbidity and mortality amongst all ages, 
especially children and elderly. It can cause a wide range of diseases such as 
meningitis, septicaemia, and pneumonia. Also, it also causes otitis media in 
children.(Siber 1994; Zhang et al. 2006b). Pneumococcus has several virulence 
factors, including capsule, cells wall, pneumolysin and surface proteins. 
Pneumococcal proteins including pneumolysin, pneumococcal surface protein A 
(PspA), pneumococcal surface adhesin A (PsaA), and choline-binding protein A 
(CbpA) have been studied as candidate vaccines against pneumococci infection 
(Briles et al. 2000a; Briles et al. 2000b). 
Pneumolysin is a cholesterol-dependent cytolytic pore-forming toxin. It is 
expressed in virtually all clinical isolates (Paton 1998). It has a number of actions, 
such as complement activation (Kadioglu et al. 2008), stimulation of host cell 
apoptosis, binding to cholesterol molecules in host cell membranes and then 
entering into the membrane to form a pore 350 to 450 Å in diameter (Price & 
Camilli 2009). It has been shown that Ply and its toxoids as vaccine candidates 
have the capability to induce a protective immunity against invasive infection and 
ccolonisation in animal models (Kirkham et al. 2006; Ogunniyi et al. 2001). Studies 
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in animal model have shown that immunization with pneumococcal antigens, 
including PspA, pneumolysin, PsaA, and CbpA by intranasal route, may induce 
immune protection against invasive disease as well as nasopharyngeal carriage 
(Briles et al. 2000a; Briles et al. 2000b; Ogunniyi et al. 2001).  
Pneumococcus colonises the upper respiratory tract and can cause invasive 
disease in some individuals, especially in the high-risk groups. Since pneumococci 
can evade and colonize the nasopharynx, mucosal vaccination may be an effective 
vaccination strategy to protect against pneumococcal infection (Zhang, Choo & 
Finn 2002). It has been found that the pneumococcal protein antigens are probable 
has the efficiency to induce protection against a vast majority of pneumococcus 
serotypes as well as they might be effective as vaccine and they are inexpensive 
for manufacture. Thus, there is a strong possibility that Immunisation of mice with 
pneumococcal protein antigens can lead to a protection from pneumococcal 
infection (Paton 1998). A combination of these antigens may provide a high degree 
of protection to a wide range of pneumococcal strains than using a single protein 
antigen. These proteins provide a T-cell dependent antigen response which is 
likely to elicit high immunological memory response in human infants. (Paton 
1998). It has been suggested that CD4 (Kadioglu et al. 2004; Malley et al. 2005) 
and T helper 17 (Th17) cells (Lu et al. 2008; Zhang, Clarke & Weiser 2009) in 
particular have important role in animal studies in mediating the clearance of 
nasopharyngeal ccolonisation of pneumococcus. For this reason, in this study, we 
studied pneumococcal protein antigens which are likely activate Treg and Th17 
cells, as we have shown in previous study that pneumococcal proteins may 
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involved in the accumulation and activation of numbers of tonsillar Treg cells with 
effector/memory phenotype (Zhang et al. 2011) as well as Th17 cells (Gray et al. 
2014). Pneumococcal whole cell antigen (WCA) can promote the increased 
numbers of Treg in adenoidal MNC (Zhang et al. 2011). It has been demonstrated 
in mice models that Th17 cell signature cytokines (IL17A, IL17F and IL22) have a 
crucial role for protection against several pathogens in the respiratory tract 
(O'Connor, Zenewicz & Flavell 2010). That suggested the mechanism of Th17 
pathway might be very important for pathogen clearance at mucosal surfaces 
(Curtis & Way 2009; O'Connor, Zenewicz & Flavell 2010). 
	  
4.2. Aims of study 
In this chapter it was sought to examine: 
1. What components of pneumococcal culture supernanant (CCS) activate 
Foxp3+ Treg and Th17 cells,  
2. Whether recombinant pneumolysin protein (rPly), its toxoid (PdB) and  
CBP activate Th17 and Treg cells.  
 
4.3. Design of experiment 
Tonsillar MNCs were stimulated by pneumococcal CCS either derived from wild 
type (D39wt), derived from Ply- or CbpA- mutant strains, or by purified 
pneumococcal proteins. Following stimulation, intracellular staining of Foxp3 and 
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IL17A was performed followed by flow-cytometry for analysis of frequency of Th17 
and Treg in tonsillar MNC. 
 
4.3.1. Human subjects and samples  
In this study, tonsillar tissues samples were obtained from adults and children 
aged between 2-36 years who had tonsillectomy. Individuals who were taken 
antibiotics within 3 weeks prior to the operation and who had serious infection or 
immunodeficiency were excluded from the study. Informed consent was obtained 
from children’s parents or custodian in each case. 
  
4.3.2. Pneumococcal culture supernatant 
A standard pneumococcal strain (D39) was used prepare pneumococcal culture 
supernatant (CCS). Pneumococcal CCS was also prepared from an isogenic 
choline binding protein A–deficient mutant (CbpA-), and an isogenic pneumolysin-
deficient mutant (Ply-) strain, (Berry et al. 1999) and (Ogunniyi et al. 2000). 
Pneumococcal CCS was prepared from all three strains mentioned above and 
concentrated by a method as previously described. To determine the optimum 
concentration of pneumococcal CCS for cell stimulation, a range of concentrations 
at 1, 2, and 4µg/ml was used for cells stimulation. To assess the response of both 
the CD4+ Th17 cells CD4+Foxp3+ Treg cells and also Th17 cytokine responses, 
tonsillar MNC stimulation by different types of pneumococcal CCS were used at 
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2µg/ml after determining the optimal concentration and dose response for cell 
stimulation.  
 
4.3.3. Purified pneumococcal protein antigens 
Recombinant proteins including wild type pneumolysin (rPly) and its toxoid PdB 
(W433F) were used as antigen stimulants. Recombinant Ply has a strong 
hemolytic activity, whereas PdB is a toxoid derivative form of pneumolysin with a 
mutation of amino acid Trp433-Phe which reduces the haemolytic activity to 
approximately 1% without affecting antigenicity (Palaniappan et al. 2005; Paton et 
al. 1991). The endotoxin level of the recombinant proteins were <0.01ng/µg of 
protein, as determined by the Limulus assay. To optimise the concentrations of 
those proteins for cell stimulation, a range of concentrations of rPly at 10, 50 and 
100ng/ml and of PdB at 0.1, 0.25 and 0.5µg/ml was used for cell stimulation. The 
optimal doses of rPly and PdB for activation of Treg and Th17 cells were at 
50ng/ml and 0.25µg/ml respectively.  Additionally, choline-binding proteins (CPB) 
that contain native proteins such as CbpA and PspA were prepared from D39wt 
pneumococcal CCS by affinity purification using a choline column (Zhang et al. 
2010). The optimal concentration of CBP was determined and used at 2µg/ml in 
cell stimulation.  
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4.3.4. Stimulation of tonsillar MNC by pneumococcal CCS and 
pneumococcal proteins 
Tonsillar MNCs were isolated from the tonsillar tissues by Ficoll were then 
resuspended at 4x106 /ml in RPMI-1640 culture medium and stimulated with 
pneumococcal CCS derived from wild type D39wt, and CbpA- and Ply- mutant 
strains at 2µg/ml or recombinant proteins (Ply, 50ng/ml), (PdB 0.25µg/ml) or (CBP 
2µg/ml). Briefly, the cells were stimulated with CCSwt and other mutant types of 
CCS for 24 hr at 37˚C, in the presence of CO2 (5%) and followed by addition of 
Brefeldin A (BFA) for 6 hr to immobilise IL-17A inside the cells. Cells were 
collected in 0.02% of BSA in PBS. To measure the Th17 cytokine production with 
in vitro CCS stimulation, cell culture supernatants were collected after 72 hr and 
stored at –70°C before analysed by ELISA. 
  
4.3.5. Intracellular staining of Treg and Th17 cells 
Following stimulation, tonsillar MNC were stained with T cell markers followed by 
intracellular staining for Foxp3 and IL17A. Fixation/Permeabilization buffer 
(eBiosciences), was used after staining the surface markers and incubated for 30 
min at 4˚C.  Subsequently, cells were incubated with mouse anti-Foxp3-Alexa-488 
and anti-IL17A-PE (BD Bioscience) for 30 min in the dark place at RT. Then, cells 
were washed with permeablisation buffer 1x. Finally, the cells were re-suspended 
in the buffer for analysis by flow cytometry (FACSCalibur; BD Biosciences).  
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Th17 cell populations and Tregs were determined within the CD4+ and CD3+ gate 
and the absolute numbers of both Th17 and Treg cells were determined as the 
percentage of cells staining by anti-IL17A and Foxp3 respectively. Flow cytometric 
data were analyzed using WinMDI software (version 2.9).   
 
4.3.6. IL17A cytokine measurement in tonsillar MNC culture supernatant by 
ELISA 
Human IL-17A Ready-Set-Go® ELISA sets (eBioscience, UK) was used, following 
manufacturer’s instructions and the detailed procedures are described in materials 
and methods’ chapter. To assess the level of IL17A cytokine in culture 
supernatant, tonsillar MNC was stimulated with D39wt pneumoCCS, CbpA- and 
Ply- for 72 hr then culture supernatant was collected and stored in -80˚C for the 
analysis. Briefly, ELISA plate was coated with 100µl/well of capture antibody for 
overnight incubation at 4°C. The plate was washed and then blocked for one hour. 
Diluted samples (1:20) were added to the appropriate wells and incubated for 2 hr. 
After washing the plate, detection antibody was added into the wells and incubated 
for 1 hour. Avidin-horse radish peroxidase (HRP) was added and incubated for 30 
min. Substrate solution was added and incubated at room temperature for 15 min. 
Finally, 50µl of stop solution (2N H2SO4) was added to each well. The plate was 
read immediately at 450nm using the plate reader (Opsys MR, Thermo 
labsystems, UK). The cytokine concentration (pg/ml) was calculated against the 
standard curve, with the help of microplate analysis software DeltasoftPC 
(Biometallics, Inc., USA). 
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4.3.7. Statistical analysis 
Data were tested for normality and followed by analysis by student’s t test non-
normally distributed data were analysed by Wilcoxon signed rank test 
(nonparametric test), to assess the difference between un-stimulated and 
stimulated cells. A p value of <0.05 was considered statistically significant. 
Statistical analysis was performed using GraphPad Prism software (version 5). 
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4.4. Results 
4.4.1. Optimal doses of pneumococcal CCS and recombinant proteins for 
Th17 and Treg cell stimulation 
To optimise dose response of D39wt CCS and pneumococcal recombinant 
proteins (rPly and PdB), tonsillar MNCs were stimulated for 24 hours at different 
doses to analyse the frequencies of both Treg and Th17 cells among CD4+T 
populations. The optimal concentration was determined by stimulation of 4 
samples (n=4) with different concentrations. Different doses were used for D39wt 
CCS  (1.0, 2.0 and 4.0µg/ml), for rPly (10, 50 and 100ng/ml) and for PdB (0.1, 0.25 
and 0.5µg/ml). The optimum doses for Treg and Th17 response for D39wt CCS, 
rPly, and PdB were 2µg/ml, 50ng/ml and 0.25µg/ml respectively (Fig.4.1. and 
Fig.4.2.). The concentration of 2µg/ml was used to stimulates tonsillar MNCs by all 
three different pneumococcal CCS (D39wt, Ply- and CbpA-) in the following 
experiments. 
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Figure 4.1 Dose-response curve for Treg cell stimulation. 
Pneumococcal D39wt CCS (a), recombinant Ply (b) and PdB (c) proteins were used to 
stimulate tonsillar MNC followed by analysis of Treg frequency (n=4). Results are 
expressed as mean percentage of cells + SEM (error bars). 
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 Figure 4.2 Dose-response curve for Th17 cell stimulation.  
Pneumococcal D39wt CCS (a), recombinant Ply (b) and PdB (c) proteins were used to 
stimulate tonsillar MNC followed by analysis of Th17 frequency (n=4). Results are 
expressed as mean percentage of cells + SEM (error bars). 
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4.4.2. Pneumococcal CCS derived from CbpA- and Ply- mutant strains elicit 
lower Treg response than wild type CCS 
To determine whether pneumococcal proteins pneumolysin or CbpA contribute to 
activation of Treg in NALT, tonsillar MNCs were stimulated for 24 hours by 
pneumococcal CCS derived from wild type, from Ply- or CbpA- mutant strains. 
Following stimulation, the cells were stained for Foxp3+ Treg as described in 
methods. Fig.4.3.a shows a representative experiment and Fig.4.3.b shows the 
mean frequencies of Treg cells.  As can be seen from the figures, CCS from CbpA- 
(**p<0.01) and Ply- (*p<0.05) mutant strains induced less Foxp3+ Treg than 
pneumococcal CCS derived from wild type (D39wt) strain; although both Ply- 
(**p<0.01) and CbpA- (*p<0.05) CCS appeared to induce higher Foxp3+ Treg cells 
than unstimulated cells.  
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Figure 4.3 Activation of tonsillar Treg cells by D39wt CCS and CCS from CbpA- and 
Ply- mutants. 
Density plot shows expression of Foxp3 in Treg cells gated for CD4+ T lymphocytes in 
one representative experiment (a). The mean frequency of Foxp3+Treg cells was 
measured after 24 hours of stimulation with D39wt, CbpA-, or Ply- CCS. ***p<0.001, 
**p<0.01, *p<0.05, compared to medium control. *p<0.05, **p<0.01, mutants compared to 
wild type pneumococcal CCS, n=14). Paired-t test was used. Mean+ SEM are shown.  
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4.4.3. Pneumococcal CCS from CbpA- and Ply- strains elicited lower Th17 
than wild type CCS 
To determine whether pneumococcal proteins pneumolysin or CbpA contribute to 
activation of Treg in NALT, tonsillar MNCs were stimulated for overnight by 
pneumococcal CCS derived from wild type or from Ply- and CbpA- mutant strains 
followed by the addition of BFA for 6 hours then cells were stained with anti-IL17A. 
Our results showed that CCS deficient of CbpA and Ply elicited lower numbers of 
CD4+ Th17 cells. Fig.4.4.a shows a representative experiment and Fig.4.4.b 
shows the mean frequencies of Th17 cells.  As can be seen from the figures, CCS 
from CbpA- (*p<0.05) and Ply- (*p<0.05) mutant strains induced less Th17 cells 
than pneumococcal CCS derived from wild type (D39wt) strain. Also, both Ply- 
(*p<0.05) and CbpA- (*p<0.05) can promote/activate Th17 cells compared to 
unstimulated cells. 
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Figure 4.4 Activation of tonsillar Th17 cells by D39wt CCS and CCS from CbpA- and 
Ply- mutants. 
Dot plots showing IL17A-producing cells gated for CD4+ T lymphocytes in one 
representative experiment (a). The mean frequencies of Th17 cells were shown after 24 
hours of stimulation with CCS from D39wt, CbpA-, or Ply- strains. ***p<0.001, *p<0.05, 
compared to medium control. *p<0.05, mutants compared to wild type pneumococcal 
CCS, n=14). Paired-t test was used. Mean+ SEM are shown. 
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4.4.4. Pneumococcal CCS derived from CbpA- and Ply- mutants elicited 
lower IL17A production than wild type CCS: 
Tonsillar MNCs were stimulated with all different CCS for 3 days then the cell 
culture supernatant was collected and analysed for IL17A detection. Similar results 
were shown as above for Th17 frequencies. The mean concentration of cytokine 
IL17A in culture supernatant of tonsillar MNCs was shown to be high after D39wt 
CCS stimulation when compared with unstimulated cells. As can be seen from the 
figure 4.5. CCS from wild type strain induced higher IL17A than CCS of CbpA- 
mutants (*p< 0.05) and Ply- CCS (**p< 0.01) (n=18). Also, Ply- (*p< 0.05) and 
CbpA- (**p< 0.01) CCS were shown to induce higher IL17A than unstimulated 
cells. 
 
 
 
 
 
 
 
 
 
Chapter 4: Results 
	  
Page	  |	  128	  	  
	  
 
 
 
	  
	  
	  
	  
	  
Figure 4.5 IL17A concentrations in adenotonsillar MNC culture supernatants 
induced by CCS from D39wt, CbpA- or Ply- mutant strains. 
IL-17A was measured after 24 hours of stimulation with D39wt, CbpA-, or Ply- CCS. 
*p<0.05, **p<0.01, ***p<0.001 compared to medium control. *p<0.05, **p<0.01 mutants 
compared to wild type pneumococcal CCS, n=18. Paired-t test was used. Mean+ SEM are 
shown. 
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4.4.5. Effect of pneumococcal proteins (rPly, PdB and CBP) on Treg and 
Th17 frequencies: 
As above results showed stimulation with CCS derived from Ply- and CbpA- 
mutants elicited less Treg and Th17 compared to wild type CCS that suggests Ply 
and CbpA may contribute to the activation of Treg and Th17, purified 
pneumococcal proteins were then used in this experiment to determine if individual 
protein activates Foxp3+Treg and Th17 cells.  
As can be seen from figure 4.6, both rPly (n=13) and PdB (n=11) induced an 
increase in Foxp3+Treg frequency (means 6.5% and 5.5% compared to (4.5%) in 
unstimulated cells). CBP (n=8) stimulation also showed an increase in Foxp3+ 
Treg frequency (mean 6 %, compared to 4.5% in medium control. **p< 0.01, 
*p<0.5, paired-t test was used. 
Effect of the proteins on Th17 frequency was shown in figure 4.7. There were 
increases in Th17 frequencies following stimulation by rPly (mean: 0.84%, n=13), 
PdB (mean: 0.76%, n=9) and CBP (mean: 0.82%, n=8) compared to unstimulated 
control (mean: 0.52%). *p<0.5, **p<0.01, paired-t test was used. 
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Figure 4.6 Pneumolysin, toxoid (PdB) and CBP increased Foxp3+ Treg in tonsillar 
cells.  
Density plot shows the percentage of Foxp3+Treg cells in CD4+ T cells in one 
representative experiment (a). Mean frequency of Foxp3+Treg cells after tonsillar MNC 
were shown following stimulation by rPly (b), PdB (c) and CBP (d) for 24hr. **p< 0.01, *p< 
0.05 compared with un-stimulated cells (medium control). Mean+ SEM are shown. 
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Figure 4.7 Pneumolysin, toxoid (PdB) and CBP activate tonsillar Th17 cells.  
Mean frequency of Th17 cells after stimulation tonsillar MNC by rPly (a), PdB (b) and CBP 
(c) for 24hr. **p< 0.01, *p< 0.05 compared with un-stimulated cells (medium control). 
Mean+ SEM are shown.  
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4.5. Discussion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Data on mucosal Treg and Th17 cells in relationship with pneumococcus in 
humans are limited. It is unclear what components of pneumococcus contribute to 
the activation of Treg cells in tonsillar tissue. A previous study showed that a 
pneumococcal whole cell antigen (WCA) induced CD4+ T cell including Treg 
proliferation in tonsillar MNC and that was inhibited by treatment of proteinase, 
therefore suggesting that pneumococcal protein(s) contribute to Treg activation in 
NALT (Zhang et al. 2011). It would be useful to identify what pneumococcal 
components activate Treg or Th17 cells, which may add important information to 
novel vaccination strategies against pneumococcal infection. 
In this study, it has been investigated whether pneumococcal Ply and CbpA 
proteins activate Foxp3+Treg and Th17 cells in NALT. The reaults showed that 
wild type (D39wt) pneumococcal CCS elicited a significant increase in the Treg 
and Th17 frequencies whereas the CCS from mutant strains (Ply- and CbpA-) 
were shown to elicit a lower increase in Treg and Th17 frequencies than wild type 
CCS. Also cytokine measurement of IL17A also showed similar results in that the 
mutant strains derived CCS induced less IL17A. Taken together, our findings 
suggest that pneumococcal Ply and CbpA proteins may contribute to the activation 
of Foxp3+ Treg and Th17 cells in tonsillar MNCs. 
Further examination was performed whether purified individual proteins activate 
Treg and Th17. The results showed that rPly, PdB and CBP proteins all induced 
an increase in Foxp3+Treg, and also appeared to induce an increase in Th17. It 
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has been demonstrated recently that WCA and pneumolysin toxoid (PdB) could 
induce the production of Th17 in human peripheral blood mononuclear cells 
(PBMC) even though Th17 cell numbers detected were low (Lundgren et al. 2012). 
Thus our overall findings in this study support the hypothesis that pneumococcal 
proteins has an important role in activation of Treg and Th17 cells.  
 
The mucosal response to pneumococcal proteins may be highly regulated by 
CD25highTreg cells and this regulation may lead to persistent colonisation and 
delay in the clearance of pneumococcus (Glennie et al. 2012). It has been shown 
that Ply could be used in immunizations to induce protection against 
pneumococcal infection and may prevent nasopharyngeal carriage (Briles et al. 
2000a; Briles et al. 2000b). A study carried out by Pido-Lopes et al also supported 
that the Treg cells have a negative impact on mucosal CD4 response that specific 
for pneumococcus. Depletion of pneumococcal-specific CD25highTreg cells from 
tonsillar MNCs was associated with a significant increase in CD4+ T cell 
proliferation to Ply (Pido-Lopez et al. 2011).   
 
The Treg and Th17 cells detected in adenotonsillar tissues are likely to be primed 
by previous pneumococcal colonisation in the nasopharynx. The findings that 
pneumococcal Ply and CbpA proteins may activate these cells suggest that 
pneumococcal proteins could prime and activate both these Treg and Th17 cells. 
Our previous results support that Foxp3+ Treg and Th17 are enriched in 
adenotonsillar tissues and the results herein further support the presence of 
Chapter 4: Results 
	  
Page	  |	  134	  	  
	  
antigen-specific inducible Treg and Th17 in human NALT, and they may play an 
important role in the modulation of pneumococcal carriage or clearance.  
 
4.6. Summary 
These findings in this study provided supporting evidence that pneumococcal 
proteins including pneumolysin, its toxoid and choline binding proteins may 
activate Th17 and Treg cells in human NALT, and that they may contribute to the 
modulation of pneumococcal carriage or clearance in human nasopharynx. Also, 
these protein antigens may constitute vaccine candidates in mucosal immunization 
against pneumococcal infection in humans. 
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5.1. Introduction 
Generally, leucocytes and epithelial cells can produce cytokines that promote cell 
recruitment and activation of host immune response in infected tissues (Hirst et al. 
2004).  
T helper 17 (Th17) cells, a CD4+T cell subset, produce several cytokines including 
IL-17A, IL-17F and IL-22. It is thought that these are potent pro-inflammatory 
cytokines and have an important role to clear extracellular pathogens. IL-17A is 
considered to mediate the recruitment of neutrophils to inflammation tissue that is 
followed by a release of chemokines and metalloproteinases from several tissues 
(Bettelli et al. 2008; Lee et al. 2010) because of the induction of antimicrobial 
peptides, including lipocalin-2, Reg3γ, β-defensins, and calprotectin (Blaschitz & 
Raffatellu 2010; Ishigame et al. 2009; Zheng et al. 2008), IL17A, IL17F and IL22 
contribute to control the dissemination of pathogens form mucosal tissues and that 
becomes apparent during colonic infection with C. rodentium, and has the 
capability to control the severity of gut pathology (Zheng et al. 2008). Furthermore, 
these cytokines can be expressed in response to mucosal infections of bacteria 
and fungi such as K. pneumoniae infection in the lung, C. rodentium and S. 
typhimurium infection in the gut and Candida albicans infection of the oral cavity 
(Dubin & Kolls 2008).  
Upon naive T cell activation with TGF-β, they can differentiate into Treg cells with 
high expression of Foxp3. However, synergy of TGF-β with IL6, promotes the cells 
to differentiate into Th17 with high expression of R0Rγt (Bettelli et al. 2006; 
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Mangan et al. 2006). The expression of CD25 and Foxp3 in inducible Treg cells 
could be up-regulated by signalling pathways which are initiated by TCR activation, 
co-stimulatory molecules, IL-2R, programmed death ligand 1 (PDL1) and TGF-β 
receptor (Francisco et al. 2009; Zhang & Zhao 2007). Treg cells can be 
differentiated from naïve T cells or expanded from the pre-existing Treg cells. 
Inducible Treg cells are generally considered antigen specific (Chatenoud 2011). It 
has been suggested by Fantini that TGF-β can directly induce the expression of 
Foxp3 through binding to inhibitory Smad 7 promoter in order to switch off its 
expression. A feedback regulation of TGF-β signalling may be induced and as a 
consequence Foxp3 accumulates and then promotes the conversion of Treg cells 
from T cells (Fantini et al. 2004).     
In the previous chapters, it has been shown that there were significant numbers of 
Th17 and Treg in adenotonsillar tissue, and pneumococcal protein antigens 
including pneumolysin could activate these tonsillar Th17 and Treg. It is 
hypothesised that pneumococcal protein antigens may induce Th17 and Treg from 
naïve T cells which may contribute to the accumulation of these cells in human 
NALT due to previous colonisation of pneumococcus. 
 
5.2.  Aims of study 
In this chapter it has been sought to examine: 
1- Whether pneumococcal proteins such as pneumolysin or its derivatives 
induce Th17 and Treg cells from naïve T cells in human NALT, and 
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2- What cytokines promote the induction of Th17 and Treg cells in NALT? 
 
5.3.  Design of experiment 
Tonsillar MNC are depleted of activated and memory T cells by CD45RO+ cell 
depletion (so only naïve T and non-T cell populations remaining), and CD25+ cell 
depletion (Treg depletion), followed by stimulation with pneumococcal culture 
supernatant (CCS) derived from wild-type (wt), CbpA- or Ply- strains, or by purified 
recombinant pneumolysin (Ply) and its toxoid (PdB) antigens for 7 days. Various 
cytokines are added to test for the induction of Th17 cells. The induction of Treg 
cells will be evaluated as well in the presence or absence of TGF-β. The response 
of Th17 cells following stimulation will be assessed by measurement of IL-17A, IL-
17F and IL-22 by ELISA and by intracellular cytokine staining followed by 
flowcytometry. Treg cell response following stimulation will be evaluated by 
analysis of expression of Foxp3, CD25 and CTLA-4. 
 
5.3.1. Human subjects and samples  
Tonsillar tissue samples were obtained from children aged between 2-16 years 
who had tonsillectomy. Individuals who were on antibiotics within 3 weeks prior to 
the operation and who had serious infection or immunodeficiency were excluded 
from the study. Informed consent was obtained from children’s parents or 
custodian in each case. 
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5.3.2. Pneumococcal culture supernatant 
Pneumococcal concentrated culture supernatant (pneumococcal CCS) was 
prepared from Streptococcus pneumoniae encapsulated type 2 strain D39 and 
was used in this project for cell stimulation.  CCS from Isogenic strains including 
choline binding protein A deficient mutant (CbpA-), and pneumolysin-deficient 
mutant (Ply-) were also tested. Tonsillar MNC depleted of activated and memory T 
cells were stimulated by these pneumococcal CCS preparations for 7 days with or 
without exogenous cytokines, followed by analysis of the frequencies of Th17 and 
Treg and related cytokines.     
 
5.3.3. Purified pneumococcal protein antigens  
Recombinant proteins including pneumolysin (rPly) and PdB txoid (W433F). rPly 
has a strong haemolytic activity, whereas the PdB antigen is a toxoid and a 
derivative of pneumolysin with a point mutation of amino acid Trp433-Phe which 
reduces the haemolytic activity to approximately 1% without affecting antigenicity 
(Palaniappan et al. 2005; Paton et al. 1991). The endotoxin levels of the 
recombinant proteins were < 0.01ng/µg of protein, as determined by the Limulus 
assay (Zhang et al. 2006a). A sublytic concentration of 50ng/ml of rPly and 
0.25µg/ml of PdB were used for cell stimulation. The induction of Treg and Th17 
cells was determined on day 7.   
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5.3.4. Depletion of CD45RO+ and CD25+ cells from tonsillar MNCs 
In this study, cellular depletion of CD45RO+ (activated and memory T cells) cells 
and CD25+ cell depletion (Treg depletion) were performed using magnetic cell 
sorting (MACS) according to the instructions of the manufacturer (Miltenyi Biotec). 
Both CD45RO+ cells and/or CD25+ cells were depleted from tonsillar mononuclear 
cells (TMNCs) population in some experiments, eg. for induction of Tregs. To 
deplete both CD25+ and CD45RO+ for Treg induction experiments, the 
appropriate amount of beads was added together at the same time to obtain 
CD25- CD45RO- population (MNC containing naïve T cell). The efficiency of cell 
depletion for CD45RO or CD25 cells were >96%.     
  
5.3.5. Induction of Th17 cells from naïve cells 
CD45RO-depleted MNCs were used and cultured for 7 days in the medium alone 
or with the presence of different combination of cytokines, and pneumococcal 
stimulants, before analysis of Th17 frequency. The optimal concentrations of 
cytokines were determined (i.e. 50ng/ml of IL-21 and 50ng/ml of IL1-beta and 
2.5ng/ml of TGF-β) and these were used in the cell culture with or without antigens 
(all recombinant cytokines were from R & D system and doses optimized). Also, 
controls including in medium alone or with cytokine alone, were used. On day 7, 
the cell culture supernatants were collected and stored in the freezer at -80°C for 
further analysis by ELISA techniques to measure the level of IL17. Also, Phorbol 
myristate acetate (PMA), Ionomycin (Ion) and brefeldin A (BFA) were added to the 
cells and incubated for another 5 hours in the incubator. The cells were harvested 
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and the plate was washed with a cold buffer (BSA/PBS 0.02%) and transferred into 
the new eppendorf tubes for intracellular staining which was described previously. 
	  
5.3.6. ELISA for IL17A, IL17F andIL22 measurement 
Human IL-17A, IL17F and IL22 ELISA Ready-SET-Go (eBioscience, UK) were 
used following manufacturer’s instructions for determination of the level of these 
cytokines in cell culture supernatants following stimulation. Detailed procedures 
were described in materials and methods’ chapter (see chapter 2). Briefly, ELISA 
plate was coated with 100µl/well of capture antibody for overnight incubation at 
4°C. The plate was washed and then blocked for one hour. Appropriate diluted 
samples (1:10 for IL17A and IL17F; 1:40 for IL22) were added to the appropriate 
wells and incubated for 2 hr. After washing the plate, detection antibody was 
added into the wells and incubated for 1 hour. Avidin-horse radish peroxidase 
(HRP) was added and incubated for 30 minutes. Substrate solution was added and 
incubated at RT for 15 min. Finally, 50µl of stop solution (2N H2SO4) was added to 
each well. The plate was read immediately at 450nm using the plate reader (Opsys 
MR, Thermo labsystems, UK). The cytokine concentration (pg/ml) was calculated 
against the standard curve, with the help of microplate analysis software 
DeltasoftPC (Biometallics, Inc., USA). 
 
5.3.7. Induction of Treg cells  
CD25+ and CD45RO+ cell depleted tonsillar MNCs were cultured for 7 days in the 
medium alone or with the addition of TGF-β and pneumococcal stimulants followed 
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by analysis of Treg frequency by flowcytometry. The optimal concentration of TGF-
β was determined and used at 2.5ng/ml. On day 7, the cells were harvested and 
the plate was washed with a cold buffer and intracellular staining was performed 
which was described previously.   
 
5.3.8. Statistical analysis 
Student’s paired t test was performed to evaluate the difference between un-
stimulated and stimulated cells for normally distributed data or Wilcoxon matched-
pairs signed rank test for non-normally distributed data was applied. Pearson’s 
correlation test was used to analyse the correlation between two different factors. 
A p <0.05 was considered statistically significant. Statistical analysis was 
performed using GraphPad Prism software (version 5). 
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5.4.  Results 
5.4.1. Induction of Th17 cells in tonsillar MNC by pneumococcal CCS 
To assess the induction of Th17 in naïve T cell-containing tonsillar MNC, the 
CD45RO+ cell depleted MNC (Figure 5.1.) were stimulated by D39wt 
pneumococcal CCS for 7 days without any exogenous cytokines added then 
followed by the addition of PMA/Ion and BFA for the last 5 hours. Intracellular 
staining of IL17A performed as described in the materials and methods. The mean 
frequency of Th17 was increased to 0.38% compared to 0.20% in medium control 
(Fig.5.2.a, n=6, *p<0.05). The concentrations of IL17A (n=8, *p<0.05) in the cell 
culture supernatants were measured by ELISA and shown to be increased 
following stimulation by D39wt CCS (Fig.5.2.b).   
 
 
 
Chapter 5: Results 
	  
Page	  |	  144	  	  
	  
 
 
 
Figure 5.1 Efficiency of CD45RO+ cell depletion from tonsillar MNC. 
The depletion of CD45RO+ cells from tonsillar MNC was performed by MACS negative 
depletion. Anti-CD4 and -CD45RO anti-human antibodies were used in cell staining. The 
efficiency of CD45RO+ T cell depletion was shown by the disappearance CD45RO+ cells. 
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Figure 5.2 Induction of Th17 cells by D39wt pneumococcal CCS. 
(a) The frequencies of Th17 (n=6) after 7 days of stimulation by D39wt pneumococcal 
CCS (*p<0.05, compared with medium control). Mean+ SEM are shown. Paired-t test was 
used. (b) Cytokine levels of IL17A (n=8, *p<0.05) in tonsillar RO+ cell depleted MNC 
culture supernatant after 7 days of CCS stimulation when compared with medium control. 
Data represent mean+ SEM of cytokine levels (pg/ml) measured by ELISA. 
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5.4.2. The effect of Th17-favouring environment on Th17 induction by D39wt 
pneumococcal CCS 
From above experiments, it was shown the level of Th17 induction by 
pneumococcal CCS stimulation alone to be low. A number of exogenous cytokines 
were then tested in order to amplify Th17 induction. A series of experiments were 
done to optimise the cytokine concentrations and combinations for Th17 induction. 
The optimal cytokines and concentrations were determined at TGF-β (2.5ng/ml), 
IL1-β (50ng/ml) and IL21 (50ng/ml).  There was a significant effect of TGF-β, IL1-β 
and IL21 combination on Th17 induction in the presence of D39wt pneumococcal 
CCS. Stimulation with the cytokines alone did not show a significant increase in 
Th17 numbers. The mean proportion of Th17 cells in total experiments performed 
after stimulation with D39wt increased by two-fold (1.1%) compared with 
unstimulated control 0.5% (Fig.5.3.b, n=17, ***p< 0.001).   
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 (a)  
 
 
 
 
 
 
 
Figure 5.3 Induction of Th17 by D39wt pneumococcal CCS in the presence of 
cytokines. 
Dot plots showing IL17A-producing cells gated for CD4+ T lymphocytes (a). CD45RO+ 
cell-depleted tonsillar MNC were stimulated by pneumo CCS for 7 days followed by 
PMA/Ion for 5 hours. One representative experiment is shown. (b) Mean frequency of 
Th17 cells after stimulation by D39wt CCS was shown (n=17 ***p< 0.001, paired-t test, 
compared with unstimulated control). Mean+ SEM are shown.  
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5.4.3. CbpA- and Ply- mutants derived pneumococcal CCS induced less 
IL17A   production than wild type CCS  
Induction of Th17 cytokine (IL17A) was analysed in CD45RO+ cell-depleted 
tonsillar MNC after 7 days of stimulation with pneumococcal CCS derived from wild 
type (D39wt), or from CbpA- and Ply- mutants in the presence of TGF-β, IL1-β and 
IL21.  As can be seen in Fig.5.4, concentrations of IL17A induced by isogenic 
mutant CCS, CbpA- and Ply- were lower than D39wt CCS (n=8, *p< 0.05, **p< 
0.01).  
 
 
 
 
 
 
 
Figure 5.4 IL17A concentrations induced by CCS from D39wt, CbpA- or Ply- mutant 
strains 
IL-17A was measured after 7 days of stimulation with D39wt, CbpA-, or Ply- CCS in the 
presence of TGF-β, IL1-β and IL21. *p<0.05, **p<0.01, compared to medium control. 
*p<0.05, mutants compared to wild type pneumococcal CCS, n=8. Paired-t test was used. 
Mean+ SEM are shown.  
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5.4.4. Pneumolysin and toxoid (PdB) promote Th17 induction  
Purified recombinant pneumococcal proteins pneumolysin (50ng/ml) and its toxoid 
(PdB: 250 ng/ml)) were cocultured with tonsillar MNC containing naive T cells in 
the presence of TGF-β, IL1-β and IL21. Th17 frequencies were analysed on day 2, 
day 5 and day 7 following stimulation. The Th17 frequencies were shown to 
increase gradually over the course of 7 days (Fig.5.5.).  
PdB and rPly were shown to induce Th17 cells from naive cells in the presence of 
optimal Th17-inducing cytokines (TGF-β, IL1-β and IL21). The increase was shown 
in figure (Fig.5.6.) by both protein antigens rPly, (n=8, **p< 0.01) and PdB (n=8, 
**p< 0.01) compared to unstimulated cells. 
Concentrations of IL17A, IL17F and IL22 were measured in the cell culture 
supernatants after 7 days of stimulation. As can be seen in Fig.5.7, both 
pneumolysin and PdB induced an increase in the concentrations of the 3 
cytokines.  
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Figure 5.5 Time course of Th17 induction by rPly and PdB.  
Tonsillar CD45RO+ cell-depleted MNCs were stimulated by Ply (50ng/ml) and PdB 
(250ng/ml) with TGF-β, IL1-β and IL21 and analysed for Th17 frequency at Day 2, 5     
and 7.  
 
 
 
 
 
 
Figure 5.6 Recombinant pneumolysin and toxoid (PdB) promote Th17 induction. 
Mean frequency of Th17 cells after 7 days of stimulation by rPly (a) and PdB (b) was 
shown (n=8, **p< 0.01, compare with unstimulated control). Mean+ SEM are shown.  
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Figure 5.7 Concentrations of IL17A, 17F and IL22 following stimulation by rPly and 
PdB in the presence of TGF-β, IL1-β and IL21. 
Th17-related cytokines (IL17A, IL17F and IL22) were measured after 7 days of stimulation 
of CD45RO-depleted MNC by rPly and PdB.  Both rPly and PdB were shown to induce 
production of all three cytokines (pg/ml) (*p<0.05, **p<0.01, compared to medium control, 
n=8). Mean+ SEM are shown. 
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5.4.5. Effect of TGF-β, IL1-β and IL21 on the induction of Th17-related 
cytokines - IL17A and IL17F  
Production of Th17-related cytokines (IL17A and IL17F) were analysed in tonsillar 
CD45RO-depleted MNCs culture supernatants after 7 days of stimulation with 
pneumococcal D39wt CCS. Without TGF-β, IL1-β and IL21, pneumococcal CCS 
had little effect on the level of IL17A (Fig.5.8.a, n=11, *p< 0.05) and IL17F 
(Fig.5.8.b, n=9). The addition of TGF-β, IL1-β and IL21 into medium alone has little 
effect on the production of IL17A, IL17F, but their effects became apparent after 
stimulation together with pneumococcal CCS. Also, incubating CD45RO+ cell-
depleted MNCs with pneumococcal CCS in the presence of TGF-β, IL1-β and IL21 
induced higher IL17A (**p<0.01) and IL17F (*p<0.05) than stimulation with 
pneumococcal CCS alone.   
However, it has been demonstrated that the addition of TGF-β, IL1-β and IL21 
appeared to reduce the induction of IFN-γ-producing CD4+T cell (Th1) from naïve 
T cells in CD45RO-MNC when analysed by flowcytometry. As can be seen in 
figure 5.9, the addition of these cytokines reduced the mean frequencies of IFN-γ+ 
CD4+ Th1 cells in the presence or absence of pneumococcal CCS stimulation 
(n=6, *p<0.05, **p<0.01, compared to without TGF-β/IL1-β/IL21).  
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Figure 5.8 The effect of TGF-β, IL1-β and IL21 on the production of IL17A and IL17F.  
Cytokine levels of IL17A (a) (n=11) and of IL17F (b) (n=9) in tonsillar CD45RO+ cell 
depleted MNC culture supernatant after 7 days of CCS stimulation with cytokines (+) or 
without (-). Significant differences (*p< 0.05 and **p< 0.01) are shown on graph. Mean+ 
SEM are shown. Paired t test was used.  
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Figure 5.9 The effect of TGF-β, IL1-β and IL21 on IFN-γ producing CD4+ T cells. 
Mean frequency of IFN-γCD4+ T cells in tonsillar CD45RO+ cell depleted MNC after 7 
days of CCS stimulation with cytokines (+) or without (-). Significant differences (*p< 0.05 
and **p< 0.01, n=6) are shown to compare with medium control. Mean+ SEM are shown. 
Paired-t test was used.  
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5.4.6. Induction of Foxp3+Treg cells by pneumococcal CCS with or without 
TGF-β 
To assess the induction of Foxp3+Treg cells, CD45RO+ and CD25+ cell depleted 
tonsillar MNC (Fig.5.10.a) were stimulated by D39wt pneumococcal CCS for 7 
days with (+) or without (-) TGF-β added. Intracellular staining of Foxp3 was 
performed as described in the materials and methods. There was a gradual 
increase in Treg cells numbers after stimulation with pneumococcal CCS and that 
was associated with TGF-β concentrations (Fig.5.10.b).  
As can be seen in Fig.5.11, in the presence of TGF-β, Treg cell numbers were 
significantly elevated by pneumococcal CCS (n=18, ***p<0.001, compared to 
unstimulated cells). In the absence of TGF-β, there was a small increase in the 
mean percentage of Foxp3+Treg cells (n=7, *p< 0.05, compared to unstimulated 
cells).  
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Figure 5.10 Efficiency of CD45RO+ CD25+ cell depletion from tonsillar MNC.  
The depletion of both CD45R0+ and CD25+ cells from tonsillar MNC was performed by 
MACS negative depletion. The cells were stained with CD4, CD45RO, CD25, Foxp3 anti-
human antibodies. The efficiency of CD45RO+ CD25+ cells depletion was shown by the 
disappearance of most CD45RO+CD25+ cells (a). (b)The mean percentage of Treg cells 
was increased gradually with high concentrations of TGF-β after 7 days stimulation by 
pneumococcal CCS.  
0 2.5 5 10
0
5
10
15
20
**
(b)
TGF-beta (ng/ml)
%
 T
re
g 
ce
lls
Chapter 5: Results 
	  
Page	  |	  157	  	  
	  
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11 Effect of TGF-β on frequency of Foxp3+ Treg cells.  
Density plot shows expression of Foxp3 in Treg cells gated for CD4+ T lymphocytes in 
one representative experiment (a). Mean frequency of Foxp3+Treg cells in tonsillar 
CD45RO+ and CD25+ cells depleted MNC after 7 days of CCS stimulation with TGF-β 
(n=18) or without (n=7). Significant differences (*p< 0.05 and ***p< 0.001) are shown to 
compare with medium control. Paired t test was used. **p< 0.01, compare D39wt  CCS + 
TGF-β to D39wt CCS. Unpaired-t test was used.  Mean+ SEM are shown. 
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5.4.7. Induction of Treg by stimulation with pneumococcal CCS derived from 
wild type, Ply- or CbpA- mutants  
The number of Foxp3+ Treg cells was analysed in tonsillar MNC depleted of 
CD25+ and CD45RO+ cells after 7 days of stimulation with pneumococcal D39wt 
CCS or with CbpA- and Ply- CCS. As can be seen in figure 5.12, pneumococcal 
CCS derived from the Ply- and CbpA- mutants induced lower numbers of Foxp3+ 
Treg (n=10, **p<0.01).  
 
  
 
 
 
 
Figure 5.12 Frequencies of tonsillar Treg cells following stimulation by CCS derived 
from D39wt, CbpA- or Ply- mutant strains. 
The mean frequency of Foxp3+Treg cells was measured after 7 day of stimulation with 
D39wt, CbpA-, or Ply- CCS in the presence of TGF-β. ***p<0.001, *p<0.05, compared to 
medium control. **p<0.01, mutants compared to wild type pneumococcal CCS, n=10). 
Paired-t test was used. Mean+ SEM are shown. 
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5.4.8. Effect of pneumolysin and toxoid (PdB) on expression of CTLA4 on 
tonsillar Treg cells  
PdB enhanced the induction of Treg at optimised concentration of 250ng/ml in the 
presence of TGF-β. Samples were collected at day 2, day 5 and day 7 (n=6). As 
seen in figure 5.13, the number of Treg cells gradually increased by time. 
Co-expression of CD152 and Foxp3 was analysed following cell stimulation by 
pneumolysin or PdB in the presence of TGF-β. One representative experiment was 
shown in Fig.5.14.a.  The mean proportion of CD152+Foxp3+ Treg cells after 
stimulation with PdB and Ply increased significantly to around 4.7% and 4.6 
respectively, compared with unstimulated control (Fig.5.14.b, n=14, ***p< 0.001).  
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Figure 5.13 Time course of Treg induction by PdB in tonsillar MNC depleted of 
CD25+and CD45RO+ cells. 
Tonsillar CD45RO+ cell-depleted MNCs were stimulated by PdB (250ng/ml) in the 
presence of TGF-β and analysed for Treg cell frequency at day 2, 5 and 7). 
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Figure 5.14 Pneumolysin and toxoid (PdB) increased the CTLA4 expression in 
tonsillar cells in the presence of TGF-β.  
Density plot shows expression of CTLA4 (CD152) in Foxp3+Treg cells in one 
representative experiment (a). CD25+ and CD45RO+ cell-depleted MNC were stimulated 
by rPly at 50 ng/ml and PdB at 0.25µg/ml (n=14) for 7 days (b). ***p< 0.001, rPly and PdB 
compared with un-stimulated cells (medium control). Mean+ SEM are shown. 
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5.5.  Discussion 
In this study, it has been sought to examine the induction of Th17 from tonsillar 
MNC that were depleted from activated and memory T cells. As our earlier studies 
demonstrated that the majority of Th17 cells were from CD45RO+ CD4+T cells, we 
therefore used CD45RO+ cell depletion to remove activated/memory cells 
containing Th17. The remaining tonsillar MNC containing only naïve T cells were 
then used to study the induction of Th17 by pneumococcal protein antigens in the 
presence of relevant cytokines. We also assessed the effect of TGF-β, IL1-β and 
IL21 on the induction of Th17.  
Naïve and memory cells are mainly two distinct subsets of CD4+ T cells in 
peripheral blood. Memory T cells are capable to mediate a rapid and effective 
response to pathogen. These memory cells are divided into major subsets with 
regard to homing capacities and effector function, CD4+ central memory T (TCM) 
cells and CD4+ effector memory T (TEM,) cells in both humans and mic (Sallusto, 
Geginat & Lanzavecchia 2004; Sallusto et al. 1999). The expression of chemokine 
receptors and adhesion molecules, CCR7 and L-selectin (CD62L) are the main 
characterisation of these memory cell subsets. CCR7 and CD62L are both 
expressed in human TCM cells and home T cell areas of the secondary lymphoid 
organs such as tonsils. TCM cells can proliferate and differentiate into effector cells 
upon antigenic stimulation but have limited effector function (Onoda et al. 2007). 
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However, human TEM cells lack the expression of lymphoid homing receptor, CCR7 
but they heterogeneously express CD62L (Onoda et al. 2007). Also, they express 
inflammatory receptors such as CCR5 and CXCR3 in order to enter the inflamed 
peripheral tissues(Qin et al. 1998). In terms of distribution, these cells are mainly 
localised in the lung, liver and gut (Campbell et al. 2001). TEM cells have much 
ability to differentiate and polarize than TCM and produce effector cytokines 
following antigenic stimulation which leads to immediate immune protection 
(Lanzavecchia & Sallusto 2000; Onoda et al. 2007). 
The induction of Th17 in CD45RO- MNC T cells was assessed by co-incubation 
with D39wt pneumococcal CCS with or without exogenous cytokines. Stimulation 
by pneumococcal CCS induced a small increase in Th17 cells. The results were 
consistent with IL17A concentrations measured in culture supernatants (Fig. 5.1).  
With the addition of cytokines including TGF-β, IL1-β and IL21, Th17 numbers 
were significantly higher compared to stimulation by pneumococcal CCS alone, 
supporting the role of the cytokines in promoting Th17. The presence of TGF-β, 
IL1-β and IL21 cytokines alone showed little effect on Th17 induction and on the 
production of IL17A and IL17F, but together with pneumococcal CCS enhanced 
the effect (Fig.5.3.). Furthermore, up-regulation of RORC2 and IL17A mRNA 
expression and differentiation of human Th17 from naive CD4+ T cells can be 
enhanced by IL21 and TGF-β in serum-free medium (Yang et al. 2008). Both 
cytokines can induce the expression of IL23R and RORγt and subsequently 
secretion of IL17A from naive CD4+ T cells (Nurieva et al. 2007; Zhou et al. 2007). 
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However, the combination of IL1-β together with IL23 or IL6 was shown to promote 
the secretion of IL17 by human central memory CD4+ T cells (Yang et al. 2008).  
It was shown that a low concentration of TGF-β was important in the induction of 
Th17 cells from naive cells in the presence of pneumococcal antigens. This is in 
agreement with previous reports in Th17 induction (Manel, Unutmaz & Littman 
2008; Volpe et al. 2008; Yang et al. 2008). Some reports showed that TGF-β may 
downregulate human Th17 cells whereas IL1β, IL23 or IL6 promote Th17 (Acosta-
Rodriguez et al. 2007; Chen et al. 2007; Wilson et al. 2007). The different results 
reported may be related to the observation that TGF-β were used, as we observed 
low concentration promoted Th17 whereas higher concentrations inhibited Th17. 
This finding was consistent with the study carried out by Mills (Mills 2008).  
 
It has been also demonstrated CCS of CbpA- and Ply- mutant strains induced less 
IL17A. Also, purified pneumolysin (rPly) and its toxoid PdB were shown to induce 
Th17 cells in the presence of the cytokines. This suggests pneumococcal proteins 
such as pneumolysin can promote Th17 cells in NALT. These data were consistent 
with our previous finding that pneumolysin domain 4 can promote Th17 
differentiation in the presence of TGF-β and IL21. (Gray et al. 2014).   
Our finding revealed that pneumolysin and PdB could induce the production of 
Th17-signature cytokines (IL17A, IL17F and IL122). It has been suggested that 
these cytokines are crucial mediators of mucosal defence (Aujla & Kolls 2009). 
Moffitt et al. has demonstrated that IL17A was elicited from splenocytes in 
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response to several recombinant proteins of pneumococcus and suggested that 
IL17-producing cells (Th17) may have the ability to provide protection against 
pneumococcal colonisation (Moffitt, Malley & Lu 2012). 
It is known that IL17A, IL17F and IL22 have a role in immune response against 
many pathogens. These cytokines are able to recruit and activate neutrophils 
through inducing the release of chemo-attractants and G-CSF from epithelial cells 
or fibroblasts. Once these cells are activated then killing are mediated by 
neutrophils. Also, these cytokines have the capability to elicit the expression of 
antimicrobial peptides such as β-defensin 2 and S100 family and the secretion of 
HCO3
–
 along with CCL20 can kill the microbes directly and draw effectors, memory 
T cells and immature dendritic cells (DCs) into site of infected tissue (McAleer & 
Kolls 2011; Wilson et al. 2007). IL22 is reported to be crucial for tissue defences at 
mucosal surface by controlling the microorganisms at the site of infection (Volpe et 
al. 2009). 
The addition of cytokines TGF-β, IL1-β and IL21 was shown to promote Th17 
induction (Fig.5.8) but appeared to suppress the induction of IFN-γ+ Th1 cells 
(Fig.5.9). This was in agreement with the previous reports (Yang et al. 2008) 
(Hebel et al. 2011) that showed IL21 and IL1-β can significantly induce the 
production of IFN-γ from human naive T cells whereas the addition of TGF-
β/IL21/IL1-β inhibit the production of IFN-γ and promote the induction of Th17 
cells. Findings herein are also consistent with that induction of Th17 by TGF-
β/IL21/IL1-β was associated with decreased secretion of IFN-γ through 
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suppressing the expression of T-bet and Th1 development (Annunziato et al. 2008; 
Volpe et al. 2008; Yang et al. 2008). Induction of Th17 just expressing IL17 was 
shown to result from TGF-β-polarising treatment, whilst Th17 cells secreting IL17A 
and IFN-γ+ were shown in the absence of TGF-β (Hakemi et al. 2011; Valmori et 
al. 2010).    
Tonsillar MNC depleted of CD45RO+ and CD25+ cells were used to test for the 
ability of pneumococcal CCS stimulation or proteins to induce Foxp3+Tregs, in the 
presence or absence of TGF-β. It has been shown that Treg cells frequencies 
were associated with higher concentrations of TGF-β following pneumococcal CCS 
(Fig.5.10.b). As can be seen in Fig.5.11, stimulation by D39wt pneumococcal CCS 
induced a marked increase in Treg in the presence of TGF-β, and that was 
significantly higher than stimulation by either CCS or TGF-β alone.  
 
It has been shown that stimulation by pneumococcal CCS derived from Ply- and 
CbpA- mutant strains appeared to induce less Foxp3+Treg cells compared wild 
type CCS. This suggests that Ply and CbpA proteins may play a role in induction of 
Treg. It has been shown the induction of Treg from naive T cells requires TGF-β 
and TCR stimulation and both are needed for the induction (Chen et al. 2003).  
The expression of CTLA-4 in Treg cells was also shown to be upregulated by 
stimulation of D39wt CCS and TGF-β. CTLA is an important marker for Treg 
function in regulating an immune response; therefore the increased Treg may have 
upregulated inhibitory activity following stimulation by pneumococcal antigens. It 
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has been demonstrated in mice that TGF-β possessed the potential to generate 
CD4+CD25+Foxp3+ Treg population from CD4+CD25-Foxp3- non-Tregs and the 
generated cells showed a high level of CTLA-4 and Foxp3 expression. Likewise, in 
humans the increased numbers of Foxp3+ Treg cells with CD25high and CTLA-4 
were shown following stimulation of human CD4+ T cells by TGF-β (Zheng et al. 
2002). The secretion of IL35 by Treg cells induces Treg population from 
conventional T cells, named iTreg35 and that leads to IL35 mediated suppression 
(Collison et al. 2010). According to Chaturvedi et al., human Treg cells have the 
capability to express and secrete IL35 and that has a significance role in the 
suppressive activity on T cells when compared to IL10 and TGF-b. This was 
confirmed by the addition of neutralising antibodies and the effective suppression 
by Treg was mediated by IL35 but not with IL10 and TGF-b (Chaturvedi et al. 
2011). Taken together, TGF-β, and IL35 have an important role in Treg induction in 
humans, which leads to suppress other T cell population. 
 
5.6. Summary 
It has been shown that pneumococcal CCS stimulation induced Th17 and Treg in 
tonsillar cells in the presence of some cytokines. Pneumococcal protein antigens 
including Ply and CbpA may contribute to the induction of both cells. A 
combination of TGF-β, IL21 and IL1 β may provide a favourable cytokine 
environment for Th17 induction from naïve cells in tonsillar tissue. Also, TGF-β 
appeared to be crucial in Treg induction. Consequently, the induction of Th17 or 
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Treg in human tonsillar tissue may be common in humans especially in children 
during natural infection/carriage, and the balance of the two may determine the 
clearance or carriage of pneumococcus.   
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6.1. Discussion 
Globally, Streptococcus pneumoniae (pneumococcus) is a major cause of 
morbidity and mortality in humans among risk groups (O'Brien et al. 2009). 
Pneumococcus is a common cause of respiratory tract infections in both 
developing and developed countries. Annually, pneumococcal diseases are 
responsible for around 1 million deaths of young children under 5 years (Obaro & 
Adegbola 2002). Healthy individuals can be colonized in the upper respiratory tract 
by pneumococcus and nasopharynx is the main reservoir for S. pneumoniae. 
Colonisation with pneumococcus in the nasopharnyx is very common in infants, up 
to 90% in some populations (Bogaert, De Groot & Hermans 2004). 
It was hypothesised that mucosal Treg and Th17 cells in NALT may play a crucial 
role in mediating the persistence or clearance of pneumococcal carriage in human 
nasopharynx. Thus, in this study we investigated the association of human 
mucosal Th17 cells and Treg cells with pneumococcus through analysing the 
numbers of Th17 and Treg cells in tonsillar tissues of both adults and children; and 
their relationship to pneumococcal carriage status.   
It has been shown that the frequency of Treg and Th17 cells in tonsillar tissue in 
each subject was generally higher than in peripheral blood. This may suggest the 
mucosal compartment within human nasopharynx develops a higher number of 
Treg due to the exposure of microorganisms than in peripheral blood, and also 
suggest the presence of antigen-specific (inducible) Treg in human NALT. Also it is 
likely that the mucosal Th17 in human NALT were primed largely by previous 
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microbial infection/colonisations in the nasopharynx. Data in previous work showed 
that the Th17 detected in NALT tissues were primarily memory Th17 cells, as the 
Th17 cells in tonsillar MNC were abrogated following depletion of CD45RO+ T 
cells (Gray et al. 2014).   
Furthermore, it has been shown that there was a difference between adults and 
children in the frequency of Treg and Th17 in tonsillar tissues. The frequencies of 
tonsillar Treg of children were generally higher than in adults, and there appeared 
an age-associated decrease in tonsillar Treg numbers (Fig.3.1). However, the 
frequency of tonsillar Th17 appeared to increase with age. There appeared to be a 
positive correlation between the ratio of Th17/Treg in tonsillar tissues and ages. 
The mean ratio of tonsillar Th17/Treg MNC was shown to be significantly higher in 
adults than in children (Fig 3.9). Overall, younger children <10 years were shown 
to have higher Treg numbers than those subjects >10 years. This would support 
the hypothesis that extensive exposures to microorganisms in childhood are 
associated with the induction of Treg. It may be that the local colonisation with 
microorganisms could induce antigen-specific Treg cells thus leading to high 
numbers of Treg in NALT tissues, and this may contribute to the 
persistence/carriage of specific microbes (Zhang et al. 2011). Whilst numbers of 
tonsillar Th17 in younger children <10 were significantly lower than those subjects 
>10 years (Fig 3.7.).  
Pneumococcal carriage is common in children especially in younger children. With 
increasing age, pneumococcal carriage rate gradually decreases (Bogaert, De 
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Groot & Hermans 2004; Granat et al. 2009). During carriage, antigen-specific 
immunity develops to protect against the subsequent colonisation (Cohen et al. 
2011; Richards et al. 2010; Zhang, Clarke & Weiser 2009). It has been 
hypothesised that mucosal Th17 in the nasopharynx may play a role in the age 
associated decrease in pneumococcal carriage because the human nasopharynx 
is a site of colonisation of many microorganisms that may prime for Th17 in NALT. 
There appeared to be a difference in the frequency of Treg cells which was higher 
in culture-positive than in culture-negative children and it has been showen earlier 
that mucosal Treg frequency also appeared to be associated with pneumococcal 
carriage rate. Indeed, the mean ratio of Th17/Treg in NALT was shown to be 
higher in culture-negative children than culture-positive children. These suggest 
that the induction/promotion of Treg in tonsillar tissues may be contributed by 
pneumococcal colonisation in the nasopharynx. Also, the delayed clearance or 
persistence of pneumococcal colonisation in children may occur in the existence of 
Treg cells (Zhang et al. 2011). This was in agreement with another study which 
revealed that the pneumococcal response at mucosal surface was highly regulated 
by the presence of Treg cells, and thus, it prolonged the nasopharyngeal 
colonisation (Glennie et al. 2012). On the other hand, the ratio of Th17/Treg may 
be a crucial determinant of pneumococcal clearance. This finding would support 
that a higher Th17/Treg ratio in NALT contributes to clearance of mucosal carriage 
of pneumococcus. There results are consistent with the hypothesis that Th17 may 
play a role in mucosal defence against microbial infection (Wu et al. 2007). 
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It is unclear what components of pneumococcus contribute to the activation of 
Treg and Th17 cells in tonsillar tissue. It would be useful to identify what 
pneumococcal components activate Treg or Th17 cells as that may add important 
information to novel vaccination strategies against pneumococcal infection. In this 
study, stimulation with pneumococcal CCS wild type (D39wt) was shown to elicit a 
significant increase in Th17 and Foxp3+ Treg number with high level of IL17A and 
TGF-β respectively. Our previous work suggested that there were memory/effector 
Th17 and Treg within the adenotonsillar tissue (Gray et al. 2014; Zhang et al. 
2011), as specific stimulation by pneumococcal antigens could activate these cells. 
Repeated exposure to pneumococcus in childhood may contribute to the increase 
in inducible Treg cells in early childhood, and that may delay the induction of Th17 
and contribute to the persistence of pneumococcal carriage. Therefore, priming for 
Th17 cells in early life that may inhibit induction of Treg in NALT might be an 
attractive vaccination strategy against pneumococcal colonisation (Gray et al. 
2014).  
In contrast, pneumococcal CCS derived from wild type pneumococcus, the CCS 
from mutant strains (Ply- and CbpA-) were shown to elicit a lower increase in Treg 
and Th17 frequencies than wild type CCS. Moreover, these isogenic mutant 
strains appeared to induce less Foxp3+Treg cells (with TGF-β) and IL17A (with 
IL21/IL1-β/ TGF-β) compared to wild type CCS. These results suggest that 
pneumococcal Ply and CbpA proteins may contribute to the activation of Foxp3+ 
Treg and Th17 cells in tonsillar MNCs and also may play a role in their induction 
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from naive T cells. Our findings demonstrated that purified individual 
pneumococcal protein antigens such as rPly, PdB and CBP were capable to prime 
and activate Foxp3+Treg and Th17 cells which were enriched in adenotonsillar 
tissue. These results support the presence of antigen-specific Treg and Th17 in 
human NALT, and they may play an important role in the modulation of 
pneumococcal carriage or clearance.  
In addition, purified pneumolysin (rPly) and its toxoid PdB were shown to induce 
Th17 cells and Th17-signature cytokines (IL17A, IL17F and IL122) in the presence 
of Th17-polarising cytokines. This suggests pneumococcal proteins such as 
pneumolysin can promote the induction of Th17 cells in NALT. These data were 
consistent with our previous finding that pneumolysin domain 4 can promote Th17 
differentiation in the presence of TGF-β and IL21. (Gray et al. 2014). It has been 
suggested that these cytokines are crucial mediators of mucosal defence (Aujla & 
Kolls 2009). Moffitt et al. has demonstrated that IL17A was elicited from 
splenocytes in response to several recombinant proteins of pneumococcus and 
suggested that IL17-producing cells (Th17) may have the ability to provide 
protection against pneumococcal colonisation (Moffitt, Malley & Lu 2012). Studies 
in mice showed that the response of IL-17A following immunisation is associated 
with decreased pneumococcal carriage which supports a critical role of IL17A in 
pneumococcal clearance (Lu et al. 2009). The secretion of Th17 cytokines in 
human tonsillar tissue lead to the recruitment and activation of neutrophils that is 
associated with phagocytic killing (Lu et al. 2009), and likely act through the 
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induction of pro-inflammatory mediators such as G-CSF and chemokines from 
epithelial cells (Aujla, Dubin & Kolls 2007b; Kolls & Linden 2004). Also, IL17A, 
IL17F and IL22 have the capability to elicit the expression of antimicrobial peptides 
along with CCL20 which can control the pathogens directly and draw effector T 
cells, memory T cells and immature dendritic cells (DCs) into site of infected tissue 
(McAleer & Kolls 2011; Wilson et al. 2007). IL22 is reported to be crucial for tissue 
defences at mucosal surface by controlling the microorganisms at the site of 
infection (Volpe et al. 2009). 
As it was demonstrated that the majority of Th17 cells were from CD45RO+ 
CD4+T cells, we therefore used CD45RO+ cell depletion to remove 
activated/memory cells containing Th17 to study the induction of Th17 in NALT. 
Stimulation by pneumococcal CCS induced a small increase in Th17 cells and 
their relevant cytokine (IL17A and IL17F) from tonsillar MNC containing naïve 
cells. However, with the addition of cytokines including TGF-β, IL1-β and IL21, 
results showed Th17 numbers were significantly higher compared to stimulation by 
pneumococcal CCS alone, supporting the role of the cytokines in promoting Th17. 
In the presence of TGF-β, the ability of pneumococcal CCS stimulation was shown 
to induce marked numbers of Foxp3+Tregs from tonsillar MNC depleted of 
CD45RO+ and CD25+ cells. The expression of CTLA-4 in Treg cells was also 
shown to be upregulated by stimulation of D39wt CCS or pneumococcal protein 
antigens in the presence of TGF-β. It has been demonstrated in mice that TGF-β 
possessed the potential to generate CD4+CD25+Foxp3+ Treg population from 
CD4+CD25-Foxp3- non-Tregs and the generated cells showed a high level of 
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CTLA-4 and Foxp3 expressions. Likewise, in humans the increased numbers of 
Foxp3+ Treg cells with CD25high and CTLA-4 were shown following stimulation of 
human CD4+ T cells by TGF-β (Zheng et al. 2002). 
Results presented here have concluded that pneumococcal proteins including Ply, 
PdB and CBP are immunogenic and capable to activate antigen-specific Th17 and 
Treg cells, and thus might be implicated for vaccine development. In the future, it is 
required to consider novel approaches that can be used to mimic natural immunity 
and provide mucosal protection. Immune response induced by vaccine 
immunisation should provide an effective mucosal protection against all serotypes 
of pneumococcus during colonisation as well as invasive disease. Candidate 
vaccines for preventing nasopharyngeal colonisation should drive the mucosal 
response toward Th17 cells rather than Treg cells. A Th17-predominant response 
over a Treg cell response would likely lead to a reduction or clearance of 
colonisation. A reduction or clearance of pneumococcal carriage may reduce the 
transmission of pneumococcus and leads to a reduction of pneumococcal invasive 
infections.  
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6.2. Conclusion 
Results presented in this study suggest that there were marked numbers of Th17 
and Treg cells in tonsillar tissues which may play an important role in mediating 
nasopharyngeal carriage of pneumococcus.  Pneumococcal simulation of tonsillar 
cells elicited a significant increase in numbers of both Th17 and Foxp3+ Treg cells 
suggesting the presence of antigen-specific Th17 and Treg in human NALT, 
presumably primed by previous colonisation of pneumococcus. In general, the 
ratio of tonsillar Th17/Treg was shown to increase with age and shown to be 
higher in pneumococcal culture-negative children than in culture-positive children.  
It suggests the balance of Th17/Treg in nasopharynx-associated lymphoid tissue is 
a critical determinant of pneumococcal clearance or persistence/carriage in human 
nasopharynx. Moreover, results from this study provided supporting evidence that 
pneumococcal proteins including pneumolysin, its toxoid and choline binding 
proteins may contribute to the induction and/or activation of Th17 and Treg cells in 
human NALT, and that may contribute to the modulation of pneumococcal carriage 
or clearance in human nasopharynx.  
A combination of different pneumococcal proteins including the use of pneumolysin 
toxoid/derivatives is currently being studied in pneumococcal protein-based 
vaccines. This implication should be performed in mouse models but instead of 
using one single pneumococcal protein, it very important to use two or three 
different pneumococcal proteins beside pneumolysin protein. Also, the use of the 
proper adjuvant in vaccine is considered very crucial for optimal response. The 
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ability of protein-based vaccines to induce an optimal T cell response at the 
mucosal level including a significant Th17 response may offer in near future 
effective vaccination strategies against pneumococcal diseases. Understanding 
the natural immune response to these protein antigens may have important 
implications in novel vaccination strategies such as mucosal vaccines against 
pneumococcal infection in humans.  
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Appendices 
 
Appendix-1: Preparation of different media and buffers 
	  
Skim milk, Tryptone, Glucose, and Glycerol Transport Medium (STGG) 
STGG transport medium was prepared using the following procedure: 
1. 40 ml 10% milk was prepared by adding 4 g skimmed milk powder (Oxoid, 
UK) into 40 ml dH2O, then it was autoclaved in 121°C for 5 minutes. 
2. In another sterile 500 ml glass bottle, 6 ml Tryptone soya broth (Oxoid, UK), 
2.2 ml 45% D-Glucose solution (Sigma Aldrich, UK), 20 ml Glycerol (Sigma 
Aldrich, UK) were taken. Then, 131.8 ml dH2O was added into the bottle to 
make the final volume 160 ml.  
3. After that the bottle with ingredients was autoclaved in 121°C for 10 minutes  
4. Then the previously prepared sterile 40 ml of 10% skimmed milk was added 
into the 500 ml bottle to make 200 ml 2% skimmed milk medium. 
5. The skimmed milk was mixed thoroughly with the other ingredients by 
gentle shaking.  
6. Aliquot of 1.0 ml media was prepared into 1.5 ml screw-capped vials. 
7. The tubes were then kept in a refrigerator (2-8°C) until used for nasal swab 
inoculation. 
8. For sterility of the STGG medium, quality control test was performed 
periodically by plating a full loop of a homogenized vial from each lot onto a 
blood agar plate, then incubating the plate at 37°C overnight. If growth of 
any organism was suspected then the lot was discarded 
	  
Todd-Hewitt Broth (THB) 
Todd-Hewitt Broth with 0.5% yeast extract was prepared using the following 
procedure. 
1. 36.4 g of Todd-Hewitt Broth (Oxoid, Basingstoke, UK) and 5 g of yeast 
extract were taken into a sterile 1 litre glass bottle. 
2. 1000 ml of distilled water was added to the bottle and mixed thoroughly, 
until all components were dissolved completely. 
3. After autoclaving at 115°C for 10 minutes, the bottle kept in the cold room 
until used for growing bacteria. 
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Laemmli Reducing Buffer 
 
For western Blot sample dilution, 10.0 ml Laemmli reducing Buffer was prepared 
using following recipe: 
 
1.25 ml  0.5 M Tris pH 6.8  
2.0 ml  10% (w/v) SDS  
0.30 ml  0.5% Bromphenol Blue  
2.50 ml  Glycerol  
3.55 ml dH2O  
0.50 ml  β-mercaptoethanol (50 µl for each 0.95 ml) 
 
 
10x Tris Buffered Saline (TBS) pH 7.4 
 
1. 1 litre 10x TBS was prepared using the following recipe: 
 
 30 g   Tris 
 80 g   NaCl 
 2 g   KCl 
 900 ml  dH2O 
 
2. Then pH was adjusted to 7.4 by adding concentrated HCl, and 
measurement with a pH meter. When the pH is adjusted then the bottle was 
topped-up to 1 litre by adding dH2O. 
 
 
Running buffer for Western Blot 
50 ml (10X Tris-SDS) buffer was added to 450 ml dH2O       
 
Resolving gel preparation 
100 ml resolving gel was prepared using the following recipe:  
40 ml   Protogel     
26 ml   Protogel buffer     
32.9 ml  dH2O      
1 ml    Ammonium persulphate (10 %)   
0.1 ml  TEMED  	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Stacking gel preparation 
10 ml of the stacking gel (4 %) was prepared using the following recipe:  
1.3 ml  Protogel       
2.5 ml    Protogel stacking buffer     
6.1 ml   dH2O        
0.05 ml Ammonium  persulphate (10 %)    
0.1 ml  TEMED   	   	  	  
 
 
ELISA and Western Blot Washing Buffer (PBS/Tween20) 
 
1 litre of Western Blot washing buffer (1xTBS with 0.05% Tween20) was prepared 
using the following recipe: 
 
100 ml  10x TBS   
900 ml  dH2O    
0.5 ml  Tween-20   
 
 
 
10x Phosphate Buffered Saline (PBS) pH 7.4 
 
1. 1 litre of 10x PBS was prepared using the following recipe: 
 
14.4 g  Na2HPO4   
2.4 g   KH2PO4   
80 g   NaCl    
2 g   KCl    
900 ml  dH2O    
 
2. Then pH was adjusted to 7.4 by adding concentrated HCl and measurement 
with a pH meter. The bottle was topped-up to 1 litre by adding deionized 
water. 
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P-Nitrophenyl Phosphate (PNPP) Substrate for ELISA 
 
1 litre of p-nitrophenyl phosphate (PNPP) substrate (1M diethanolamine) 
buffer (pH 9.8) was prepared using the following recipe: 
 
97 ml   Diethanolamine   
800 ml   dH2O     
100 mg   MgCl2   
 
Then the pH was measured and adjusted to 9.8 by adding 10M hydrochloric 
acid. Once the pH is adjusted, dH2O was added to obtain a final volume of 
1000 ml. Thereafter, the buffer was transferred back to the bottle and stored 
at 4°C. Finally, the substrate was prepared by dissolving p-nitrophenyl 
phosphate disodium salt (5mg) tablet into 5 ml of substrate buffer to give a 
PNPP concentration of 1 mg/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  Page	  |	  219	  	  
	  
Appendix-2: List of publications 
	  
Scientific papers  
	  
1- Zhang, Q., Leong, S.C., McNamara, P., Mubarak, A., Malley, R., Finn, A. 
2011. Characterisation of Regulatory T Cells in Nasal Associated Lymphoid 
Tissue in Children: Relationships with Pneumococcal Ccolonisation. PLoS 
Pathog 7(8): e1002175. doi: 10.1371/journal.ppat.1002175 
 
2- Gray, C., Ahmed, M.S., Mubarak, A., Kasbekar, A. V., Derbyshire, S., 
McCormick, M. S., Mughal, M. K., McNamara, P. S., Mitchell, T., Zhang, Q. 
2013. Activation of memory Th17 cells by domain 4 pneumolysin in human 
nasal-associated lymphoid tissue and its association with pneumococcal 
carriage. Mucosal Immunology, 7 (3,  #4). pp. 705-717. 
 
 
Accepted abstracts 
 
1- Mubarak, A., Kasbekar, A., McCormick, M., Beer, H., Cunliffe, N., 
McNamara, P. S., and Zhang, Q. (2012) Association of Th17/Treg in NALT 
with pneumococcal carriage in children and adults. Immunology, 137 
(Suppl. 1), 185-772. 
 
2- Mubarak, A. S., Kasbekar, A., McCormick, M., Beer, H., Cunliffe, N., 
McNamara, P. S., and Zhang, Q. (2013) Induction of Th17 in nasopharynx-
associated lymphoid tissue by pneumococcus and the effect of cytokines. 
Immunology, 140 (Suppl. 1), 39-184. 
 
3- Rider, A., Mubarak, A., Derbyshire, S., McNamara, P., Kadioglu, A., and 
Zhang, Q. (2013) Induction of T regulatory cells by streptococcus 
pneumonia. Immunology, 140 (Suppl. 1), 39-184. 
 
4- Mubarak, A., Casey, V., Upile, C., Sharma, R., Beer, H., McCormick, M., 
Ahmed, M., McNamara, P., and Zhang, Q. (2014) Relationship between 
Th17 and Treg in nasopharynx-associated lymphoid tissue and their 
association with age and pneumococcal carriage in humans. Immunology, 
143 (Suppl. 1), 12-42. 
